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INTRODUCTION AND OVERVIEW OF THE THESIS 
Background 
The study of ventricular function has been addressed by several noninvasive and 
invasive teclmiques. Among the first, echocardiography and nuclear imaging 
have gained a widespread popularity and a good profile. In patticular 
echocardiography has shown a widespread availability, is low-cost and safe (I). 
The introduction of sympathetic stressors, such as dobutamine, in combination 
with echocardiography, has significantly increased the potential of 
echocardigraphy in detecting' functional response of the myocardium. Tlris is 
especially so in the case of myocardial viability and ischemia (2-6). However, a 
major Iinritation of echocardiography remains its dependence on subjective 
operator interpretation. It requires an extensive learning curve on the part of the 
interpreter in evaluating the stressor effects on the dynamic response of 
ventricular function (7). Dobutamine stress echocardiography was the stressor 
selected in the present thesis and we addressed the problem of reducing its 
subjectivity, by introducing new quantitative tecluriques (8-9). So far, numerous 
attempts tried to quantify stress echocardiography, however this is beyond the 
goal of the present thesis. Examples are: centreline method in combination with 
invasive catheterization perfonncd during exercise testing (10), automated edge 
detection applied to endocardial border contour detection (II). Recently Doppler 
tissue imaging addressed the task of measuring the myocardial tissue dynanrics. 
In our opitrion the introduction of Doppler tissue imagitlg and other quantitative 
techniques became recently feasible by software developments, such as the 
Digital Imaging and Communication in Medicine (mCOM 3) system for 
imaging digitalization. An ideal goal regarding this would be the development of 
partially automatcd echocardiography. 
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Aim of the present thesis 
This thesis is an insight investigation in some recently developed noninvasive 
imaging advances to quantitatively assess left or right ventricular function. The 
focus is on dobutamine stress echocardiography, with some reference to a 
recently developed nuclear imaging technique: 99mTechnetium-tetrofosmin-18F-
fluorodeoxyglucose-single photon emission computcd tomography (FDG-
SPECT) (12). Among many attempts to pass from a subjective and qualitative to 
an objective and quantitative evaluation of ventricular function we analyzed 
Doppler tissue imaging. Left vcntricular ftmction, as stimulated by dobutaminc, 
was studied by applying Doppler tissue imaging as a test on myocardial 
ischemia and contractile reserve, the latter being even more subjected to inter-
observer variability, than the assessment of myocardial ischemia. 
Short overview of the dobutamine stress echoca]'(liography criteria used in 
the present thesis 
Dobutamine stress echocardiography is an established imaging technique. Our 
protocol complied with the standards of the American Society of 
Echocardiography (13). Dobutamine was intravenously administered with an 
inftlsion rate of 5 and 10 pg/kg/min for 5 min in the case of severe left 
ventricular dysftmction for assessment of contractile reserve, or just 10 
flglkg/min for 3 minutes in the case of normal left ventricular ftmction, 
incrcasing by 10 flg/kg/min every 3 minutes up to a maximum dose of 40 
flg/kg/min for evaluation of myocardial ischemia. In patients not achieving 85% 
of their age and gender predicted maximal heart rate and without evidence of 
myocardial ischemia, atropine was administcred, starting with 0.25 mg 
intravenously and repeated up to a maximum of 2.0 mg within 4 minutes, while 
continuing thc inftlsion of dobutamine (14). 
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We aligned the scoring systems of dobutamine stress echo cardiography and 
FDG-SPECT 
By echo cardiography the left ventricle was divided 1I1 16-segments (13) and 
visually assessed for both systolic wall thickening and inward wall motion. Each 
segment was graded on a 5-point scoring system: I = normo- or hyperkinesis; 2 
= mild hypokinesis; 3 = severe hypokinesis; 4 = akinesis and 5 = dyskinesis; by 
an experienced observer blinded to the reference data. Myocardial viability was 
defined as an improvement, and myocardial ischemia as a worsening of wall 
motion of at least two adjacent ventricular segments at any step of the test, 
unless an akinetic segment at rest became dyskinetic at peak dobutamine stress 
(15). By FDG-SPECT analysis the left ventricle was also divided in 16-
segments, corresponding to the echocardiographic segments, and semi-
quantitatively scored according to the uptake of tetro[osmin and/or FDG using a 
4-points scoring system: 0 = nonnal, 1 = mildly-moderately reduced, 2 = 
severely reduced and 3 = absent uptake. By adopting a similar scoring model [or 
both imaging techniques we optimized the segmental assessment, combining 
myocardial perfusion, metabolic uptake and contraction, with further possibility 
to assign each myocardial segment to a coronmy mtelY field. 
Reduction ofinter-institlltional variability (Chapter 1) 
In order to improve inter-institutional agreement, we adopted newly 
standardized guidelines for imaging and scoring, as derived from our multicentre 
experience (16). Image quality and severity of wall motion abnormalities were 
the strongest predictors of interinstitutional agreement. The variability achieved 
was less than in a similar previous study (7), thus emphasizing the i1l1pOltance of 
improving compliance to guidelines among the operators to improve agreement. 
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Development of Doppler tissue imaging (Chapters 2-3) 
We analyzed velocity colors in either 2D maps and M-mode display by 
reconstructing frame by frame the sequence of color changes along each cardiac 
cycle and each echocardiographic window or M-mode display. This analysis was 
performed off-line by freezing each subsequent frame of each echo view of the 
videotaped itnages. Each color represents a velocity range and a dit'ection of 
motion. Velocities are depicted from red to orange and yellow when moving 
toward the transducer from low to high velocity values respectively. Conversely, 
they are dcpicted from blue to turquoise and green when moving away from the 
transducer. After a period of appropriate training we were able to recognize at a 
glance either in 2D or M-mode the following cardiac phases: isovolumic 
contraction, ejection phase, isovolumic relaxation, early diastole, diastasis and 
late diastole. However, we suffered thc limitation of a qualitative eye-dependent 
approach. In absence of a quantitative software for Doppler tissue imaging, wc 
reduced using pulsed wave Doppler tissue sampling, as the only quantitative 
approach not requit·itlg any customized software (17 -21). 
Quantification of ventricular function by using pulsed wave Doppler tissue 
sampling (Chapters 2-3) 
Pulsed wave Doppler tissue sampling is a Doppler sample volume placed over a 
region of interest within the myocardium to display the con'esponding velocity 
profile over time. Pulsed wave Doppler tissue sampling was performed with the 
Toshiba Powervision Echocardiographic System. The sample volume was used 
in apical echo views. Both electrocardiogram and phonocardiogram were 
sitnultaneously recorded with the pulsed wave Doppler tissue sampling velocity 
profile to obtain a precise timing of the cardiac cycle intervals, in order to 
measure the peak velocity of each interval by pulsed wave Doppler tissue 
sampling. Velocity measurements were made of ejection phase, early and late 
diastole by using an off-line computer assisted drawing system and the velocity 
values were expressed in cm/s. Early/late diastole velocity ratio was also 
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calculated. Fivc consccutive beats were analyzed and mean velocity values 
calculated, in order to minimize the measurement variability determined by 
respiration. Cardiac cycles with extrasystolic, post-extrasystolic beats or any 
disturbance of the rhythm were excluded. Recordings and measurements were 
repcated at baseline, low-dose (l 0 ~lg/kg/min) and peak-dose of dobutamine. 
Quantification of wall motion during dobutamine stress echocardiography 
(Chapters 2-3) 
Quantitative data may be obtained by customized software fi·om colour Doppler 
tissue imaging, however the temporal resolution is limited. In absence of 
customized soihvare, we obtained velocity by using pulsed wave Dopplcr tissue 
sampling. Pulsed wave Doppler tissue sampling velocity values are significantly 
higher than by Doppler tissue imaging color analysis, because pulsed wave 
Doppler tissuc sampling shows the peak velocity profile, while color Doppler 
tissue imaging averages velocity from the modal values (22-23). However, the 
major disadvantage of pulsed wave Doppler tissue sampling is that it requires 
repetitivc sampling of different sites during stress, due to its limited spatial 
resolution. This can cause feasibility problcms whcn perfonncd in multiple sites 
and sequence of cardiac beats during the short time of dobutamine stress 
echocardiography, especially at peak test. Our best criterion of using pulsed 
wave Doppler tissue sampling in apical views by sampling only the basal 
segments and using systolic velocities and their percentage of variations during 
stress echocardiography, was a compromise to optimize spatial and temporal 
resolutions with its fcasibility during dobutamine stress echocardiography. Our 
protocol was confirmed by others (23). We investigated different clinical 
settings of our pulsed wave Doppler tissue sampling protocol applied to 
dobutamine strcss cchocardiography (24-25). 
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Advantages of longitudinal motion assessment by pulsed wave Doppler 
tissue sampling (Chapters 2-3) 
An impOitant advantagc of the pulsed wave Doppler tissue sampling protocol, 
applied to the basal segments of each left ventricular wall in apical views, is the 
amplification effect of longihldinal ventricular velocity assessmcnt (19, 26-27). 
By using pulsed wave Doppler tissue sampling at the basal level of left or right 
ventricular wall in apical echocardiographic unages, the velocity of longihldinal 
displacement may be considered expression of the longihldinal myocardial 
contraction. These longitudinal velocities are higher than inward wall motion 
velocities measured in para-sternal views (23). This amplification effect is 
determined by the vectorial sum of the contraction velocity of each myocardial 
fiber intelposed between the base and apex. The same protocol of pulsed wave 
Doppler tissue sampling was also analyzed in pigs using micro-manometers 
implanted in the sub-endocardial and sub-epicardial layers by Derumeaux et al 
(23). Both endocardial inward wall motion and longihldinal contraction 
contribute equally to ejection fraction (28) and add prognostic information (29). 
A second advantage of this protocol is in reducing the divergence angle of 
longitudulalmotion from the direction of Doppler beam, as both remain almost 
parallel each other. The relative fixation of the cardiac apex, which is used as a 
reference pivotal point, allows evaluation of all the myocardial segments moving 
towards it, thus towards the transducer, without the need of furthcr corrections 
(30-32). The longihldinal approach minimizes the global cardiac translational 
movement, compared to the para-sternal approach and allows the use of the 
mitral annulus as a fixed and reproducible anatomical landmark. Another 
advantage is the highcr temporal resolution of pulsed wave Doppler tissue 
sampling compared to either M-mode or 20 Doppler tissue ul1aging. A further 
advantage of pulsed wave Doppler tissuc sampling is to measure higher vclocity 
values, compared to color Doppler tissue imaging data which arc auto-
correlated, thus averaged from the modal velocities which are lower than the 
velocity of pulsed wave Dopplcr tissue sampling. 
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Pitfalls of pulsed wave Doppler tissue sampling and Doppler tissue imaging 
(Chapters 2-3) 
The angular dependence is the intrinsic main limitation of the Doppler 
technique. When the direction of movement diverges from the interrogating 
Doppler beam more than 20°, the accuracy of the velocity measurements 
becomes not acceptable and when the direction of movement is perpendicular to 
the Doppler beam, no measurement is achievable. A second limitation of 
Doppler tissue imaging is the global cardiac motion, particularly in the para-
sternal views, as it distorts the accurate encoding of myocardial velocities. A 
third limitation is the presence of atiifacts, such as side lobes, as their colour 
coding by Doppler tissue imaging affects the correct evaluation of the 
underlying image. A further limitation is the inability of Doppler tissue imaging 
to completely colour code evety pati of the ventricular wall, especially the walls 
imaged at the border of the echocardiographic sector. A possible explanation 
could be low intensity of the signals reflected from the myocardial backscatters 
(33). Therefore, the best assessment of the ventricular walls is performed when 
they are located in the central part of the sector, because a location close to the 
echocardiographic sector borders is affected by a lower spatial resolution. For 
fmiher details about Doppler tissue imaging teclmique we refer to chapters 2 and 
3. 
Pulsed wave Doppler tissue sampling assessed right ventricular dysfunction 
(Chapter 4) 
Right ventricular shape entangles echocardiographic assessment (34-35). 
Moreover, the visual scoring usually misses the longitudinal component of 
motion (36). Pulsed wave Doppler tissue sampling, applied to the basal segments 
of right ventricular frce wall in apical 4-chamber view exhibited a blunted 
pattern of increased velocities during dobutamine stress echo cardiography in the 
case of right ventricular dysfunction, mainly determined by right coronalY atiety 
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disease. Thus, pulsed wave Doppler tissue sampling response predicted the 
presence of significant right coronalY artelY stenosis (37). An identical 
conclusion was reached more recently by Alam et al. (38). We could speculate 
about a more complex patho-physiological meaning to this finding. In agreement 
with Yamada et al (22) it is likely that a mixture of resting necrosis and 
jeopardized viability at low-dose, possibly resulting in some ischemia at peak-
dose, is responsible for bi-phasic myocardial velocity of right ventricular free 
wall. Tlus pattel1lresembles the bi-phasic pattel1l of myocardial segments during 
dobutamine stress echocardiography: the strongest predictor of myocardial 
viability. A potential application of this technique could be to quantify the right 
ventricular function at rest. It could also be used during stress in the follow-up of 
patients with a left ventricular dysfunction that is so severely impaired that it 
escapes reproducible assessment, thus requiring alternative measures. We used 
quantitative coronary atielY angiography as a reference standard (39). 
Short overview of left ventricular functional reserve 
We studied myocardial viability using pulsed wave Doppler tissue sampling and 
dobutamine stress echocardiography with FDG-SPECT used as a reference. 
Ischemic left ventricular dysfimction increases morbidity, mortality rate and 
worsens quality of life (40). This data justifies the present enormous effmi of 
recognizing myocardial viability (41-43). Among the therapeutic options, 
coronaty revascularization appears to improve the left ventricular filllction. Tlus 
reduces both morbidity and mortality, provided that an adequate proportion of 
viable myocardium is present. Myocardial viability encompasses myocardial 
stunning and hibel1lation. Many defilutions of myocardial viability are available; 
these depend on the reference parameter 01' teclnuque used. One widely used 
defnution of myocardial viability is based on the presence of contractile reserve 
under inotropic stimulus. Another definition relies on preserved myocardial 
metabolic activity 01' tracer uptake, regardless of reduced coronary flow; this is 
called metabolic/perfilsion mismatch. Among the many techniques used to 
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assess myocardial viability, echocardiography and nuclear imaging provides the 
best combination of accuracy and cost-effectiveness. If the aspect of resting 
dyssynergic myocardium is of value for predicting viability (44), the number of 
viable segments and the magnitude of their improvement the added value of 
predicting improvement of left ventricular ejection fraction (45). Among various 
stressors, dobutamine has become the most popular for recognizing myocardial 
viability. A top predictor of dobutamine stress echocardiography is the bi-phasic 
patte1'll (46) with improvement of wall motion and thickening in severely 
dyssynergic segments at low-dose dobutamine and worscning at peak. Tlus is 
indicative of viable but jeopardized myocardium. Contractile reserve must be 
present in at least two adjacent segments for it to improve after coronary 
revascularization (47). Other techniques show a minor cost-effectiveness ratio, 
such as Positron Emission Tomography (PET), traditionally considered the gold 
standard of myocardial viability, and magnetic resonance imaging, presently 
promising to quantify regional ventricular dynamics. These techniques arc 
expensive and of limited availability. 
We selected pulsed wave Doppler tissue sampling 
among many new techniques to detect myocardial viability 
Many new tecluuques are aiming to quantify myocardial viability. For example a 
quantitation of grey-scale imaging by video-densitometry has been studied for 
the recognization of myocardial viability (48), myocardial acoustic 
backscattering as acoustic quantification/colour kinesis (49), contrast 
echocardiography (50) and tracking of the speckle patte1'll within the 
myocardium have been investigated. Digital Imaging and Comunication in 
Medicine (DICOM 3) system has been introduced recently, and is the new 
standard of digital imaging and communication. It is consolidating efforts to 
quantify ventricular function. Among so many new approaches, we addressed 
pulsed wave Doppler tissue sampling to detcct myocardial viability (33, 38). 
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FDG-SPECT as a reference standard for myocardial viability 
FDG-SPECT is a new nuclear imaging technique that assesses simultaneously 
myocardial perfusion and membrane uptake, utilizing a double sequential 
intravcnous injection of radionuclide tracers (12,51-53). Briefly an intravenous 
injection of 99mTechnetium-tetrofosmin allows myocardial perfusion imaging. 
Then a dose of 500 mg of Acipimox (Byk, The Netherlands) is administered 
orally (57). Acipimox is a potent nicotinic acid derivative, blocks lipolysis and 
reduces free fatty acid plasmatic availability, thereby stimulating glucose and 
FDG uptake. A carbohydrate-emiched meal is given to stimulate insulin release 
and further FDG uptake. This protocol offers obvious practical advantages over 
the hyperinsulinemic cuglycemic clamping, which consists of an intravenous 
infusion of insulin to activate glucose uptakc from myocardial cell membranes 
together with glucose to maintain nonnoglycemia (55-56). A second intravenous 
injection introduces FOG and the resulting images of membrane uptake are 
matched with myocardial perfusion. The simultaneous imaging of dual isotope 
FDG-SPECT allows an optimal aliglllnent of myocardial segments, thus 
increasing accuracy to dctcct myocardial viability. 
Pulsed wave Doppler tissue sampling increased sensitivity of dobutamine 
stress echocardiography to recognize myocardial viability versus wall 
motion (Chapters 5-6) 
Nuclear imaging was found more sensitive than dobutamine stress 
echocardiography to detcct myocardial viability. Pulsed wave Doppler tissue 
sampling appeared more sensitive than dobutamine stress echocardiography for 
detection of myocardial viability. Tllis technique, combined with dobutamine 
stress echocardiography appears almost as sensitive as nuclear imaging. The 
pattems of pulsed wave Doppler tissue sampling overlapped those of 
dobutamine stress echocardiography with a lligher prevalence of sustained 
improvement. By considering only low-dose dobutamine and a multi-segment 
approach of pulsed wave Doppler tissue sampling to left ventricle, this technique 
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showed its potential to quantify myocardial viability, with good cOl1'elation to 
FDG-SPECT (57-58). Our absolute velocity values reproduced those repOlted by 
Yamada et al (59). 
FDG-SPECT was the reference standard of dobutamine stress 
echo cardiography for myocardial viability assessment (Chapter 7) 
FDG-SPECT is used to study resting myocardial viability (1, 60-62). Compared 
to FDG-positron emission tomography (FDG-PET), it can be used as a cheaper 
and more available reference teclmique (63-66). FDG-SPECT exhibits patterns 
analogous to FDG-PET, with the only limitation of a semi-quantitative, instead 
of a quantitative scoring. A normal or moderately reduced perfusion/membrane 
uptake, a mismatch between hypo-perfusion or a nOl1nal or increased uptake is 
regarded as a sign of myocardial viability. Conversely, a minimal perfusion and 
uptake is indicative of non-viable myocardium. For evaluation of ischemia a 
stress protocol of FDG-SPECT could possibly be developed. Of all nuclear 
techniques FDG-SPECT appears more sensitive than dobutamine stress 
echocardiography in detecting myocardial viability. This technique detects 
myocyte membrane activity, while actomyosine function is lost, as this requires 
a higher metabolic activity of the cell (67). Notwithstanding different myocardial 
viability mechanisms assessed by echocardiography and nuclear teclmiques, we 
found a good con·elation between dobutamine stress echocardiography and 
FDG-SPECT when using a similar scoring model. The maximum agreement for 
the two teclmiques evaluating myocardial viability was found for the bi-phasic 
pattern during dobutamine stress echo cardiography. 
Safety of dobutaminc stress echocardiography in patients with 
severe left ventricular dysfunction (Chapter 8) 
In patients with severe left ventricular dysfunction (ejection fraction <35%) 
dobutamine stress echocardiography low-high dose protocol is safe and feasible 
(68-69). Our fmdings answer some concerns expressed by Rahimtoola (70) and 
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Nagueth and Zoghbi (71), concerning the safety of dobutamine stress 
echocardiography in severely dysfunctional left ventricles. Atropine addition is 
required in 113 of the tests and may be infused safely, as the most frequent side 
effects: hypotension and arrhythmias (72-79), do not relate to either atropine or 
ischemia induction. Thus, a low-high dose protocol can be used in these patients. 
It increases accuracy in the detection of myocardial viability by inducing 
ischemia after initial improvement. This is essential for both predicting a worse 
prognosis (80) and making the decision about coronmy revascularization (81). 
Ejection fraction improvement during low-dose dobutamine predicted 
myocardial viability (Chapter 9) 
Volume changes during dobutamine stress echocardiography have been found to 
predict coronmy altelY disease and unfavorable outcome (82-85). In our 
experience an increase of ejection fraction> 10% at low-dose dobutamine stress 
echo cardiography, especially if followed by worsening at peak-dose (bi-phasic 
response), accurately predicts functional recovery after revascularization. This is 
defined as an increase of ejection fraction >5%, measured by 99mTechnetium 
ventriculography (86). Left ventricular-function improvement after 
revascularization is propOitional to the degree of ejection fraction improvement 
at low-dose dobutamine stress echocardiography, linearly related to the number 
of viable segments. Thus ejection fraction appears to overestimate viability less, 
when compared to wall motion score index by dobutamine stress 
echo cardiography (87-88) and nuclear tests (89). 
The angiographic success of percutaneous transluminal coronary 
angioplasty in chronic totally occluded coronary arteries could be 
immediately confirmed 
by dobutamine stress echocal'diography (Chaptel'10) 
Patients with angina and chronic totally occluded coronmy arteries were 
traditionally recanalized by coronmy artelY bypass grafting (CABO) (90). 
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Recanalization by percutaneous transhuninal coronmy angioplasty (PTCA) 
showed higher failure rate (91-93) and restenosis rate. However, the proven 
advantage of revascularization in reducing ischemia has supported continuous 
effOlts in developing new teclmologies. As a new alternative approach excimer 
laser guide-wire was introduced in 1993 (94-97). In this approach the guide-wire 
contains laser fibres that are activated whenever an obstacle stops the 
advancement of the guide-wire. We studied the functional impact of the 
angiographic success of percutaneous transluminal coronmy angioplasty by 
comparing a dobutamine stress echo cardiography performed the day before, 
with a dobutamine stress eehocardiography performed the day after a successful 
recanalization. We were able to confirm that a significant improvement of both 
stress-induced ischemia and resting dyssynergy occurs after a successful 
angiographical procedure (98-99). 
Dobutamine stress echo cardiography predicted hypotension duriug 
hemodialysis (Chapter 11) 
The prevalence of coronary artery disease among patients with terminal renal 
dysfunction is as high as 50% (100). However, exercise stress testing in this 
population IS generally unfeasible. Therefore, dobutamine stress 
echocardiography appears a safe and feasible alternative in detecting myocardial 
ischemia (101-103). An additional role of dobutamine stress echo cardiography 
performed before hemodialysis could be the prediction of hypotension during 
hemodialysis. This occurs in about 30% patients (104). We found evidence that 
the absence of dobutamine-induced contractile reserve, expressed as the failure 
of stroke index to increase during low-dose dobutamine stress echocardiography, 
appears predictive of hypotension during hemodialysis (105). Even if the patho-
physiological mechanism of tltis finding remains to be explored, this marker 
could possibly stratify a higher risk group of patients. 
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CHAPTER 1 
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INTERPRETATION OF DOBUTAMINE 
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ABSTRACT 
Subjective interpretation of dobutamine echo cardiograms provides only 
moderate interinstitutional observer agreement if non-unified data acquisition 
and assessment criteria are applied. The present study was assigned to evaluate 
parameters associated with low interinstitutional observer agreement in the 
intelpretation of dobutamine echoeardiograms and to analyze whether 
standardized interpretation criteria improve interinstitutional observer 
agreement. 150 dobutamine echocardiograms (dobutamine up to 40 ~lg/kg body 
weight per min and atropine up to I mg) were evaluated at five centers. Clinical, 
procedural, and echo cardiographic parameters were included in the analysis of 
variables with significant impact on interinstitutional agreement. Standardized 
intelpretative criteria were established, and 90 dobutamine echocardiograms 
were reanalyzed by three observers using a standardized image display. 
Multivariate analysis demonstrated low llnage quality (Odds ratio [OR] 0.19, 
95% Confidence interval [CI] 0.08-0.45, p~0.0002), low severity of the induced 
lVallmotion abnormality (OR 0.17, 95% CI 0.07-0.40, p<O.OOOI) and a low peak 
rate-pressure product (OR 0.93, 95% CI 0.43-2.27, p~0.0382) to result in a low 
lllterinstitutional agreement. Standardization of image display in cine loop 
format and of dobutamine stress echo lllterpretation criteria resulted in 
improvement of test result categorization as normal or abnormal, with a kappa 
value of 0.50, compared with 0.39 USlllg the original subjective interpretation. In 
conclusion, llnage quality, the severity of induced wall motion abnormalities and 
the obtained rate-pressure product have a significant impact on the lllterpretation 
homogeneity of dobutamine echocardiograms. Standardization of image display 
in cine loop f01111at and of reading criteria results in llnproved interinstitutional 
agreement in lllterpretation of stress echocardiograms. 
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INTRODUCTION 
Dobutamine echocardiography (DE) has proven to be an accurate method for the 
non-invasive diagnostic of coronary artely disease (1-2). Beside a high 
diagnostic accuracy consistency of test result interpretation by different 
observers is of critical importance to facilitate cOll'nllunication of test results. In a 
multicenter study we demonstrated significant differences between experienced 
centers in the interpretation of DE if non-unified unage display and readulg 
criteria are applied (3). Higher interobserver interpretation agreement on DE has 
been reported for observers of the same ulstitution uldicating that implicit 
agreement on reading criteria might result in improved homogeneity in the 
interpretation of test results (4-8). Improved agreement between different centers 
on interpretation of test results could be demonstrated for perfusion scintigraphy 
after standardization of image display and interpretation (9). The purpose of this 
study was (i) to analyze the reasons for the relatively low interinstitutional 
agreement in the interpretation of DE and determine clinical, procedural and 
echocardiographic parameters which predict low interinstitutional agreement, 
(ii) to evaluate whether standardized ullage display and reading criteria result in 
improved consistency between readers of different institutions in the 
interpretation of DE. 
METHODS 
Patients: Thirty consecutive patients scheduled for angiography due to 
suspected coronmy artelY disease underwent DE at each of five experienced 
institutions with a high volume of stress echocardiograms. Patients with previous 
Q wave myocardial infarction, congestive heart failure, severe congenital or 
acquired valvular heart disease or documented cardiomyopathy were excluded 
from the study. No patient was excluded on the basis of poor echocardiographic 
image quality. Thus, a total of 150 DE from 146 patients (116 men, 30 women; 
mean [±SD] age 46±12 years) were studied. Four patients underwent a second 
examination after ulterventional therapy had been performed. Medical therapy 
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included nitrates in 78 patients, calcium antagonists in 48 patients and beta 
blocking agents in 45 patients. One hundred thirteen patients had angina at the 
time of examination. A non-Q wave myocardial infarction had been previously 
documented in 14 patients, and in 26 patients previous myocardial 
revascularization had been performed (20 with coronaty angioplasty, 6 with 
coronaty artery bypass grafting). 
Dobutamine stress protocol: Dobutamine was infused intravenously, starting at 
a rate of 5 J.lg/kg body weight per min, increasing the dosage evety 3 min to 10, 
20, 30 and 40 J.lg/kg per min. In case 85% of age-predicted maximal heart rate 
was not reached and the test was negative, 0.25 mg atropine was given evety 
minute up to a maximum of 1.0 mg atropine i.v. Blood pressure and 12-lead 
electrocardiograms (ECG) were recorded at baseline and at the end of each 
dobutamine stage or before the premature cessation of the test. The presence of 
horizontal or downsloping ST -segment depression of at least 0.1 m V, 0.08 s 
after the J point versus baseline recordings was considered diagnostic for ECG 
evidence of myocardial ischetnia. Endpoints were maximal pharmacologic 
stress, development of new wall motion abnormalities, a heatt rate of 85% of 
age-predicted maximal heatt rate, progressive and severe angina, dyspnea, 
severe ventricular arrhytlnnias, > 0.2 m V of downsloping ST segment 
depression, development of hypotension (decrease in systolic blood pressure ;>, 
20 nun Hg) and significant hypertension (systolic blood pressure> 240 mmHg). 
Stress echo image acquisition: Patients were placed in the left lateral decubitus 
position before, during and after dobutamine infusion. Imaging was performed 
in the parasternal long- and shOlt -axis as well as apical 2- and 4-chamber views 
in each patient. Images at rest and peak stress conditions were stored for review 
and exchange between centers. Individual centers maintained their standard 
practice of image acquisition, resulting in videotape recorded images in 82 
shtdies and digitized itnages in quad-screen cine loop format itl 68 studies. All 
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recorded echo studies were transferred to S-VHS-videotapes to have a unifonnly 
readable media for off-line analysis. 
Stress echo cardiographic interpretation: At each of the five involved centers 
all 150 DE studies were evaluated by a physician experienced in stress 
echocardiography. Image interpretation was performed without the knowledge 
of clinical or angiograpbic data, data on the maximal dobutamine or atropine 
dosage or the reason for stress test termination. For wall motion analysis, the left 
ventricle was divided into 16 segments according to the recommendations of the 
American Society of Echocardiography (10) and each segment was scored using 
a 4-point scale: I ~ nonnal, 2~ hypo kinetic, 3~ akinetic, 4~ dykinetic. An 
abnormal DE was defined as an increase in score from rest to stress in at least 
one segment. Echo image quality was assessed semi-quantitatively on a five 
point scale: A~complete endocardial defmition; B~visualization of all segments 
but not adequate as A; C~inadequate visualization of one or two segments but 
adequate visualization of adjacent segments within the same coronary territOlY; 
D~inadequate visualization of d segments but adequate visualization of 
adjacent segments of the same territOlY; E~inadequate visualization of one or 
more whole territories. 
Quantitative coronary angiography: Coronmy angiography was performed on 
all patients. Analysis of all coronmy angiograms was performed with electronic 
calipers by an independent angiographer. Significant coronmy artelY stenosis 
was considered present when;:' 50% reduction of vessel diameter was observed 
in at least one major coronalY mielY. 
Analysis of reasons for interpretation heterogeneity: In order to evaluate 
possible reasons for different interpretation of stress echo images and to 
elucidate factors increasing the likelihood of interpretation heterogeneity the 
degree of agreement was analysed depending on clinical, procedural and 
echocardiographic variables. Clinical parameters consisted of the patient age, 
antianginal therapy prior to dobutamille stress test (nitrates, calchull antagonists, 
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p-receptor blocking agents) and the findings of the coronaty angiogram. 
Procedural parameters consisted of maximal dobutamine dosage, additional 
administration of atropine, premature termination of pharmacologic stress, 
achieved rate-pressure product (RPP), achievement of the targeted heart rate. 
Echocardiographie variables consisted of the result of the echo study (positivity 
vs. negativity), the size of the induced wall motion abnormality (four or more 
segments of induced wall motion vs smaller area of induced dyssynergy), the 
degree of induced dyssynergy (hypokinesis/akinesis/dyskinesia) and the image 
quality of stress echo cardiograms. These variables were determined using the 
majority assessment of the five echo readers. Furthermore, it was analyzed 
whether interpretation agreement was more detennined by the image acquisition 
or the image interpretation process. 
Standardized cine loop display and reading criteria: Tln'ee of the five centers 
reanalyzed 90 DE after standardizing unage display and reading criteria. A joint 
reading session on 30 DE was performed by the three reanalyzulg centers to 
unprove homogeneity in stress echo reading before reanalyzing the DE. In 
addition to the general readulg criteria, further interpretive guidelines were 
stipulated to reach improved homogeneity Ul cases of uncertainty: (1) Basal 
inferior and basal septal hypokulCsis are not identified as being abnormal unless 
an adjacent segment is also affected by a new dyssynergy or there is a clear 
deterioration of function to akinesia or dyskinesis, (2) uldueed delayed 
contraction should be used as an uldex of ischemia in the absence of conduction 
disturbance, (3) the identification of ischemia was based upon anticipated 
coronary telTitories, (4) significant resting wall motion abnonnalities 
(hypokinesia in at least three segments or akinesia in at least one segment) 
should also suggest an abnormal test and the presence of coronary disease. The 
90 DE reanalyzed subsequyntly were displayed Ul a standardized digitized cine 
loop format. Thus, all stress echocardiograms were digitized from the initial 
videotape recorded study. This .allowed direct .comparison of rest and stre.ss 
images in quad-screen format. The time interval between thc first and second 
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reading of the 90 echocardiograms by the three selected centers was at least 12 
months. 
Statistical analysis: All analysis was carried out using the SAS software 
package. Continuous data are presented as mean±SD, and categorical data are 
presented as frequency. Concordant interpretation of stress echocardiogl'ams was 
defined as the presence of identical reading by four or all five of the interpreting 
centers. Chi-square test was perfonned to test for significant differences. 
Univariate and multivariate logistic regression analysis were .performed to 
determine clinical, stress procedural and echocardiographic parameters with 
significant impact on the interobserver agreement in test interpretation, with low 
interobserver agreement being defined as agreement of less than four of the five 
centers on positivity or negativity of a test result. Univariate parameters with 
significant impact (p value < 0.2) on interobserver agreement were entered into 
the multivariate model. A level of 0.05 was considered statistically significant. 
The kappa test was used to test the hypothesis that agreement was 
greater than by chance alone (11). The coefficient of agreement (kappa) was 
graded as follows: 0 to 0.2 = poor to slight; 0.21 to 0.4 = fail'; 0.41 to 0.6 = 
moderate; 0.61 to 0.8 = substantial; 0.81 to 1.0 = nearly perfect. 
RESULTS 
Pharmacologic stress included a maximal dobutamlne dosage of35±8 !lglkglmin 
and additional atropine administration in 53 patients. The maximal 
obtained RPP was 20136±5245 nnnHg/min. Concordant interpretation of DE 
was obtained in 109 studies. 
Clinical parameters influencing interpretation agreement: Age and 
medication with nitrates, calcium antagonists or beta-receptor antagonists were 
no parameters with impact on inteqJretation agreement by univari~te analysis. 
Severity of coronary artelY disease by angiography was a univariate parameter 
with significant impact on interpretation agreement (p=O.O 181) (Table I). 
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Table I. Clinical, procedural and echocardiographic parameters with significant 
impact on interpretation agreement of dobutamine echocardiograms 
P 
Vessel disease 0.0181 
Rate pressure product 0.0179 
Dobutamine echo result (pos/neg) 0.0280 
Extent of wall motion abnormality <0.0001 
Severity of wall motion abnormality <0.0001 
Image quality <0.0001 
Procedural parameters influencing interpretation agreement: While 
maximal dobutamine dosage, additional administration of atropine, maximal 
heart rate, achievement of target heart rate, and premature stop of dobutamine 
stress were no univariate predictors of interpretation agreement, the maximal 
achieved RPP during stress test was a univariate parameter with significant 
impact on interpretation agreement (p~O.O 179). 
Echocardiograpbic parameters inflilencing interpretation agreement: 
Concordant agreement of at least four centers on positivity or negativity of a 
study was more frequent for agreement on negativity and less frequent for 
positivity of a test. The extent of a wall motion abnormality was a significant 
univariate parameter influencing the interpretation agreement with higher 
agreement for induced wall motion abnol1nalities of four or more segments than 
for smaller segments of dyssynergy. The degree of dyssynergy also influenced 
the interpretation agreement. Hypokinesis was associated with a lower 
interpretation agreement. Image quality was another univariate parameter with 
significant impact on interobserver interpretation agreement; in studies with 
highest image quality concordant intelpretation (agreement of at least four of 
five centers) was achieved in 100%, wlrile it was only achieved in 43% of those 
with lowest image quality (Table I). 
Multivariate predictors of interpretation agreement: Image quality, severity 
of induced wall motion abnol1nality and maximal RPP were independent 
variables with significant impact on intelpretation agreement (Table II). 
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Table II Multivariate predictors of interpretation agreement 
Majority agreement on stress echo 
result 
OR 95%CI P 
Image quality 0.19 0.08-0.45 <0.0001 
Severity of wall motion abnormality 0.17 0.07-0.40 0.0002 
Rate-pressure product 0.92 0.43-2.27 0.0382 
CI: confidence mterva1, OR: odds ratIO 
Acquisition ys. interpretation of stress eChocardiograms: Omission of those 
30 studies submitted by one center did not result in a significant change of 
interpretation agreement for the remaining 120 studies (Table Ill). However, 
omission of one analyzing center resulted in an increase of concordant 
interpretation (agreement of at least four of five centers) from 110/150 studies 
(73%) to 116/150 studies (77%; agreement of at least tiuee of the remaining four 
centers) and even 130/150 (86%) (Table III). Thus, significant increases in 
agreement (p<O.OI) could be obtained depending on which of the five centers 
was omitted fium intelpretation. The greater impact of interpretation vs 
acquisition on test agreement is reflected by different mean kappa values 
obtained for each of the five centers. The mean kappa value .indicating the 
intelpretation agreement of one center with the other four centers ranged from 
0.26 to 0.47. 
Table III. Influence of omission of specific centers from acquisition and reading 
0 f db' I d' I d f' . o utaml1le ec IOcar lograms on t le concor ance 0 mtelpretatlon 
Col of ailS Col after omission of Change in Col after Change 
centers center from acquisition of Col omission of in Col 
studies center from 
p reading P 
Center 1 73% 74% n.s. 84% <0.05 
Center 2 73% 72% n.s. 86% <0.01 
Center 3 73% 74% n.s. 81% n,s, 
Center 4 73% 73% n.s. 77% n.S. 
Center 5 73% 73% n.s. 80% n.S. 
Col: Concordant lllterpretatlOn 
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Standardization of image display and stress echo reading criteria: Table IV 
demonstrates the effect of standardized stress echo reading criteria and 
standardized image display on interpretation agreement. For categorization of 
test results as normal or abnol1nal, the kappa value increased from 0.39 (original 
agreement of the tln'ee centers on the 90 test studies) to 0.50. 
Table IV. Effect of digitization and unification of image display as well as 
standardized stress echo reading criteria on agreement of dobutamine echo 
. t t t' fi 90 tid' 1 t db tl t 111 ell)re a IOn or s ress ec lOcar IOgrmlls eva ua e )Y lree cen ers 
Agreement before Agreement after 
standardization standardization 
Kappa 95%CI Kappa 95%CI 
Center I vs Center 2 0.26 0.09-0.44 0.42 0.23-0.61 
Center I vs Center 3 0.50 0.36-0.64 0.56 0.38-0.73 
Center 2 vs Center 3 0.42 0.29-0.56 0.51 0.33-0.69 
Mean 0.39 0.50 
Considering the majority opinion (two or more) on DE result of the three 
reanalyzing centers for the detection of angiographically defined coronalY artelY 
disease in the patients with thc 90 reanalyzed DE diagnostic accuracy was non-
significantly changed using standardized image display and reading criteria. 
Sensitivity, specificity and accuracy werc 78%, 87% and 81 % respectively, 
without standardization and 76%, 88% and 80%, respectively, with 
standardization. 
DISCUSSION 
Differences in interpretation are a well known limitation of most diagnostic 
procedures in cardiology. Low levels of interobserver agreement have been 
repOlted for exercise ECG (12-13), perfusion scintigraphy (14) as well as 
coronaty angiography (15-16). Recently we reported a relatively modcrate 
agreement between readers of five institutions in the intelpretation of DE (3). 
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Reasons for the moderate agreement on DE intelpretation between readers of 
different institutions were analyzed in this study. 
Causes of interpreter variance: In tills study image quality, sevcrity of induced 
wall motion abnormality and maximal RPP were found to be the only 
independent parameters influencing the interobscrver agreement. This rcsult 
stresses the importance of acquiring the best possible image quality. The finding 
that the severity of induced wall motion abnormalities was the second major 
parameter influencing the interobselver agreement points to the difficulty in 
differentiating between normal and pathologic in borderline situations. The 
known substantial variations in segmental left vcntricular wall motion response 
to dobutamine stress within each patient add to the difficulties (17,18). Despite 
the differences in both echo acquisition and interpretation at different centers, 
differences in acquisition techniques between these experienced centers had only 
minor effects on the degree of agreemcnt, and it was the intel]lretation which 
was the source of most of the variance. The importancc of the observer in the 
subjective process of stress echo interpretation has been stressed before (19). 
Tills study indicates that some readcrs have a tendency to "under-read" resulting 
in more false negative results while others havc a tendency to "over-read" 
resulting in more false positive studies. 
Standardized image display and reading criteria: While somc of the factors 
causing interobserver variability in interpretation of stress echocardiograms 
might reflect aspects such as the normal regional variability of left ventricular 
function in response to dobutamine stress and impaired image quality, other 
factors may be easier to alter. Minor induced wall motion abnormalities might be 
transformcd to more significant wall motion abnormalities if patients are always 
stressed maximally, implying that the protocol should not be tClminated because 
of the development of new minor wall motion abnOimalities. 
The commonly used stress ccho reading criteria - scoring wall motion according 
to four grades and regarding deterioration of wall motion by one scale in at least 
one segment as pathologic - do not consider the normal inhomogeneity in wall 
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motion response and leave enough room for different reading practices. In this 
respect, joint reading sessions for multicenter studies, or the availability of 
interpretation examples to guide individual practitioners may enhance 
interpretive concordance, especially with small and less pronounced wall motion 
abnormalities. In our study, uniform criteria were aimed at preventing 
disagreement on hypokinetic basal inferior and septal wall motion abnormalities 
and interpretation of delayed contraction. Furthermore, it was required that wall 
motion analysis should take the anatomy of coronary perfusion beds into 
account, e.g. a separate new wall motion abnol1nality in the middle septal 
segment was disregarded if the apical septal segment did not demonstrate a new 
wall motion abnormality. 
Further effOlts to improve image quality or endocardial border defmition and 
techniques allowing a quantification of endocardial or myocardial wall motion 
are required. Improved endocardial border definition has been described with 
contrast echo cardiography (20) and second hannonic imaging (21), while color-
coded endocardial wall motion analysis (22) and color-coded tissue Doppler 
analysis (23) have been used to quantifY endocardial or myocardial wall motion. 
However, the value of these approaches in the context of routine stress 
echo cardiography needs to be proven. 
Limitations of the study: Only patients without significant wall motion 
abnonnalities at rest were included in this study. The observer variability might 
be higher in patients with more difficult to read DE. This study does not 
differentiate between the relative effects of a standardized image display and 
those ofunifol'ln interpretation citeria. 
Conclusion: Low interobserver agreement in the interpretation of DE is mainly 
due to studies with low image quality and studies with minor wall motion 
abnol1nalities, in which varieties in reading habits result in different test result 
interpretation. Substantial efforts should be undertaken to acquire stress echo 
studies with high image quality and obtain pronounced wall .motion 
abnormalities during stress testing. At present, conformity in data acquisition is 
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higher than conformity in DE interpretation. Standardized unage acquisition and 
reading criteria result in improved ulterinstitutional agreement on DE 
interpretation. 
We gratefidly ackllowledge the e.\pert statistical analysis ojThorstell Reilleke 
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ABSTRACT 
Doppler tissue imaging is one of the most recent technical achievements of 
clinical echocardiography. Different Doppler modes are encompassed by 
Doppler tissue imaging: tissues velocity, pulsed wave-Doppler, acceleration, 
phase, synchronicity and energy modes. With the exception of the energy mode, 
all are based on the Doppler shift, according to the strength of the Doppler 
signals from the tissues. The most widely used is the tissue velocity, in which 
the velocity of moving tissue is calculated in relation to the transducer from the 
Doppler shift and displayed as colour-encoded velocity maps in M-mode and 
two-dimensional imaging formats. Both curved M-mode, applied on two-
dimensional images, and tln'ee-dimensional reconstruction appear among the 
most promising applications of velocity mode for the quantitative assessment of 
regional left ventricular function. A second Doppler mode, pulsed wave-Doppler 
tissue imaging, displays the velocity profile of a region of interest versus time. 
The velocity data are displayed with high temporal resolution, but with the 
disadvantage of a low spatial resolution. A third Doppler mode, tissue 
acceleration, displays the differences in velocity between subsequent frames in 
colour-encoded maps. A clinical application has been found in the 
electrophysiologic field. Other Doppler modes, phase and syncln'onicity, still 
require clinical assessment. Lastly, the tissue energy or power mode displays the 
strength of the Doppler signal from the tissues as gradations of the colour 
intensity in colour-encoded maps. One of its fields of application appears the 
study of myocardial perfusion with contrast agents. The development of new 
dedicated algoritluns for colour quantification, along with the begimllng of the 
new era of digital echocardiography, should help to bring Doppler tissue 
imaging into the clinical arena. 
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BACKGROUND 
Echocardiography provides unique anatomical and functional informations of 
the heart which are superior to e.g. nuclear imaging techniques with respect to 
availability, radiation and costs (l). Anatomical informations of the cardiac 
structures have improved with the introduction in echocardiography of new 
imaging technologies: three-dimensional echocardiography, contrast 
echo cardiography, high resolution imaging and acoustic backscatter-derived 
imaging: e.g. acoustic quantification. Parallel effOits have been made to obtain 
detailed informations on myocardial function. However, for both these 
anatomical and functional infol111ations the subjective nature of the 
echocardiographic examination remains the limiting factor. Different strategies 
have been developed to overcome this problem. For example, in stress 
echocardiography the ventricular function evaluation has been improved by 
semiquantitative scoring systems. However the reduction in interobserver and 
interinstitutional variation has globally been moderate, regardless of an effective 
learning curve (2). To make the situation worse, echo cardiographic ally "silent" 
myocardial ischemia, such as subendocardial infarctions or syndrome X, 
contribute increasing discrepancies between operators. All the 
echocardiographic techniques, primarily introduced to improve the anatomical 
infol111ations, have been soon after adopted to improve the functional 
informations. In this context Doppler tissue imaging combines important 
feahu'es: its ability of measuring intramural myocardial function, its low 
attenuation rate by the interposed chest wall, its high spatial aud temporal 
resolutions and its suitability for a three-dimensional quantification of the 
myocardial function. However, its clinical diffusion has been hampered by 
limitations, mainly related to an inadequate digital imaging processing. 
This review will be focused on Doppler tissue imaging, ranging from its 
conception to the most recent developments and potential applications. The data 
derived from our clinical experience were obtained by using the Toshiba 
Powervision ultrasound system. 
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DOPPLER TISSUE IMAGING TECHNOLOGY 
In 1989 Isaaz et al (3) first repOlted the use of a modified pulsed wave-Doppler 
to measure the myocardial velocities of the ventricular posterior wall. 
In 1992 the Doppler tissuc imaging technique was independently developed by 
McDickcn et al. (4) and Yamazaki et al. (5). 
According to the same principles of colour Doppler flow imaging, Doppler 
tissue imaging utilizes the multi gated pulsed Doppler technology to calculate 
tissue velocity at consecutive points along multiple scan lines. These velocities 
are displayed both in M-mode and two-dimensional formats using a colour 
scheme (4). Each image unit or pixel displays one colour representing a mean 
velocity value. Cardiac structures have a velocity range of 6-24 cm/s, 8 to 10 
times lower than blood flow and an amplitude -40 decibel (dB) higher than 
blood flow. Therefore, to obtain Doppler tissue imaging, the high-pass filter, 
employed in colour Doppler flow imaging to remove the low velocity Doppler 
signals from cardiac stmctures, must be removed, to allow these signals to enter 
the auto-correlator, where complex computations are performed, resulting in 
Doppler output data as mean velocities and variances. To eliminate the low 
amplitude Doppler signals from the blood flow, it is sufficient decreasing the 
overall gain. In this way blood flow signals are eliminated ancl only high 
amplitude signals from the tissues are processed by the auto-correIa tor. 
The low tissue velocities allow Doppler tissue imaging to operate at low level of 
pulse repetition frequency (PRF/8-16), far below the Nyquist or aliasing limit, 
which is one half the pulse repetition frequency (PRF/2). Therefore, aliasing 
never occurs. When tissue velocities exceed the preset velocity range, 
homogeneous colours are displayed. When operating at velY low velocities, like 
in the dyssynergic myocardial segments, the preset velocity range of the 
instnul1ent must be widened to discriminate between different levels of colour 
within the colour band. In this setting the highest velocities enter the non 
informative homogeneous eolour band. For the operator would be useful to 
recognize within this homogeneous eolour band when the Nyquist limit is 
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exceeded and aliasing occurs. Therefore, the ongoing trend is to add the colour-
encoding of aliasing (6). 
A problem of Doppler tissue imaging analysis is a change in velocities and 
hence in colours faster than the standard frame rate. This can be solved by 
increasing the frame rate, usually limited to 25 frames/s when videotape 
recording are used. Toshiba Powervision Doppler tissue imaging system, by 
using digital parallel processing tec1miques, allows two-dimensional Doppler 
tissue imaging scanning with a 3.75 MHz transducer and a 60° sector at 40-60 
frames/s, which is equal to or greater than the standard grey-scale two-
dimensional image frame rate. A even higher temporal resolution is achieved by 
Doppler tissue imaging in M-mode, where the scanning rate is as high as 90 
multigated lines/s (Figure I). This tec1mology is the core of both tissue velocity 
and tissue acceleration mode. 
Fig 1: Healthy subject. Doppler tissue imaging in parasternal sh0l1-axis M-mode. The 
posterior wall is encoded in red-yellow during the ejection phase and blue-green during 
the relaxation phase. The colours in the endocardial layers are brighter than those in the 
epicardial layers, indicating a higher velocity of motion. The cardiac cycle phases arc 
indicated by vertical lines. Ie: isovolumic contraction, EJ: ejection phase, 1R: isovolumic 
relaxation, Em: early diastole, D: diastasis, Am: late diastole. PW: posterior wall, M-
m.ode SAX: M-mode parasternal short axis view. 
An alternative display of velocity is obtained by pulsed wave-Doppler tissue 
imaging. This technology allows to place a small sample volume in a point of 
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interest of the myocardium and to display its velocities over time with a 
temporal resolution of 4 ± 3 ms. Thus, it is possible to measure with the highest 
echocardiographic accuracy instantaneous peak velocities of each cardiac phase. 
Although this not an imaging modality, to date the trend is to include it in the 
general defmition of Doppler tissue imaging. 
A different Doppler tec1mology is involved in tissue energy mode. In tlus case 
colour itnages are not derived from the phase shift of the Doppler signal, but 
from the integration of the power spectrum of the Doppler signal, wluch reflects 
the composition of the tissue. Therefore, yet using part of the Doppler signal 
path within the ultrasound mac1une, tissue energy mode measures only the 
strength of the returning ultrasound signal. For tlus reason these images are both 
angle and velocity independent. They are available in two-dimensional fOlmat, 
at a 30-60 frames/s and logarithnucally compressed. The main advantage of this 
imaging modality is its ability to recogluze signals from the background noise, 
which is less intense than the background of grey-scale format. 
EXPERIMENTAL STUDIES 
The validation of Doppler tissue imaging has been perfonned USitlg "tissue-
nllmicking" phantoms rotated itl a water bath at different constant speeds, 
sinular to the velocities of normal and pathologic myocardium (7,8). The 
correlation found between the velocities of these phantoms and the velocities 
measured by Doppler tissue itnagitlg is velY high. Only itl the ve1Y low or high 
velocity range a distorted estimation and a poor spatial resolution occur (5,9). 
The spatial resolution of velocities of single layers of gel phantoms sliding one 
on the other, as displayed in two-dimensional velocity maps, is 3x3 111111 when 
using a 2.5 MHz transducer and a low transmit pulse repetition frequency (9). A 
three-dimensional velocity reconshuction has been tested on phantoms with a 
spatial resolution of I x I mm (10). 
50 
Phantoms of different composition have been used to validate the Doppler 
energy mode and a close correlation has been found with the integrated tissue 
backscatter imaging (II). 
Animal studies have shown that I minute after coronary occlusion in pigs, 
decreased wall velocities are visually detected by Doppler tissue imaging in the 
ischemic area, with reversion to nOl1nal after reperfusion (II). The analysis of 
velocity changes during ischemia by pulsed wave-Doppler tissue imaging offers 
a higher temporal resolution, allowing an earlier detection of velocity changes 
(12). After 10 seconds of ischemia both a significant reduction of early diastolic 
peak velocity and a reduction of early/late diastolic ratio occur, followed by an 
increase in late diastolic peak velocity (13). 
The presence of transmural velocity gradients (the increase of velocity from epi-
to endocardium) has been validated with the implantation of piezoelectric 
clystals in the endocardial and epicardial layers in dogs (14). A decrease of 
transmural velocity gradients with the development of ischemia has been 
detected (14). 
The use of Doppler energy maps in pigs has shown an enhancement of contrast-
associated coronary perfusion in the left ventricular walls after a peripheral 
intravenuous injection of SHU508A (Levovist) (II). Following a right atrial 
injection of 8 ml of Levovist in pigs, Doppler energy mode has been more 
sensitive than grey-scale imaging, calculated as background-subtracted peak 
videodensitometly, in detecting dipyridamole-induced coronmy artelY 
hyperaemia, reduced perfusion or immediate reperfhsion (15). 
CLINICAL APPLICA nONS 
Doppler tissue imaging may be applied to all echocardiographic views. Thus far 
its application has been focused on the standard parasternal and apical views. 
In parasternal views the posterior wall exhibits higher velocities than the anterior 
wall. The total anterior displacement of the heart during systole adds to the 
posterior wall velocities and subtracts from the inward endocardial velocities of 
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the anterior wall. Therefore for an accurate measurement of myocardial 
velocities in parasternal views a correction formula or the measurement of the 
velocity gradient should be introduced. Myocardial velocity gradient mapping 
displays only the increase of velocity fi'om subepicardial to subendocardial 
layers, without velocity relation to the transducer. In tltis way it is possible to 
eliminate the interference introduced by the global cardiac movement (16,17). 
However its application is limited to the anterior and posterior segments in 
parasternal views, the only exhibiting a direction of contraction and relaxation 
pm'allel to the Doppler beam. 
In apical views all the standard segments are displayed. In these views Doppler 
tissue imaging is able to detect the longitudinal motion of the cardiac base 
toward and away from the apex, which may be considered as a fixed reference 
point (18). A velocity gradient is also present in apical views, with the maximal 
velocities at the cardiac base and a progressive decrease toward the apex. As the 
velocity component perpendicular to the interrogating sound beam is not 
measured, the horizontal inward wall motion in apical views is partially missed. 
Both the horizontal inward wall motion and the longitudinal shortening are 
known to play an equivalent role for the global ejection fraction (19), therefore 
an integrated assessment of their resulting velocity vector should be desirable. 
QUALITATIVE OR VISUAL ASSESSMENT OF DOPPLER TISSUE 
IMAGING 
The first approach to Doppler tissue imaging has been visual. A scheme encodes 
tissue velocities in colours. Each colour represents a velocity range and a 
direction of motion. The lowest velocities toward the transducer are displayed as 
red, the intermediate velocities as orange and the highest velocities as yellow, 
with intermediate hues. The lowest velocities away fi'om the transducer are 
displayed as blue, the intermediate as turquoise and the ltighest velocities as 
green. Myocardial seglllellts with velocities too low to reach the colour threshold 
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are imaged in black and white. A multicolour scheme is also used to display the 
acceleration maps. 
A non-colour non-imaging approach is offered by pulsed wave-Doppler tissue 
imaging, wWch allows the sampling of a selected point in the myocardium and 
the display of its velocity versus time. 
For display of tissue energy maps, a mono- or bichromatic (redlblue) scheme is 
used, with an increase in brightness parallel to the increase in Doppler signal 
intensity from tissue. 
Velocity and energy data can be represented both in M-mode, to improve 
temporal information, and two-dimensional imaging, to improve spatial 
information. Acceleration data may be displayed only in two-dimensional 
imaging. 
A frame by frame analysis of Doppler tissue imaging has been accomplished in 
our laboratmy to study the normal myocardial contraction and relaxation 
sequences, by using as a reference both electrocardiogram and 
phonocardiogram. The phases of the cardiac cycle are visually rccognizable in 
both M-mode and two-dimensional Doppler tissue images: isovolumic 
contraction, ejection phase, isovolumic relaxation, early diastole, diastasis and 
late diastole. In M-mode the systo-diastolic phases may be detected with high 
temporal resolution (Figure 1). As an example, it is possible to discriminate the 
velocity ratio of the early versus the late diastole by visually comparing the 
colour ratio of the cOlTesponding cardiac phascs. The M-mode motion pattern 
has been well correlated with ejection and filling parameters (20). In parasternal 
views the systolic septal wall motion is displayed in blue (posterior direction) 
and the posterior wall motion in red-yellow (anterior direction). During diastole 
opposite colours are displayed (Figures 2 and 3). In apical views red-to-yellow 
colours spread from base to apex during both isovolumic contraction and 
ejection phase in systole and blue-to-green colours do the same during 
isovolumic relaxation, early and late diastole. The apical area usually remains 
encoded in grey or dark hues of colour, as it is almost immobile. Virtually no 
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motion is present during diastasis, therefore the ventricular walls are not colour-
encoded during tllis phase. 
Fig 2: Healthy subject. The parasternal ShOli axis view shows in mid systole a red 
encoded posterior wall and a blue encoded anterior wall (left panel). A pattem of 
opposite colours is visible in early diastole (right panel). PW: posterior wall, LV: left 
ventricle, IVS: interventricular septum, RV: right ventricle, SAX: parasternal short axis 
view. 
Fig 3: Healthy subject. The parasternal long axis view shows the posterior wall 
encoded in red-yellow and the anterior sephllll in blue-green in systole (about 80-120 ms 
after the QRS). An opposite color pattem is evident in diastole. PW: posterior wall, LV: 
left ventricle, IVS: interventricular sephllll, RV: right ventricle, PLAX: parastcmai long 
axis view. 
The qualitative experience acquired from the visual analysis of nonnal subjects 
may be useful as a reference to describe pathological patterns. As an illustration, 
a left ventricular hypertrophy exhibits an asyncln'onous contraction pattel1l in the 
seph!m,with bJue al)d red colours in adjacent myocardial layers (Figure 4, A), a 
septal myocardial infarction shows no colours in the akinetic area (Figure 4, B), 
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and a global hypokinetic left ventricle is characterized by darker hues of red and 
blue (Figure 4, C). As a further example, by comparing the appearance of the 
corresponding colours, in hypertrophic cardiomyopathy the onset of relaxation 
in early diastole has been found delayed in the septum relative to the other walls 
(21). 
Fig 4: Doppler tissue imaging frames in early systolic apical four chamber view in 
cardiac patients. A: patient with left ventricular hYPC11rophy: an asynchronous 
contraction pattem is visible in the septum with blue and red colours in adjacent 
myocardial layers. B: patient with a septal myocardial infarction: the akinetic area 
shows no colours. C: patient with low ejection fraction: dark hues of red arc visible all 
over the left ventricular walls. LV: left ventricle, RV: right ventricle, AP4CH: apical 
four chamber view. 
QUANTITATIVE ASSESSMENT OF DOPPLER TISSUE IMAGING 
The visual assessment of Doppler tissue imaging appears less important than the 
quantitative manipulation of imaging data. Many algorithms have been 
developed and others are under consideration to elicit quantitative informations 
from Doppler tissue imaging and especially to convert colours in velocities (16). 
In compatison with other technologies, Doppler tissue imaging appears superior 
e.g. to the tracking of the speckle pattern within the myocardium, an angle-
independent technique providing informations on intramural myocardial 
velocities, but unlikely to be introduced in the near future, because of the 
sophisticated algorithms required (22). 
Most of the velocity measurements are made in M-mode tissue Doppler 
imaging, because of its high temporal resolution, as based on its high sampling 
rate. This allows accurate measurements of velocities and time intervals versus 
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time. A good con'elation has been found between paraste11lal M-mode Doppler 
tissue imaging and the endocardial motion profile of the echocardiogram (17) or 
the transmitral Doppler velocity profile (23). One example of parameter 
calculated in M-mode tissue Doppler imaging is the mean transmural velocity, 
defined as the mean of all the velocities calculated along an individual M-mode 
line from epicardium to endocardium. From all the mean transmural velocities 
over one cardiac phase interval a maximal or peak velocity may be calculated. 
Therefore, each cardiac phase may be represented by a peak velocity. In healthy 
subjects the peak systolic velocities of both the anterior septal and the posterior 
walls, calculated in parasternal views, show a wide range of normal values (17). 
An altemative approach is the display of transmural velocity gradient maps. 
These are obtainable by using a software which refers to the centre of ventricular 
contraction all the colour-encoded sampling lines. According to tllis algorithm 
the transmural velocity gradient is colour-encoded from the subcpicardium to the 
subendocardium. Its best feasibility is for the anterior and posterior segments of 
left ventricle in parasternal views, according to the Doppler angle-dependence. 
The transmural velocity gradient is represented in systole with the same colours 
in both anterior and posterior walls and with opposite colours in diastole, 
therefore eliminating the interference from the global cardiac movement relative 
to the Doppler transducer (7,24). As an examplc, in conditions of right 
ventricular volume overload, like in presence of atrial septal defect, the cardiac 
translocation is increased. In this setting the myocardial velocity gradient coding 
is able to detect a nonnal contraction pattem of the left ventricle (25). During 
myocardial ischemia, a reduction of transmural systolic and diastolic velocity 
gradients has been recorded (7). In dilated cardiomyopatllies a reduction of 
transmural velocity gradient has been found to con'elate with their severity 
(26,27). In patients with hypertropllic cardiomyopathy, both systolic and early 
diastolic velocity gradients exhibit lower values than in athletes or normal 
subjects (2&), The. myocardial velocity gradient may be also displayed in tlu'ee-
dimensional fonnat (29). 
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Another quantitative application of Doppler tissue imaging, pulsed wave-
Doppler tissue imaging, allows a temporally accurate velocity measurement of 
both systolic and diastolic cardiac phases from a point of interest within the 
myocardium. As an example, in healthy subjects the regional myocardial 
relaxation has been found preceding the starting of early diastolic transmitral 
flow, with a resulting shortened isovolumic relaxation time (30). In our 
laboratOlY we have mainly developed the pulsed wave-Doppler tissue imaging 
approach by sampling the basal part of each ventricular wall in standard apical 
views. The velocity values obtainable in apical views are different from thosc 
obtainable in parastemal views and also limll one wall to another. In our 
experience and in agreement with Sun et al (31), the velocity range of healthy 
subjects in apical views is wider than in parasternal views and the velocity 
values exhibit regional heterogeneity (32). For this reason, time intervals or 
ratios are occasionally prefel1'ed to absolute velocity values. In patients with 
cardiomyopathies peak velocity values were found lower than in healthy 
subjects (33). 
An angle-corrected clllved M-mode is under consideration in order to sample 
colour two-dimensional images, as stored on a digital SUppOlt at a high frame 
rate, thus combining both temporal and spatial high resoluti,ons. Another 
important development is the display of myocardial velocities in tln'ee-
dimensional format for the assessment of intramural contractile function, by 
reconstructing the three-dimensional velocity vectors, as obtained by three-
dimensional colour Doppler tissue images (34). 
CLINICAL APPLICATIONS OF DOPPLER VELOCITY MODE 
Both chronic and acute ischemic myocardial segments may be studied by 
Doppler tissue imaging. Rest or stress induced dyssynergic segments appear as 
darker hues of colour in M-mode and two-dimensional displays (II). 
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M-mode tissue Doppler imaging during dobutamine stress has measured 
decreased velocity values during early diastole and systole in ischemic segments 
at peak stress (35). 
Pulsed wave-Doppler tissue imaging has also been used during dobutamine 
stress echo cardiography by sampling the 6 basal segments of each wall in the 
standard apical views, with the addition of the right ventricular free wall (Fig 5), 
or by sampling 12 or 16 segments (36,37). 
Fig 5: Resting frame showing a sample volume of pulsed wave-Doppler tissue 
imaging located on the basal part of the right ventricular free wall in apical 4-chamber 
view (Right side). The velocity profile shows systolic velocities over the baseline and 
early and late diastolic velocities below the baseline (Left side). Ie: isovolumic 
contraction, EJ: ejection phase, Em: early diastole, Am: latc diastole, AP4CH: apical 
four chamber view. 
In our opinion, to date, pulsed wave-Doppler tissue imaging, especially by 
sampling the basal segments in apical views, offers many advantages compared 
to other quantitative approaches non supported by adequate algorithms. A first 
advantage is the amplification of the velocity profile detellnined by the many 
myocardial fibres interposed between the cardiac base and the cardiac apex, with 
a consequent improvement of measurement accuracy. Moreover, the direction of 
contraction is always close to the direction of the Doppler beam, while in short 
axis view the velocity of contraction of the posterior septum and lateral walls is 
not detectable, as perpendicularly oriented to the Doppler beam. Another 
advantage is the relative fixed position of the cardiac apex, relative to the 
transducer, therefore reducing the bias determined by the global cardiac 
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translational movement. This translation is more evident in parasternal than in 
apical views, bccause the heart moves toward the thoracic anterior wall during 
systole and in the opposite direction during diastole, as a result of the 
interventricular interaction, mainly oriented in the horizontal axis. A fmther 
advantage of pulsed wave-Doppler tissue imaging is the presence of the mitral 
allllUlus, an important intra-patient reproducible anatomical landmark. 
Pulsed wave-Doppler tissue imaging is able to detect the onset of ischemia, as a 
prolongation of isovolumic relaxation time, a reduction of carly diastolic peak 
velocity, a delayed time to peak early diastolic velocity and an increase of late 
diastolic velocity, all preceding the reduction of systolic peak velocity. 
Modifications of systo-diastolic parameters, as measure by pulsed wave-Doppler 
tissue imaging, have been correlated with the severity of the coronary stenosis 
(38). At peak stress a decreased early diastolic velocity bigher than 2 cm/s and a 
decreased early/late diastolic ratio cOll'elate with regions supplied by coronary 
arteries with more than 50% of stenosis diameter (36). In our experience patients 
with an histmy of more than 50% of stenosis diameter in the proximal or 
medium Patt of the right coronmy attery exhibit a blunted (less than 25%) 
increase of the ejection phase velocity from low dose to peak dobutamine, when 
measured in the basal part of the right ventricular wall in apical.four chamber 
view, compared to patients without right coronaty disease, who exhibit a 
sustained increase of the ejection phase velocity. Therefore, these different 
patterns may be helpful in predicting the presence of a significant right coronary 
disease (39). 
A presence of viability in dyssynergic myocardium may be demonstrated by 
comparing rest and low dose dobutamine infusion as an appearance of brighter 
velocity colours in colour-encoded displays (40,41) and increased velocities in 
pulsed wave-Doppler tissue imaging recordings. In patients with poor left 
ventricular fimction we found a correlation between the ejection velocities of 
pulsed wave-Doppler tissue imaging in the basal segment of each ventricular 
wall in apical views and the corresponding wall motion score index. Therefore, 
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an agreement exists betwecn the longitudinal and the horizontal components of 
ventricular contraction. The same results may be confirmed during dobutamine 
stress echocardiography at each step of thc test (42). Moreover, a sustained 
improvement from low dose to peak dobutamine seems to correlate with the 
presence of viability and a blunted increased with the absence of viability, as 
defined by the standard wall motion score index for each ventricular wall (43). 
By using three-dimensional Doppler tissue imaging at rest, viable segments 
exhibit systolic, early and late diastolic peak velocities higher than non viablc 
segments. The increase of velocity from rest to low dose is also higher in viable 
than in non viable segments (44). 
Myocardial segments with cln'onic coronmy artelY stenosis exhibit at rest 
reduced early diastolic velocity, reduced early/late diastolic ratio and prolonged 
isovolumic relaxation time (45). 
In patients with microvascular angina the myocardial segments have shown an 
increased isovolumic relaxation time and an increased early/late diastolic ratio 
(37). 
During percutaneous coronmy angioplasty pulsed wave-Doppler tissue imaging 
in apical views is able to detect, as early as 30 second after the beginning of 
occlusion (46), a decrease of early diastolic peak velocity and early/late diastolic 
ratio, followed by a decrease of late diastolic peak velocity (47). Similar results 
have been confirmed with colour M-mode in short axis view (48), able to detect 
a decrease of myocardial velocity gradient and a disappearance of heart cycle 
intervals during acute coronary occlusion, with reversion during reperfusion 
(49). 
In hypertrophic cardiomyopathy a prolongation of isovolumic relaxation time 
and an early/late diastolic ratio higher than I in the septum, compared to an 
early/late diastolic ratio lower than I in the lateral wall, have been correlated 
with regional diastolic dyssynergies (50). 
A prolollgation of the isovolumic relaxation time is also measured in 
amyloidosis. In this cardiac disease peak systolic and diastolic velocities appear 
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both flattened and delayed, while in two-dimensional imaging an intramural 
reduction of colour in the interventricular septum is described, probably due to 
the infiltrative process (50). 
Pulsed wave-Doppler tissue imaging has shown that the ventricular relaxation 
seems relatively preload independent, as the pattern of early diastole, recorded 
by pulsed wave-Doppler tissue imaging, is different from the simultaneous 
pattern of trans mitral Doppler velocity profile (51). 
In patients with poor quality of grey-scale unages, Doppler tissue unaging is 
able to measure the left ventricular volumes with the Simpson's formula. A 
validation was made by Sutherland et al. (52) against volumes obtained by two-
dimensional echocardiography and the interobserver agreement was improved 
by Doppler tissue imaging. For the right ventricular volumes the best correlation 
has been found between the area-length method Ul apical view and the volumes 
measured by magnetic resonance imaging (53). 
A low intra- and inter-observer variability for the left ventricular volume 
assessment has been repOlted with three-dullensional echocardiography (54). A 
three-dimensional echocardiographic reconstruction of the left ventricle may be 
also obtauled by USUlg the Doppler energy mode (55,56). By converting the 
colour Doppler tissue ullages Ul grey-scale format is also possible to evaluate the 
regional left ventricular mass (24). However, the most promising three-
dimensional application is the colour velocity display, allowulg the quantitative 
regional analysis of left ventricular function in correlation with the 
corresponding coronary artery fields, or the analysis of left ventricular systo-
diastolic volume variations in correlation with myocardial velocities of 
contraction and relaxation. Many cardiac pathologies will be addressed by this 
approach (57). The three-dimensional technology combined with Doppler tissue 
imaging results also helpful in the assessment of right ventricular volumes (58). 
In our experience a correlation exists between the pulsed wave-Doppler tissue 
ilnaging ejection velocity, as measured at the basal part of ventricular walls in 
61 
apical views, and the resting ejection fraction, obtained by radionuclide 
ventriculography. 
CLINICAL APPLICATIONS OF DOPPLER ACCELERATION MODE 
In the Wollf-Parkinson-White syndrome, the mapping of the insertion of left-
sided accessOlY atrio-ventricular pathways appears a clinical application of the 
acceleration maps (59). During radiofrequency ablation procedures it is also 
possible to monitor on line the successful ablation of the accessOlY pathway 
(60). 
Other potential applications in the electrophysiological domain seem the location 
of both focus and sequence of the atrial activation. 
CLINICAL APPLICATIONS OF DOPPLER ENERGY MODE 
Doppler energy maps used in combination with echo-contrast agents appear 
promising in the study of myocardial perfusion. However, to date, the 
effectiveness of a peripheral intravenous injection of contrast agent in measuring 
perfusion changes of left ventricular walls in the clinical setting remains low 
(II). A potential exists to combine second hannonic technology to Doppler 
energy imaging. 
Another application is the tissue characterization by measuring the integrated 
backscatter levels. However, the current logarithmically compressed format of 
Doppler energy imaging hampers a flne discrimination of different backscatter 
levels (61). 
Doppler energy appears superior to grey-scale nnagmg in patients with poor 
transthoracic acoustic views because of its high signal-to-noise ratio and 
superior border detection. Its potential for a backscatter-based three-dimensional 
echo cardiographic reconstruction of the left ventricle is under investigation (55). 
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FURTHER CLINICAL APPLICATIONS OF DOPPLER TISSUE 
IMAGING 
FlIlther clinical applications of Doppler tissue imaging are here illustrated by 
few examples. 
Pulsed wave-Doppler tissue imaging with the sample volume on the mitral 
amlUlus shows early diastolic peak velocities lower in constrictive pericarditis 
than in restrictive cardiomyopathy (62). With the same technique, late diastolic 
peak velocities have shown a con'elation with the left atrial stroke volume (63) 
and left atrial appendage cycle length has been transthoracically determined in 
atrial fibrillation, in order to predict a successful cardioversion (64). 
In heart transplanted patients, colour M-mode, placed over the subendocardial 
posterior wall, exhibits a decrease of early diastolic velocity during mild acute 
rejection and a £luther decrease during moderate-severe rejection (65). 
Fmthennore, in heart transplanted patients, atrial contraction exhibits highest 
velocities only when the recipient atrium contracts in late diastole, 
simultaneously to the donor atrium. However, all the atrial velocities remain 
lower than in nonnal subjects, indicating a poor contribution of atrial contraction 
to left ventricular filling (66). 
In the assessment of aOltic £lmction a reduced tinle to peak velocity both in 
systole and diastole helps to distinguish patients with arterial hypertension and 
coronalY 31telY disease from healthy subjects (67). 
Other applications are the assessment of regional diastolic syndromes (68), 
infarct-induced thrombi (69), endocardial vegetations (70) cardiomyoplasties 
(71), and other cardiac parameters, as obtaincd for example by transesophageal 
echocardiography (72). 
LIMITATIONS 
The angular dependence is the intrinsic main limitation of the Doppler 
technique: when the direction of movement diverges from the interrogating 
Doppler beam more than 20°, the accuracy of the velocity measurements 
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becomes not acceptable and when the direction of movement is perpcndicular to 
the Doppler beam, no colour and hence no measurement is achievable. 
A second limitation of Doppler tissue imaging is the global cardiac motion, 
patticularly in the parasternal views, as it distOlts the accurate encoding of 
myocardial velocities. 
A third limitation is the presence of artefacts, such as side lobes, as their colour-
encoding by Doppler tissue imaging affects the correct evaluation of the 
underlying unage. 
A flllther limitation is the inability of Doppler tissue imaging to completely 
colour-encode evelY part of the ventricular wall, especially the walls depicted at 
the border of the echo cardiographic sector. A possible explanation seems a low 
intensity of the signals reflected from the myocardial backscatters (9). 
Accordingly, the best assessment of the ventricular walls is perfollned when 
they are located in the central part of the sector, because a location close to the 
echo cardiographic sector borders is affected by a lower spatial resolution. 
FUTURE PERSPECTIVES IN THE ERA OF DIGITAL 
ECHO CARDIOGRAPHY 
Doppler tissue unagulg offers the potential to study in a quantitative way aspects 
of myocardial dynamics to date missed by other noninvasive clinical teclmiques. 
A possible competiton to Doppler tissue unaging could arise from techniques, 
like the tracking of the speckle pattern within the myocardium to calculate 
intramural myocardial velocities, as its angle-uldependence represents an 
advantage over Doppler tissue unagulg. However, algorithm limitations render 
unlikely an imminent introduction in echocardiography of this technique and its 
low signal-to-noise ratio remains a disadvantage in comparison with Doppler 
tissue unagulg. Other approaches to the ventricular function assessment, like 
colour kinesis, are waitulg adequate algoritlnns and comparative studies with 
Doppler tissue unagulg. 
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The high spatial resolution offered by two-dimensional Doppler tissue imaging 
and the high temporal resolution offered by pulscd wave-Doppler tissue imaging 
will be combined with the developmcnt of new algorithms (73). Pulsed wave-
Doppler tissue imaging, a time-consuming a spatially limited approach, is likely 
to be replaced in the near futurc by e.g. the angle-corrected curved M-mode, 
applied on two-dimensional velocity maps recorded at a frame rate high enough 
to guarantee a useful temporal resolution. With tlus approach thc early 
recognition of diastolic abnormalities induced by myocardial ischemia during 
stress echocardiography should become a clinical routine reality. Real time 
bordcr detection will be another interesting development of this technique. 
Transthoracic three-dimensional reconstruction will allow thc assessment of 
regional myocardial function and the introduction of new cardiac functional 
indices. A three-dimensional on-line system, for a real-time reconstmction of the 
left ventricle, will be the subsequent step. Doppler acccleration maps will help in 
electrophysiologic studies and procedures. Phase and synchronicity parameters 
still wait for their assessment. Second hannOluc Doppler power imaging in 
combination with myocardial contrast agents will help in the quantification of 
myocardial perfusion. 
All these improvements are moving parallel to the beginning of the new era of 
digital medicine. The new standard of digital imaging and communications in 
medicine (mCOM 3.0 Standard) is a set of rules that allows medical images 
with all associated informations to bc exchanged between imaging equipments, 
computers, institutions and individual operators. Traditional videotapes and cine 
films will be replaced by writable CD-ROM and digital database. In the case of 
echo cardiographic images, a new era of digital storing, processing and 
worldwide exchanging will start. 
By having Doppler tissue images in lugh frame rate colour digital format, a 
substrate to perfolln sophisticated calculations of myocardial function 
parameters will be provided. Easily retrievable images will allow serial intra-or 
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inter-patients comparisons. Both CD-ROM-stored and network-transmitted 
images will permit any level of colour processing at any PC-equipped location. 
In conclusion, either the development of new Doppler tissue imaging-dedicated 
algorithms or the beguming of the new era of digital echo cardiography appear 
the intenningled master-keys to enter Doppler tissue imaging in the clinical 
arena. 
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ABSTRACT 
Tissue Doppler imaging (TDI) has recently been introduced in clinical 
echocardiography. Most widely used are tissue velocity maps, in which the 
velocity of moving tissue is calculated relative to the transducer from the 
Doppler shift and displayed as colour-encoded velocity maps in either M-mode 
or two-dimensional image formats (Doppler velocity mode). This allows 
detection and quantification of dyssynergic areas of the myocardium. 
Additionally, the velocitics may be studied with pulsed wave-tissue Doppler 
sampling (PW-TDS) which displays the velocity ofa selected myocardial region 
vcrsus time with high temporal resolution. Less often used, are tissue 
acceleration maps which display acceleration or velocity change of subsequent 
frames as different colours (Doppler acceleration mode). These maps may find 
application in clinical electrophysiology. Anothcr TDI modality is tissue energy 
imaging, which is based on the integration of the power spectrum of the Dopplcr 
signals from the tissue. This technique provides maps of Doppler energy which 
are rcpresented as colour brightness. Such maps offer potential for the study of 
myocardial perfusion. TDI modalities have promise to become clinically useful 
for quantifying myocardial function. 
Abbreviations: 
TDI ~ tissue Doppler imaging. 
PW -TDS ~ pulsed wavc-tissue Dopplcr sampling. 
INTRODUCTION 
TDI is a new imaging technique to assess cardiac function. Parallel to improved 
techniques for the imaging of cardiac structures i.e: two- and three-dimensional 
echocardiography, contrast echo cardiography, acoustic backscatter and 
improved blood flow representation by colour Doppler flow imaging, effOits 
have been made to obtain detailed information on the myocardial function. TDI 
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uses the Doppler shift data from the myocardium to obtain both qualitative and 
objective or quantitative informations on ventricular wall dynamics. 
TDi TERMINOLOGY 
Tissue Doppler imaging (TDI) is the most accepted term to refer to the imaging 
of myocardium. It encompasses three major colour display modes of the Doppler 
shift processing method: I) tissue velocity imaging; 2) tissue acceleration 
imaging and 3) tissue energy or power imaging. Pulsed wave-tissue Doppler 
sampling (PW -TDS) is a teclmiquc not imaging the myocardium, but displaying 
velocities over time from a sample volume. 
TDI METHODOLOGY 
TDI is based on the same principles applied in colour Doppler flow imaging. In 
shott, colour Doppler flow imaging utilises multigated pulsed Doppler 
technology to calculate blood velocity at consecutive points along multiple scan 
lines and displays these velocities in M-mode or two-dimensional fonnats using 
a colour scheme (1). 
Blood flow within a cardiac chamber has a 8 to 10 times higher velocity and a 
lower amplitude of Doppler signals compared to cardiac structures. Therefore a 
high-pass filter must be employed to remove the low velocity Doppler signals 
from cardiac structures. These filtered data are processed in an auto-correlator, 
which performs complex computations and yields Doppler output data as mean 
velocities and variances. 
TDI development progressed fi·om 1992-1994 with clinical applications being 
demonstrated tln·eafter (1-2). Doppler signals from the myocardium have a 
velocity range of 6-24 cm/s and an amplitude -40 dB higher than those derived 
from the blood pool. The principle of TDI is based on selecting the low 
velocities of cardiac structures by bypassing the high-pass filter and on rejecting 
the low amplitude Doppler signals from the blood pool, by decreasing the 
overall gain. In this way blood flow signals are eliminated and only the high 
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amplihlde-Iow velocity signals from tissue are processed in the auto-colTelator 
(3). This technique enables TDI to be more sensitive than colour Doppler flow 
imaging and less affected by the attenuation caused by chest wall structures. 
However, the principle of image reconstruction is the same, displaying more 
than 16 millions of colours, each one conveyed by a single pixel, representing 
the smallest unit of colour imaging and a single velocity value. Thus, TDI 
technique, as requiring special programs, is implemented only in upgraded 
eehocardiographic systems. 
Moreover, TDI differs from colour Doppler flow imaging, because aliasing 
never occurs. Due to the low velocities of tissue motion, TDI usually operates at 
one sixteenth the pulse repetition frequcncy (PRF 116), far below the Nyquist or 
aliasing limit which is one half the pulse repetition frequency (PRF/2). 
Therefore, the Doppler frequency shift data from tissue are always far below the 
Nyquist limit. When velocity of tissue exceeds the pre-set velocity range of the 
instrument, uniform rather than invelted colours are displayed. In this case, by 
widening the colour band series, it is possible to extend the discrimination 
among different colour levels. 
A problem for TDI analysis is the rapid change in velocities and hence in 
colours. This can be solved by increasing the frame rate. A maximum of 25 
frames/s is allowed when videotape recordings are used, but digital processing 
techniques, such as in the Toshiba Powervision TDI system, allow two-
dimensional TDI scamung with a 3.75 MHz transducer and a 60° sector at 40-60 
frames/so Moreover, a high temporal resolution ofTDI is achieved in the TDI M-
mode where the scamling rate is as high as 90 multigated lines/s (Figure 1). 
Tissue velocities are encoded by using a multicolour scheme. In tissue velocity 
maps each colour represents a range of velocities and a direction of motion. 
These bi-directionalmaps display the lowest velocities toward the transducer as 
red, intermediate velocities as orange and the highest velocities as yellow, with 
intermediate hues. Velocities away from the transducer are displayed in .blue, 
progressing to turquoise and fmther to green at the highest velocities. 
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Myocardial segments with velocities too low to reach the threshold to be 
encoded in colour are imaged in grey, or in black when the background tissuc 
image is subtracted. 
Fig 1: M-mode TO! obtained from a healthy subject. The parasternal short-axis M-
mode recording shows the posterior wall encoded in red-yellow in the ejection phase and 
blue-green in the relaxation phase, while the interventricular septum shmvs opposite 
colours in the corresponding phases. The colours in the endocardial layers are brighter 
than those in the epicardial layers, indicating a higher velocity of motion. Brighter 
colours in the posterior wall indicate higher velocities than those in the septal wall. This 
is explained by the anterior cardiac motion in systole, relative to the fixed transducer, 
adding velocity to the posterior wall and subtracting velocity from the septum. The 
phases of contraction and relaxation of the posterior wall are indicated by vertical lines. 
The same lines should be slightly shifted to mark the corresponding phases of the 
septum, according to its earlier activation. Ie: isovolumic contraction, EJ: ejection, lR: 
isovolumic relaxation, Em: early diastole, D: diastasis, Am: late diastole, P\V: posterior 
wall, LV: left ventricle, IVS: interventricular septulll, RV: right ventricle, F\V: free waH 
ofthe right ventricle. 
Tills technology is the core of both tissue velocity maps (Doppler velocity modc) 
and tissue acceleration maps (Doppler acceleration mode). 
Doppler acceleration mode displays acceleration or velocity change of 
subsequent frames as different colours (Doppler acceleration mode). These maps 
may be represented only in two-dimensional image format, according to a 
multicolour schemc. M-mode may not display acceleration because it does not 
represent a temporal sequence of fJ·ames. 
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PW -TDS is also based on the Doppler shift principle, however it does not 
display velocities in unage format, but as a profile versus time by sampling a 
region of interest Ul the myocardium (Figure 2) (4). In contrast with TDI, PW-
TDS can be obtauled with minor adaptations from all the echocardiographic 
systems. 
Fig 2: PW-TDI with the sampling on the basal part of a dyssynergic posterior-septal 
wall in apical four chambers (AP4CH) view. The velocity profile (left panel) shows 
systolic velocities over the baseline and eady and late diastolic velocities below the 
baseline. During infusion of 10 ftg/kg/min of dobutamine (right panel) systolic velocities 
increase, expressing a contractile reserve, whlle diastolic Em/Am ratio inverts, possibly 
predicting a fm1her development of posterior-septal ischemia. Ie: isovolumic 
contraction, EJ: ejection, Em: early diastole, Am: late diastole, AP4CH: apical four 
chamber view. 
A different Doppler tecllllology is involved in tissue energy maps. They are not 
derived from the phase shift of Doppler signals, but from their intensity, as 
obtained from the integration of the power spectrum of the Doppler signals, 
reflectulg the composition of the tissue (Doppler energy mode). These Doppler 
signals, therefore, are both angle and velocity independent (non-directional). For 
display of tissue energy imagulg, a mono- or bichromatic (redlblue) scheme is 
used, with a progressive ulcrease in brightness. 
EXPERIMENTAL VALIDATION BY PHANTOM STUDIES 
Validation of TDI velocities was performed using "tissue-mimicking" phantoms 
rotated in a water bath at a series of constant speeds, such as encountered in 
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nonnal and pathologic myocardium (5,6). A good correlation was found 
betwecn the velocities of these phantoms and the velocities measured by TDI, 
but overestimation and poor spatial resolution was encountered in the velY low 
velocity ranges (2,7). Accurate representation of velocities of single layers of gel 
phantoms sliding one on the other was demonstrated (7). Both axial and lateral 
resolutions of the two-dimensional velocity maps were 3x3 nun when using a 
2.5 MHz transducer and a low transmit pulse repetition frequency (7). 
Tissue energy imaging was also validated by using phantoms and the images 
obtaincd closely resembled those obtained with integrated tissue backscatter 
imaging (8). 
VALIDA nON BY ANIMAL STUDIES 
Experimental studies in pigs showed that decreased wall velocities were visually 
detected by TDI in a ischemic area I min after coronmy occlusion with reversal 
after reperfusion (8). PW -TDS allowed a more accurate time analysis of velocity 
changes during ischemia (9). Transmural velocity gradients (the velocity 
increased from epi- to endocardium) and their decrease parallel to ischemia were 
validated with the implantation of piezoelectric clystals in the subendocardial 
and subepicardial layers in dogs (10). 
Using Doppler energy maps in pigs, contrast-enhanced perfusion in the left 
ventricular walls was demonstrated after a peripheral intravenuous injection of 
SHU508A (Levovist) (8). 
CLINICAL APPLICA nON OF DOPPLER VELOCITY MODE 
When using TDI most information on myocardial contraction is obtained in 
apical and parastemal views, because they allow the assessment of the complex 
left ventricular contraction and relaxation from two perpendicular transducer 
positions (see Figures 3-5). 
Since only the velocity component relative to the interrogating sound beam is 
measured, the pelpendicular motion, such as e.g. the inward motion in the lateral 
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walls, is not recorded. In parasternal images the posterior wall exhibits higher 
velocities and velocity gradients than the antera-septal segmcnts. Total cardiac 
anterior displacement during systole adds to the posterior wall velocities and 
subtracts from the inward posterior velocities of the anteroseptal wall. In normal 
subjects there is a velocity gradient within the myocardium which gradually 
increases from subepicardial to subendocardial layers in parastemal views 
(11,12) and decreascs from base to apex in apical views (13) (See Figures I and 
5). 
Fig 3: TDI velocity maps obtained from a healthy subject in the parasternal shOl1 axis 
(SAX) vicw. In early systole (about 80-120 tnS after QRS: left panel) the posterior wall 
is encoded in red-yellow and the anterior wall in blue. In early diastole (right panel) this 
colour pattern is the opposite. P\V: posterior wall, LV: left ventricle, IVS: 
interventricular septum, RV: right ventricle. 
Fig 4: TDI velocity maps obtained from a healthy subject in the parasternal long axis 
(PLAX) view. In early systole (about 80-120 tnS after QRS) the posterior wall is 
encoded in rcd-ycllO\v and in diastole in blue-green. An opposite colour pattern is visible 
in the interventricular sephun. P\V: posterior wall, LV: left ventricle, IVS: 
interventricular septum, RV: right ventricle. 
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The importance of TDI to measure both equatorial and longitudinal regional 
myocardial dynamics was suggested by the observation that both the endocardial 
inward motion and the longitudinal shortening contribute equally to the ejection 
fraction (14) and the quantitative regional assessment of ventricular asynergy 
adds independent prognostic data to the global ejection fraction (15). TDI may 
therefore offer advantages for comprehensive assessment of both global and 
regional ventricular wall function. 
VISUAL ASSESSMENT OF DOPPLER VELOCITY MODE 
In our experience, frame by frame analysis of TDI allows the study of the 
myocardial contraction and rcIaxation sequences. All phases of the cardiac cycle 
can be visually identified from two-dimensional TDI images. In apical views the 
red-yellow colours spread from base to apex in systole, while the blue-green 
colours spread from base to apex in early and late diastole (Figure 5). 
Fig 5: TDI velocity maps obtained from a healthy subject in the apical four chamber 
(AP4CH) view. In systole the walls are encoded in red-yellow and in diastole in blue-
green. In both cardiac phases the basal segments are moving faster than the other 
segments, therefore encoded in brighter colours. The apex is almost immobile and 
encoded in dark colours. LV: left ventricle, RV: right ventricle, LA: left atrium, RA: 
right atrium. 
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The ventricular walls appear often red-yellow during the isovolumic contraction, 
which coincides with the rapid change of shape of the left ventricular cavity 
during this phase (16). The apical area usually remains encoded in grey or dark 
blue, as it is almost immobile (13). Virtually no motion is present during the 
diastasis phase, therefore the ventricular walls are not colour-encoded duriug tIus 
phase. It is possible to discriminate the velocity ratio of the isovolunuc 
contraction versus the ejection phase and of early diastole versus late diastole by 
visually comparing the colour ratio of the conesponding cardiac phases. In the 
parastemal view the systolic antera-septal wall motion is displayed in blue-grecn 
(posterior direction) and the posterior wall motion in red-yellow (anterior 
direction). During diastole these colours are invelted (Figures 1,3) (17). The 
myocardial velocity during the rapid filling phase shows lugher intensities of 
blue. The same colour pattern is seen during atrial contraction when the filling 
velocity is increased. A lugher temporal resolution of the motion of selected 
areas of the myocardium is obtained when the M-mode is used and the motion 
pattemcorrelated well with ejection and filling parameters (Figure 1) (18). 
We \lsed the.q\Ialitativeexperience acquired fram normal subjects as a reference 
. . . 
to study pathological'paiterns. As 'anex3mple, hypo' and akinetic segments are 
characterized by darker hues of red 01' blue (Figure 6). Dyskinetic segments are 
charaCterized by colours opposite to the neighbouring segments (Figure 61\:). In 
dilated cardiomyopathy the absence of colors or the presence of dark hues of 
colors iudicate velY low velocities (Figure 6B). In patients with left bundle 
branch block, the early red-yellow colours indicating contraction are delayed in 
the septum, as compared to the opposite wall according to a later activation 
(Figure 6e) (19). 
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Fig 6: TDI velocity maps in different 
cardiac conditions obtained at a similar 
timing range (80-120 ms after the onset of 
QRS) of systole. 6A: Myocardial infarction 
of the mid-distal scgments of the posterior-
septum in apical four chamber (AP4CR) 
view. The darkest or absent colours indicate 
the infarcted segments. A a dyskinetic basal 
segment of the posterior wall during early 
systole is encoded in blue, as moving away 
from the transducer, while the adjacent 
segments are encoded in red, as moving 
towards the transducer. 6B: Dilated 
cardiomyopathy. Absent colours or only 
dark hues of red indicate velY low 
velocities in all segments, caused by 
systolic impail1nent. 6C: Left bundle 
branch block in apical long axis (APLAX) 
view. In this frame, approximately 80 illS 
after the onset of QRS, the activation of the 
basal part of the septum appears delayed 
and interrupted, compared to the posterior 
wall. Tins indicates a delayed pattern of 
contraction. AP4CH: apical four chamber 
view, APLAX: apical long axis view, LV: 
left ventricle, RV: right ventricle. APLAX: 
apical long axis view, LV: left ventricle, 
LA: left atriulll 
QUANTITATIVE ASSESSMENT OF DOPPLER VELOCITY MODE 
More intriguing than the visual assessment of TDI is the TDI quantification. 
Theoretically, each of the more than 16 millions of colours by which TDI is 
displayed can be converted in a cOlTesponding velocity value. Obviously, an 
average must be calculated among many pixels representing a region of interest. 
As an example, an on-line algorithm in the Toshiba Powervision system allows 
the measurement of 4 velocities from 4 colour-encoded regions of interest. 
Dedicated algorithms were developed to obtain similar quantitative data off-line 
(11). Most often measurements of velocities were made from M-mode TDI 
recorded in the parasternal views. Due to its high sampling rate, accurate 
measurements of velocities and time intervals were possible. A good correlation 
was found with both endocardial motion profile echocardiograms (12) and 
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transmitral Doppler velocity profiles (20). Examples of parameters calculated in 
M-mode TDI were the mean transmural velocity, defined as the mean of all 
velocities measured along an M-mode line from epicardium to endocardium and 
the maximal or peak transmural velocity, defined as the maximal velocity of all 
mean transmural velocities in each cardiac phase: isovolumic contraction (Ie), 
ejection (EJ), isovolumic relaxation (IR), early diastole (Em), diastasis (D) and 
late diastole (Am) (21). In healthy subjects studied in these different phases of 
cardiac cycle the peak systolic velocities of the posterior and the antero-septal 
walls showed a wide range of values (12). Preejcction left ventricular peak 
velocities measured by colour M-mode on the posterior wall correlated with 
ejection fraction (22). These values were lower III patients with 
cardiomyopathies (23). Another dedicated software allowed the reconstruction of 
transmural velocity gradient maps. According to this algoritlnl1 the multigated 
colour-encoded velocities along each sampling line were not referred to the 
transducer but to the center of the ventricle or centre of contraction, thus in 
systole the transmural velocity gradient from the subepicardium to the 
subendocardium was oriented toward the center of the ventricle. A velocity 
gradient of opposite directiol1 was present during diastole. In shOlt axis view all 
the walls appeared in red-yellow during systole and blue-green during diastole, 
therefore eliminating the interference from cardiac translational movement 
relative to the Doppler transducer (5,24). The independence from the 
translational motion allowed the assessment of myocardial contraction even in 
presence of atrial septal defect, characterized by exaggerated translation of the 
left ventricle (25). A reduction of transmural systolic and diastolic velocity 
gradients was recorded during myocardial ischemia (5) or correlated with the 
severity of dilated cardiomyopathy (26,27). Also velocity gradients suffered, 
however, from the angular dependence, which allowed their best application to 
the anterior and posterior walls in short axis views. 
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Another quantitative application of TDI is possible with PW -TDS. The zero 
baseline and the velocity profile of PW-TDS offer reference points to measure 
peak velocities, time intelvals and time velocity integrals. 
VISUAL AND QUANTITATIVE CLINICAL APPLICATIONS OF 
DOPPLER VELOCITY MODE 
Patients with myocardial ischemia during stress were studied by dobutamine 
TDI. Rest or stress induced dyssynergic segments appeared with darker hues of 
colour in M-mode and two-dimensional displays (8). At the onset of ischemia, a 
reduction of early diastolic peak velocity and an increase of late diastolic peak 
velocity was recorded with PW-TDS, preceding the reduction of systolic wall 
velocity and these changes cOlTelated with the severity of coronary artery 
stenosis (Figure 2) (28). Increased isovolumic relaxation time by PW-TDS 
appeared an early index of regional ischemia (29). During coronHlY angioplasty 
myocardial velocities and velocity gradients decreased, while colour-coded heart 
cycle intelvals were lost (30). An interesting application was the sampling of all 
segments from the standard apical views during dobutamine stress 
echocardiography. Off-line measurements of velocities from infarcted segments 
in early and late diastole showed reduced values at rest and peak stress (31). At 
peak stress decreased velocities of early diastolic phase with a corresponding 
decreased early/late diastolic velocity ratio correlated with regions supplied by 
coronmy artelY stenosis >50% of diameter (31). In our experience, the the 
application of PW -TDS to dobutamine stress echocardiography protocol is 
limited by the 3 minutes available for each dobutamine step. The time required 
to sample 5-10 heart cycles at each dobutamine step, including adjustements of 
image quality, angulation and echocardiographic system settings, prevents its 
application to each of 16 ventricular segments. A compromise is sampling the 
basal part of each ventricular wall in apical view, close to the mitral.Dr tricuspid 
annulus, thus obtaining data which reflect the entire wall dynamics. Patients with 
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stenosis >50% of diameter in the proximal or medium part of the right coronaty 
artelY exhibit a blunted increase of the ejection phase velocity from low dose to 
peak dobutamine, when measured by PW -TDS sampled at the right ventricular 
free wall close to the tricuspid alUlUlus in apical four chamber view. A different 
pattern is obtained from patients without right coronaty artelY disease, who 
exhibit a sustained increase of the ejection phase velocity. Therefore, the blunted 
pattel11 may predict a significant right coronary artery disease (32). 
The presence of myocardial contractile reserve could be demonstrated at low 
dose dobutamine infusion when myocardial contraction and velocities were 
elicited. This resulted in brighter colours (33) on two-dimensional maps and 
increased velocities on PW-TDS recordings, as compared to resting values. 
Viability in hibel11ating myocardium also exhibited less decrcase of EI A ratio at 
rest (34). In our preliminaty experience, by sampling the dyssynergic 
myocardium at the level of mitral annulus in standard apical views with PW-
TDS the ejection phase velocity is increased from rest to low dose dobutamine in 
walls showing improved thickening to confirm the presence of longitudinal 
viability (Figure 2). 
M-mode TDI allowed the study of myocardial velocities of wall segments III 
different phases of the cardiac cycle and their timing was validated against 
invasive pressure recordings (II). Decreased peak velocities during early 
diastole were demonstrated in ischemic segments during dobutamine stress (35). 
Left ventricular volumes could be measured by applying Simpson's f0l111ula in 
patients with poor quality of grey scale images using TDI and were validated by 
Sutherland et al. (36) against volumes obtained by two-dimensional 
echocardiography. Measurement of volumes by TDI improved the inter-obselver 
agreement, because of the higher sensitivity of Doppler imaging. A good 
correlation was also established with three-dimensional echo cardiography (37). 
Left ventricular mass could also be calculated by combining TDI with three-
dimensional.echocardiography (38). 
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The useflllness of investigating diastolic parameters by TDI was reported in 
many examples. Early diastolic parameters measured by PW -TDS at the mitral 
annulus level showed a correlation with the invasively measured time constant 
of isovolumic relaxation (39). This approach appeared relatively pre-load 
independent in evaluating diastolic function (40). 
The differential diagnosis of restrictive cardiomyopathies from constrictive 
pericarditis appeared related to lower early relaxation velocities in the restrictive 
disease, measured by PW -TDS sampled at the level of lateral mitral annulus 
(41). 
In dilated cardiomyopathy an increased early diastolic myocardial velocity 
gradient by TDI detected a restrictive pattel11 (42). Conversely, a reduced early 
diastolic myocardial velocity gradient discriminated hypertrophic 
cardiomyopathy from hypertensive, athlete and nonnal heatts (43). 
An early recognition of acute rejection in heatt transplanted patients was 
suggested by decreased isovolumic relaxation time, early diastolic relaxation 
velocity and deceleration time, as measured by PW-TDS (44). 
CLINICAL APPLICATIONS OF DOPPLER ACCELERATION MODE 
In the Wolff-Parkinson-White syndrome, the ventricular insertion of accessory 
atrio-ventricular pathways could be recognized as an early appearance of colour 
in the acceleration maps (45). According to acceleration colour-encoding, this 
early appearance represented an early variation of myocardial velocities versus 
time. Other examples of electro-physiological applications were the location of 
focus and sequence of atrial activation (46) and the on-line monitoring of 
successftd radio-fl-equency ablation procedures, as disappearance of early colour 
activation in the pre-activated area (47). 
CLINICAL APPLICATIONS OF DOPPLER ENERGY MODE 
The use of echo-contrast agents with Doppler energy maps potentially increased 
the sensitivity of both myocardial perfusion (8) and endocardial border 
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definition in suboptimal echocardiographic images, as compared to standard 
grey-scale images or TDI alone (48). 
LIMITATIONS 
The major limitation of any Doppler technique is its angular-dependence: when 
the velocity direction diverges from the intel1'ogating Doppler beam, more than 
20°, the accuracy of the measurements becomes not acceptable and when the 
direction of movement is perpendicular to the Doppler beam, no colour and 
therefore no measurement, is obtainable. 
Cardiac translational movement is a second limitation, particularly in the 
parastemal views, as it distorts the accurate encoding of myocardial velocities 
and it moves the walls under the sample volume of PW-TDS, therefore 
rendering almost impossible keeping it on the same endocardial, transmural or 
epicardial positions. The three-dimensional twisting contraction of the heart still 
escapes from a correct evaluation. The algoritinl1 for the intramyocardial 
velocity gradient imaging has overcome tillS problem, but it remains affected by 
the angle dependence. Less influenced by the global cardiac movement are the 
standard apical views, able to assess the longitudinal component of contraction 
toward a relatively fixed apex. However, in these views the horizontal 
component of contraction is missed, as a result of the Doppler angular-
dependence. 
Another limitation, sometimes encountered with TDI, is its inability to 
completely colour-encode the ventricular wall, especially the lateral and anterior 
walls in apical views. Possible explanations are a low intensity of the signals 
reflected from the myocardial backscatters or a reduced spatial resolution, 
detennined by the eccentric position of these ventricular walls in the 
echocardiographic two-dimensional sector (7). Usually the best assessment is 
obtained from walls located in the central part of the sector. 
Artifacts, such as side lobes, represent a further limitation, as they are colour-
encoded by TDI and prevent the evaluation of the underlying unage. 
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Finally, the lack of a high frame rate digital storage with corresponding 
quantification software and of guide-lincs for TD! e1inical standard applications 
remain at the present fmther limitations. 
FUTURE PERSPECTIVES AND CONCLUSIONS 
As a recently introduced tcchnique and although some technical limitations, 
partially liable to be eliminated, TD! offers the potential to study in a qualitative 
and quantitative way aspects of myocardial dynamics so far missed by other 
non-invasive e1inical tcchniques. By using either Doppler velocity mode or PW-
TDS it is possiblc to interpret regional systolic and diastolic events, as they are 
reflected by different intramyocardial or trallsmuralmcasurable velocities, e.g. 
viable or ischemic reactions elicited by stress tests. The colour application may 
be helpful in the tlll'ee-dimensional rendering of left ventricular volumes. 
Doppler acceleration mode may contribute to electrophysiologic studies and 
procedures. By adding Doppler energy mode to echo-contrast agents may be 
improved the non-invasive assessment of regional myocardial perfusion. 
However, for a clinical impact, especially for stress echocardiography, larger 
number of studics are required. A recently introduced simple software seems 
able to rapidly exploit TDI potential for quantification of myocardial dynamics 
in the setting of stress echo cardiography (49). 
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CHAPTER 4 
USEFULNESS OF PULSE-WAVE DOPPLER TISSUE 
SAMPLING AND DOBUTAMINE STRESS 
ECHO CARDIOGRAPHY FOR THE DIAGNOSIS OF 
RIGHT CORONARY ARTERY NARROWING 
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ABSTRACT 
To study the feasibility and diagnostic accuracy of right coronaty artery (RCA) 
nat1'Owing by right ventricular (RV) pulse-wave Doppler tissue sampling during 
dobutamine stress echocardiography (DSE), 30 patients (mean age 55 ± 10 
years, 26 mcn) with suspected coronary artery disease, underwent DSE (up to 40 
~lg/kg/1l1in with additional atropine in submaximal heatt rate responses). Pulse-
wave Doppler tissue sampling of RV free walls close to the tricuspid annulus 
was perf011l1ed in the apical 4-chamber view. The maximum velocity during the 
ejection phase, early, and late diastole was measured. Data from 5 consecutive 
beats were averaged. The measurements were repeated at rest, low dose (10 
llg/kg/min) and at peak dobutamine stress. The results were evaluated for the 
prediction of significant proximal or medium RCA narrowing (~50% diameter 
stenosis, assessed by quantitative coronaty angiography within the previous 3 
months). A progressive increase of the ejection phase velocity (>25% between 
10 ~lg/kg/min and peak stress) was predictive of a n011l1al RCA, whereas a 
blunted increase and/or decrease «25% of increase) was predictive of 
significant RCA narrowing: sensitivity (95%CI): 82% (68-96), specificity: 78% 
(67-93), positive predictive value: 69% (52-86), negative predictive value: 88% 
(75-100), accuracy: 79% (65-94). Pulse-wave Doppler tissue sampling provided 
analyzable data in 100%, whereas the visual assessment of gray-scale images 
was possible only in 90%. Thus, in patients with suspected RCA narrowing, 
pulse-wave Doppler tissue sampling during DSE was able to diagnose 
significant RCA narrowing. 
INTRODUCTION 
Right ventricular (RV) function is a prognostic determinant of many heart 
diseases (1-3). However, both RV anatomy and function escape from a reliable 
echocardiographic examination, mainly because of a complex shape (4-5). 
Visual assessment of the RV fi'ee wall by echocardiography in apical 4-chamber 
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in most instances leads to an underestimation of mild hypokindia, due to an 
asynmletrical contraction of the RV walls toward its center (6). Pulse-wave 
Doppler tissue sampling displays tissue velocity profiles of areas of interest with 
high temporal resolution. By sampling the RV free wall close to the tricuspid 
annulus in the apical 4-chamber view, pulse-wave Doppler tissue sampling 
estimates longitudinal RV dynamics, expressed as motion velocities of the 
cardiac base towards and away from the cardiac apex (7), which is used as a 
fixed reference point (8). This longitudinal assessment usually escapes from the 
visual scoring (9). Aim of our study was to diagnose right coronary altelY 
(RCA) narrowing by pulse-wave Doppler tissue sampling during dobutamine 
stress echocardiography (DSE). 
STUDY PATillNTS AND METHODS 
Patient selection. The study population included 30 consecutive 
patients (mean age 55 ± 9.5 years, 26 men) referred for evaluation of suspected 
coronary artelY disease who fulfilled the following criteria: 1) a recent (within 3 
months) coronalY angiography, with no change in clinical conditions, 2) no 
relevant valvular heart disease, pulmonary or systemic hypertension resulting in 
moderate-severe left and/or right ventricular hypertrophy, cardiovascular shunts 
or any cardiac disease interfering with either cardiac preload or afterload and 3) 
a left ventricular ejection fraction >45%, as assessed by echocardiography. The 
antianginalmedication was not a criterion of exclusion. 
Coronary angiography. CoronalY angiography was performed within 3 
months before DSE. Significant coronalY altelY disease was defined as a 
diameter stenosis ~50%. The stenosis diameter was quantified using the 
Quantitative Coronary Angiogl'aphic method previously described by our center 
(10). According to the absence or presence of a significant RCA narrowing 
patients were respectively divided into group I and 2. 
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Assignment of the myocardial segments to coronary arteries. The 
present stndy focused on the RV function. We assigned RV free wall to RCA, . 
according to an angiographically proven RCA dominance in all our patients. A 
standard assignment was applied to match the 3 coronalY arteries to the 16 left 
ventricular segments (II). 
Dohutamine stress echo cardiography. Dobutamine was intravenously 
administered with an infusion rate of 10 Ilg/kg/min per min for 3 minutes, 
increasing by I 0 ~lg/kg/min evelY 3 minutes up to a maximum dose of 40 
Ilg/kg/min. In patients not achieving 85% of their for age and gender predicted 
maximal hemt rate and without symptoms or signs of myocardial ischemia, 
atropine was administered, starting with 0.25 mg intravenously and repeated up 
to a maximum of 2.0 mg within 8 minutes, while continuing the infusion of 
dobutamine. Throughout dobutamine infusion the electrocardiogram (3 leads) 
was continuously monitored and recorded (12 leads) at one minute intervals. The 
criteria to internlpt DSE were: achieved 85 % of the maximal predicted target 
heart rate, achieved maximal dose of both dobutamine and atropine infusions, 
extensive new wall motion abnormalities, horizontal or downsloping ST-
segment depression >0.2 mV 80 ms after the J point compared with the baseline, 
ST-segment elevation >0.1 mV 80 ms after the J point in patients without prior 
myocardial infarction, severe angina, symptomatic reduction in systolic blood 
pressure >40 mm Hg from baseline, hypertension (blood pressure >240/120 nnn 
Hg), significant arrhythmias or any serious side effect regarded as being due to 
dobutamine infusion. 
Grey scale echocardiographic imaging. The left ventricle was divided 
in 16 segments and visually assessed for both systolic wall thickening and 
inward wall motion. Each segment was graded on a 5-point scoring system (1 = 
normo- or hyperkinesia; 2 = mild hypokinesia; 3 = severe hypokinesia; 4 = 
akinesia and 5 = dyskinesia ) by an experienced observer blinded to the 
angiographic data. Ischemia was defined as a deterioration in score at any step of 
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the test in one or more segments, unless an akinetic segment at rest and low dose 
dobutamine became dyskinetic at peak dobutamine stress. Left ventricular wall 
motion score index was defined as the sum of the scores of the individual 
segments divided by the total number of segments. The RV free wall was 
evaluated for the quality of the visual assessment. 
Pulse-wave Doppler tissue sampling. Pulse-wave Doppler tissue 
sampling was performed with the Toshiba Powervision echocardiographic 
system (Toshiba Corp., Otawara-Shi, Japan), using a 2.5 MHz transducer and a 
pulse repetition frequency of 45-60 KHz. Pulse-wave Doppler tissue sampling 
was sampled from the RV free wall close to the tricuspid lateral annulus in the 
apical four-chamber view with high temporal resolution [4 ± 3 (1-7) ms]. The 
depth of the sample volume was kept constant in each patient during DSE. A 
sample volume with a fixed length of 4 nun was used. Both electrocardiogram 
and phonocardiogram were simultaneously recorded with the pulse-wave 
Doppler tissue sampling velocity profile and stored on videotape. The peak 
pulsed wave-Doppler tissue sampling velocity amplitude of ejection phase, early 
and late diastole were measured off-line using a computer assisted drawing 
system and the values were expressed in cm/s (Fig I). Five consecutive beats 
were analyzed and mean velocity values calculated, in order to minimize the 
measurement variability determined by respiration. E/ A ratio was also 
calculated. Cardiac cycles with extrasystolic, post-extrasystolic beats or any 
disturbance of the rhythm were excluded. Recordings and measurements were 
repeated at baseline, low dose (10 Jlg/kg/min) and max dobutamine infusion 
rate. 
Statistical analysis. Unless specified, data were expressed as mean 
values ± SD. Comparison of continuous variables was performed with the 
unpaired Student's t test. Comparison of propOltions was performed with the 
chi-square test and the Fisher's exact tests. A p <0.05 was considered 
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statistically significant. Sensitivity, specificity, predictive value and accuracy 
were presented with their corresponding 95% confidence interval (eI). 
Fig. 1: Pulsed wave-Doppler tissue sampling of the right ventricular free wall at rest 
(panel A), low dose (10 ~Ig/kg/min) (panel B) and peak dobutamine stress (panel C) in 
subject without right coronary alielY narrowing (Group I). Ejection phase velocity 
progressively increases from rest to peak dobutamine stress. EJ = ejection phase, E = 
early diastole, A = latc diastole. 
RESULTS 
Patient characteristics (Table I). There was no significant difference 
between group I and 2 with regard to clinical and angiographic data. Twenty 
patients (67%) had an old (> 3 months) myocardial infarction. Q wave in 03/a VF 
Table I. Clinical and angiographic data of patients without (group I) and with (group 2) 
. I . rIg 1t coronalY artelY nmTOWll~g. 
Group I Group 2 
(N ~ 19) (N ~ II) 
Age (years) 58.6 ± 10.7 53.6±9.9 
Male gender 16 (84%) 10 (91%) 
Previous infarction II (58%) 9 (82%) 
Anterior infarction 8 (42%) 3 (27%) 
Posterior infarction 3 (16%) 6 (55%) * 
Left ventricular ejection fraction 55 ±9 56 ± 10 
Left anterior descending coronary artelY stenosis 13 (68%) 6 (55%) 
Left circumflex coronary artery stenosis 8 (42%) 6 (55%) 
Antianginal therapy 18 (95%) 10 (91%) 
Beta-blocking agents II (58%) 6 (54%) 
* P < 0.05. . 
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electrocardiographic leads, which indicates posterior myocardial infarction, was 
encountered more frequently in group 2 (p <0.05; 6 patients). 
Coronary angiography (Table I). All patients had RCA dolllinance. In 
19 patients (group I) no significant narrowing was present in RCA. In this group 
a significant single vessel stenosis was found in the left anterior descending 
coronmy artery in 9 patients, in the circumflex coronary artery in 4 patients and 
in both in 4 patients. Two patients had a normal coronary angiogram and were 
included in group 1. In II patients (group 2) a significant narrowing was present 
in the proximal or medial part of RCA. In this group an additional single vessel 
stenosis was present in the left anterior descending coronmy artery in I patients, 
in the circumflex coronary artery in I patients and in both in 5 patients. 
Dobutamille stress echocanliography (Table II). There was no 
significant difference between group I and group 2 with respect to DSE 
parameters. Based on increase of wall motion score index fro111 rest to peak do-
Table II. Dobutamine stress and hemodynamic data of patients without (group I) and 
'h( ~ . I . Wit group ng It coronmy artery narrowlllg. 
Group I Group 2 
(N ~ 19) (N ~ II) 
Resting HR (bpm) 75 ± 12 76 ± 17 
Peak dobutamine HR (bpm) 131 ± 19 137± 10 
Resting SBP (mm Hg) 130 ± 21 128 ± 8 
Peak dobutamine SBP (nnn Hg) 139 ± 30 131±21 
HR x Systolic BP 9,750± 1,944 9,728 ± 2,036 
Peak HR x Systolic BP 18,209 ± 3,344 17,947±2,857 
Angina during the test 12 (63%) 3 (27%) 
ST -segment depression 8 (42%) 2 (18%) 
ST -segment elevation 1(5%) 1(9%) 
LV resting wallmotioll score index 1.30 ± 0.45 1.33 ± 0.33 
LV stress wall motion score index 1.35 ± 0.34 1.39 ± 0.33 
Left anterior descending coronary artelY field II (58%) 1(9%) • 
ischemia 
Left circumflex coronmy artery field ischemia 6 (32%) 3 (27%) 
Right coronmy artery field ischemia 0(0%) 4 (36%) * 
Atropine 9 (47%) 5 (45%) 
HR ~ heart rate (beats/min ~ bpm), L V ~ left ventricle, BP ~ blood pressure, * p < 
0.05. 
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butamine stress, ischemia prevailed in group I for the left anterior descending 
coronary mtelY field and in group 2 for the RCA field (p <0.05). 
Pulse-wave Doppler tissue sampling (Tables III-IV). A progressive 
increase of the ejection phase velocity, expressed by >25% increase from 10 
llg/kg/min (low dose) to peak dobutamine stress (Figure I) was predictive of a 
normal or non-significantly narrowed RCA, while a blunted increase, expressed 
by <25% increase of velocity (Figure 2) was predictive of a significantly 
narrowed RCA. 
Fig. 2: Pulsed wave-Doppler tissue sampling of the right ventricular free wall at rest 
(panel A), low dose (10 flg/kg/min) (panel B) and peak dobutamine stress (panel C) in 
subject with right coronal)' artcIY n3lTowing (Group 2). Ejection phase velocity does not 
increase from low dose to peak dobutaminc stress, EJ = ejection phase, E = early 
diastole, A ~ late diastole. 
Table III. Diagnostic accuracy of pulse wave-Doppler tissue sampling for the prediction 
of right coronary artery narrowing , 
Sensitivity Specificity PPV NPV Accuracy 
% 82 78 69 88 79 
95% C.1. 68-96 67-93 52-86 75-100 65-96 
C.l. = confidence intervals, NPV = negative predictive value, PPV = positive predicti-
ve value. 
The diagnostic accuracy of pulse-wave Doppler tissue sampling is shown in 
table III. In table IV a significant difference appears by comparing the mean 
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percentages of increase from low dose to peak dobutamine stress of the two 
groups: +37 % ± 27 (group I), + 4 % ± 27 (group 2) (p <0.01). The comparison 
of absolute velocities between the two groups was difficult because of a wide 
range of RV velocity values for each group and at each dobutamine step. 
Ejection 
Phase 
Velocity (cm/s) 
25 
20 
15 
10 
5 
o 
p < 0.05 
Group 1 Group 2 
BRest 
II Low Dose 
OPeak 
Fig 3: Pulsed wave-Doppler tissue sampling of right ventricular free wall during 
dobutull1illC stress echo cardiography. At peak dobutamine stress, ejection velocity 
absolute values of group 1 are significantly higher than group 2. 
Table IV. Pulsed wave-Doppler tissue sampling data of patients wilhout (group I) aud 
with (group 2) right coronmy artery narrowing , , 
Group I Group 2 
(N ~ 19) (N ~ II) 
EJ velocity at rest 12.4 ± 2.2 11.3±4.7 
EJ velocity at low dose IS.9±3.8 14.3 ± 6.S 
EJ velocily at peak stress 20.6 ± 7.S IS±7.2* 
%EJ rest-low dose 37 ± 27% 4±27% * 
E velocity at rest 10.7 ± 2.8 10.7 ± 4.9 
E velocity at low dose 1l.2 ± 3.3 12.7 ± 4.9 
E velocily at peak stress (18 patients) Il.9±3.4 12.2 ± S.3 
A velocity at rest 17.1±4.3 13.2 ± 6.4 
A "elocily at low dose 20.1 ± 4.7 IS.9 ± 8.8 
A velocity at peak stress (18 patients) 2S.3 ± 7.8 23.5 ± 7.8 
EtA at rest 0.6 ± 0.2 0.8 ± 0.3 
EtA at low dose 0.6 ± 0.2 0.8 ± 0.4 
EtA at peak stress (18 patients) O.S ± 0.4 O.S ± 0.2 
A ~ late diastole, E -' early diastole, EJ ~ej"eli()ilphase, *p< O:OS. 
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However, a borderline difference was found of the absolute velocity values at 
peak dobutamine stress between group I: 20.6 ± 7.5 cm/s and group 2: 15 ± 7.2 
cm/s (p ~ 0.05) (table IV) (Figure 3). 
E and A wave velocities were not measurable in 12 patients (40%) at 
peak dobutamine stress, because of the superimposition of both waves. 
Therefore, diastolic velocities could be measured in 18 patients (60%) at peak 
dobutamine stress. In spite of this non-significant difference, we noticed a trend 
to a deeper decrease of EI A ratio during DSE in group 2 (Table IV). The visual 
assessment of the RV free wall in grey-scale images was of poor quality in 3 
patients, while pulse-wave Doppler tissue sampling velocity profile could be 
recorded in all patients. Therefore, the feasibility of pulse-wave Doppler tissue 
sampling was 100%, vs 90% of visual assessment. 
DISCUSSION 
The main findings of our study were: I) a high predictive value of a 
significant RCA stenosis detected by a blunted increase pattel1l of pulse-wave 
Doppler tissue sampling ejection phase velocity values of RV free wall, 
measured at the tricuspid level, during DSE, and 2) a higher feasibility of pulse-
wave Doppler tissue sampling than grey-scale inlaging for RV free wall motion 
analysis, because of its higher signal-to-noise ratio. 
The amplification effect of longitudinal ventricular velocity 
assessment. By using pulse-wave Doppler tissue sampling at the basal level of 
RV wall in apical echocardiographic llnages, the velocity of longitudinal 
displacement may be considered expression of the longitudinal myocardial 
contraction. These longitudinal velocities are higher than inward wall motion 
velocities measured in parastel1lal views (12). This amplification effect, typical 
of the longitudinal asscssment, is determined by the vectorial SUln of the 
contraction velocity of each myocardial fibre interposed between the base and 
apex. 
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Myocardial mechanisms involved ill the present study population. 
According to titis amplification effect, longitudinal velocities do not increase 
during any step of DSE in the presence of a large nonviable scarred 
myocardium. Tn contrast, viable myocardial fibres interposed between the 
cardiac base and the apex are likely to increase proportionally the resulting 
velocity, measured at the base, at any step of DSE. According to the Bowditch 
phenomenon (13) the increased heart rate may partially counterbalance the 
hypo-contractile effect deriving from the shOltening of diastolic filling time at 
the ltighest heart rates, deriving from the Frank-Starling law. Dobutamine 
inotropic stimulation should further counterbalance this hypo-contractile effect. 
Therefore, considering the comparable level of heart rate achieved by each 
group of our patient population, we can assume that group 2, who exltibited a 
blunted increase of myocardial velocities from low dose to peak dobutamine 
stress, may had an amount of non-viable myocardium unable to counterbalance 
the Frank-Starling law. Conversely, group I may had a favourable balance 
between normal fibres and non-viable or ischemic fibres, thus enabling the RV 
wall to keep its contractile power at peak dobutamine stress. In absence of an 
accepted gold standard for pulse-wave Doppler tissue sampling or an 
ltistological myocardial evaluation, we emphasize the higher prevalence of RCA 
narrowing, posterior myocardial infarction and RCA field ischemia in the 
patients (group 2) with blunted increase of pulse-wave Doppler tissue sampling 
ejection velocities. 
Previous studies. We can make some assumptions from previous 
studies that used techniques which were different from pulse-wave Doppler 
tissue sampling to evaluate RV function. The tricuspid annulus excursion 
reflects the global function ofRV, as shown by Kaul et al. (14) and Wilson et al. 
(15). The hypothesis of impaired RV function in presence of a significant 
elu'onic RCA stenosis, regardless the presence of myocardial infarction, is 
sUPPOlted by Fujiwara et al. (16). These authors found reduced RV,ejection 
fraction at rest by MRT in presence of RCA disease without inferior myocardial 
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infarction. Our study found similar data during DSE: absolute velocity values 
were lower in group 2 than in group I, regardless the presence of a posterior 
myocardial infarction (17), yet more frequently documented (Table I) in group 2, 
or the presence of posterior myocardial ischemia. Therefore, a subendocardial 
fibrosis of the RV free wall is likely to prevent many patients of group 2 from 
achieving a further increase of ejection velocities at peak dobutamine stress. 
Study limitations. A bluntcd increase of velocity at peak stress, as 
shown by group 2, could also derive from the Frank-Starling law. The Bowditch 
phenomenon (13) should balance this limitation, as shown by our patients whose 
velocity patterns were not influenced by the level of heart rate achieved during 
DSE. Furthermore, the 85% of maximum heart rate, as criterion to stop the test 
and the absence of any ventricular dysfunction (18) further minimize any 
relevant interference from the Frank-Starling aw. A second limitation is the 
cardiac translational movement, further increased by DSE. Tlus movement is 
mainly influenced by the interventricular interaction in the direction of the 
ventricular short axis (19). Therefore, by excluding parasternal images, and by 
using the cardiac apex as a fixed reference point, this limitation could be 
minimized. 
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The assessment of myocardial viability has important clinical relevance. Since 
cunent acute coronaty revascularizations and acute tln'ombolysis in patients with 
acute coronaty ischemic syndromes, have rcsulted in recovelY of regional and 
global dyssynergic myocardium, it is of utmost clinical importance to determine 
myocardial regions which have potential to improve their function (i.e. 
myocardial viability). 
This so-called recovelY of function has becn studied by several noninvasive 
cardiologic techniques. Among these are nuclear techniques to evaluate 
myocardial flow and metabolism and echo Doppler techniques using 
phannacological inteventions. 
Myocardial viability is defined by reversible myocardial dysfunction which may 
be caused by eithcr myocardial stunning or myocardial hibernation. Several 
factors as summarized in Table I may influencc recovelY of myocardial 
dysfunction. 
Table I 
Potcntial factors that may influence recovery of myocardial dysfunction 
• amount and degree of stunning 
• amount and degree of hibernation 
• amount and degree of myocardial scar 
• presence of coronalY collaterals 
• overall left ventricular function 
• pri1l1aty myocardial disease (-it is or myopathy) 
Myocardial stunning is a transient prolonged post-ischemic dysfunction that may 
occur after restoration of coronary blood flow. Thus, despite the absence of 
irreversible damage mechanical dysfunction may persist for longer periods even 
after coronalY intervention procedures such as percutaneous trans luminal 
coronalY angioplasty or coronary artery bypass grafting. 
Hibernating myocardium is defined as myocardial dysfunction due to a chronic 
reduction in myocardial blood flow. It has beeen suggested that hibernating 
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myocardium IS caused by a chronic down regulation of contractile cellular 
function. 
A number of studies nowadays is directed towards the question whether 
restoration of myocardial blood flow by coronary revascularization may induce 
an improvement in myocardial function. If no recovery of myocardial is present 
in myocardial dysfunction then these areas are either necrotic or replaced by scar 
tissue fonnation. 
It is known that in patients with coronmy artelY disease either chronically or 
acutely both reversible and irreversible myocardial dysfunction can be present. 
The following methods both accepted and investigational have been used for the 
assessment ofmyoca"dial viability (see Table II). 
Table II 
Methods to determine myocardial viability 
Current: FDG-PET (gold standard) 
Tl injection 
Tc-qqm sestamibi 
Dobutamine stress echocardiography (ischemic and viability) 
Dobutamine stress elettrocardiography 
Investigational: Low dose dobutamine echocardiography with myocardial contrast 
Doppler tissue imaging 
Color kinesis 
Tc-qqm sestamibi, 201T! both at rest and after stress and recently studies with F-
18 Fluorodeoxyglucose (FDG) have been described and there are good 
correlations between these techniques. 
Currently FDG studies using Positron Emission Tomography (PET) are 
considered to be the gold standard for the assessement of myocardial viability. 
The same studies have been done with SPECT using a dual isotope technique 
(Tetrofosmin/FDG). Also Low Dose Dobutamine Echocardiography (LDDE) is 
proposed as an alternative method to determine residual myocardial viability. 
III 
Since at low doses of 5 to 15 Jlg/kg/min of dobutamine an inotropic effect is 
seen with moderate increase in heatt rate, LDDE scems a good altemative 
approach for the cardiologist. 
The LDDE studies are determined and analyzed by visual assessment of two-
dimensional echo (2DE) images. Although reasonable inter- and intra-observer 
variabilities (between 84% and 92%) have been described for all kinds of 
dobutamine stress echocardiography respectively there is still need for 
improvement. 
Therefore we propose an alternative approach and report our preliminaty 
experience using Doppler Tissue Imaging (DTI) for measurements of 
myocardial viability. 
DOPPLER TISSUE IMAGING 
For a detailed description of the method we refer to previous manuscripts (l,2). 
Briefly, Doppler tissue imaging uses pulsed wave Doppler to intenogate low 
velocity shifts. Doppler tissue imaging differs from standard blood pool Doppler 
in that high amplihlde, low frequency signals fonn the myocardium are 
processed and velocities calculated. Thus, high frequencies from the bloodpool 
are filtered and excluded from the analysis by Doppler tissue imaging. 
The myocardial velocities are currently displayed in the 2DE B-mode 
representation 'using a color-encoded overlay or as a graphic display of pulsed 
wave Doppler recordings. 
Low fi'equency shifts corresponding of 2 to 200 nun/sec are encoded in a color 
scheme analogous to that of standard color Doppler flow imaging. 
Doppler tissue imaging may be displayed either as a two dimensional tomogram 
or in color M-mode of a single spatial dimension over time. 
In Table III potential uses of Doppler tissue imaging are reported as modified 
from Bach and Armstrong (1). 
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Table III 
Potential uses of Doppler tissue imaging (DTI) 
• Wall motion analysis (diastolic and systolic) 
• Myocardial contractility 
• Intravenous contrast echo perfusion 
• Ventricular pre-excitation 
• Infarct size 
• Myocardial viability 
1 not yet validated 
1 not yet validated 
It is clear from this table that myocardial viability might be potentially studied 
by OTI but that the method has not been clinically validated yet. 
PRELIMINARY THORAX CENTER EXPERIENCE WITH DTI AND 
MYOCARDIAL VIABILITY 
The machine used in our Institution is the Toshiba Powervision. Sutherlandt et al 
(2) were the first to suggest a potential role for DTI in the assessment of 
myocardial viability. These authors found preserved systolic velocities on DTI 
within myocardial regions that appear akinetic on standard B-mode 
echocardiography. As will be discussed later we were not able to reproduce the 
finding of these authors. Mainly because we find it hard to observe color 
changes in a small region of interest. 
Using a M-mode display the myocardial velocities are displayed with greater 
sensitivity. It is seen that we use registration of heart sound in addition to 
Electrocardiography (ECG) for timing purposes. TIlls is especially impOltant if 
the myocardial velocities are displayed in a graphic format. Using this approach 
(graphic display of myocardial pulsed wave Doppler velocities) we studied right 
ventricular myocardial velocities in patients with and without a severe stenosis 
of right coronalY mtelY as the supplying mtelY (3). We found that pulsed wave 
OTI myocardial velocities used in conjunction with dobutamine can distinguish 
between patients with and without a >50% stenosis of the right coronmy mtelY. 
Innol1nal patients a continuous increase in myocardial velocities is seen whereas 
in patients with severe RCA stenosis a bi-phasic response is present. 
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In this respect we were directly confronted with a technical limitation of Doppler 
tissue imaging. We were not able to reproducibly put our Doppler sample 
volume on a akinetic area and keep the sample volume at this same place during 
dobutamine infusion. Therefore, as is shown in Figure I, we had to put the 
sample volume first outside the akinetic areas as assessed from 2DE llnages. So 
no information can be obtained from the akinetic area. We hypothesized that if 
no viable tissue was present, and no recovery of myocardial function was 
obtained after I 0 ~lg/kg/min of dobutamine, DTI myocardial velocities will not 
change. Conversely, if viable myocardium was seen then myocardial DTI 
velocities would lllCrease. Figure I shows 2DE images before and after low dose 
dobutamine (left and right side respectively). It is seen that after low dose 
dobutamine myocardial velocities of the regions first outside the akitletic area 
increase as is seen from the pulsed Doppler graphic display. 
Myocardial viability assessed by TOI 
Fig 1: Two-dimensional echo from AP4C views before and after LDDE. Sample 
volume of DTl is placed just outside the dyssynergic region with pulsed Doppler graphic 
display at the left side of both pichlres. Observe an increase in velocities after 10 
flglkglmin dobutamille concordant with viable tissue on 2DE imaging. For fmiher 
explanation see text. 
From the 2 DE analysis in this particular patient the so-called akinetic area 
shows recovety after LDDE: this analysis however has not excluded an increase 
of myocardial velocities of the studied region itself. In the fmt patients studied 
USlllg tlus methodology we could show a defuute increase in myocardial 
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velocities in patients with viable myocardium whereas in patients with scar 
tissue the increase of myocardial velocity was less (See Table VI). Furthermore, 
a regional analysis of pulsed wave Doppler forms from the myocardium was 
found to be too time consuming and impractical. 
In conclusion: although we show that our proposed method is feasible there are 
cunent strong limitations for Doppler tissue imaging inherent to the Doppler 
technology. Our preliminmy results show that this method until now precludes a 
useful assessment of myocardial viability. Further studies or improvements of 
Doppler tissue imaging methods are needed to increase our confidence of 
Doppler tissue imaging in patients myocardial dysfimction for the assessment of 
viability. A digital analysis system for color analysis on a pixel to pixel format is 
obligating for Doppler tissue imaging analysis. 
Table VI 
Problems encountered with DTI for myocardial viability 
• Technical 
• Time consuming (no regional pulsed waves Doppler) 
• High variability in color analysis 
• No algorithms for analysis of color on pixel to pixel formatting 
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ABSTRACT 
Background: Both nuclear imaging with Fl8-fluorodeoxyglucose [FDG] and 
dobutamine stress echo cardiography [DSE] have been used to identify viable 
myocardium, althongh DSE has been demonstrated less sensitive. 
Aim: To compare the accuracy of Pulsed-wave Doppler tissue sampling [PW-
DTS] with DSE for the detection of viable myocardium; using FDG imaging as 
a reference. 
Methods: FOity patients with chronic coronaty attelY disease and LV 
dysfunction [mean ejection fraction 33±11 %], underwent FDG imaging, DSE 
and PW-DTS. Evaluation was performed using a 6-segment model. 
Results: Visual assessment by resting echo was feasible in 230 out of 240 
segments [96%]; 177 [77%] segments showed severe dyssynergy at rest. FDG 
imaging showed viability in 95 [54%] segments while 82 [46%] were nonviable. 
Ejection [EJ] phase velocity at rest was not significantly different; EJ velocities 
during low-dose and peak-dose dobutamine however, were significantly higher 
in viable myocardium [8.6±2.9 vs. 6.0±1.8 and 9.3±3.1 vs. 6.2±2.l cm/sec]. 
Using receiver operating characteristic curves the optimal cut-off value for 
viability assessment was an increase of EJ phase velocity low-dose of 1±0.5 
cm/sec, while 0±0.5 cm/sec predicted non-viability. The sensitivity and 
specificity [95%CI] of PW-DTS and DSE for prediction of viability was 
respectively 87% [82-92] vs. 75% [67-81] [p<0.05] and 52% [44-59] vs. 51% 
[45-59] [p=NS]. 
Conelusions: Sensitivity of PW -DTS is superior to DSE for the assessment of 
myocardial viability. 
SUMMARY 
Both nuclear testing and dobntamine stress echo cardiography are used to assess 
myocardial viability. Pulsed-wave Doppler tissue sampling during dobutamine 
stress is a new technique for quantification of wall motion. The agreement 
between Pulsed-wave Doppler tissue sampling and nuclear scanning for 
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myocardial viability assessment was superior to that of dobutamine stress echo 
using the nuclear test as a reference. 
INTRODUCTION 
The presence of dysfunctional but viable myocardial in patients with severe LV 
dysfunction has therapeutic implications since revascularization may improve 
both the functional status and survival [I]. Among the different techniques to 
demonstrate myocardial viability, much experience has been gained with nuclear 
imaging using Fl8-fluorodeoxyglucose [FDG] or dobutamine stress 
echocardiography [DSE] and higher sensitivity of FDG imaging has been 
demonstrated [2]. Moreover, FDG imaging allows semi-quantitative analysis, 
while DSE relies on subjective visual intelpretation of wall motion [3]. Pulsed-
wave Doppler tissue sampling [PW-DTS] provides a quantitative parameter of 
myocardial contraction of the vectorial sllln of contraction velocities of 
myocardial fibres [i.e. longitudinal and equatorial contracting fibres] between 
the base and apex [4-6]. The importance of measuring longitudinal myocardial 
contraction was based on the observation that both the endocardial inward 
motion and the longitudinal contraction contribute equally to the ejection 
fraction [7]. 
In the present study we compared the use of PW-TDS with DSE for the 
identification of myocardial viability in patients with chronic coronaJY artelY 
disease and severe LV dysfunction, using FDG-SPECT as a reference method 
[8]. 
METHODS 
Patients: The study population comprised 40 patients [29 males, mcan age 56±9 
years] with reduced LV function [mean RNV-EF 33±11%] who underwent both 
DSEIPW-DTS and FDG-SPECT for the evaluation of viable myocardium 
[Tablel]. 
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Number of patients [%]. 
Previous M1 26 [65] 
History of angina pectoris 31 [78] 
Beta blocker therapy 14 [35] 
ACE-inhibitors 29 [73] 
Cardiac disease potentially interfering with either cardiac preload or after/oad, 
[e.g. valvular heatt diseases, pulmonaty or systemic hypertension, 
cardiovascular shunts] was a criterion for exclusion. 
Resting flVo-dilllensional echocardiography: All echocardiograms were 
performed with an ATL HDI 3000 imaging system equipped with a 1.8 MHz 
transducer using second hannonic imaging to optimise endocardial border 
visnalisation. Standard parasternal long- and short-axis views were obtained as 
well as apical long-axis 2- and 4-chamber views as described by the American 
Society of Echocardiography [9]. The LV was divided into six segments, 
[posterior septum, anterior septum, lateral, inferior, anterior, and posterior]. Each 
segment was divided into 3 sub-segments; wall motion was scored by the pattern 
displayed by 2/3 of the sub-segments. 
Pulsed-wave Doppler tissue sampling. Beta-blockers were not interrupted before 
testing. PW -DTS was performed with the Toshiba Powervision 
echocardiographic imaging system, by using a 3.7 MHz probe, with a pulse 
repetition frequency of 4.5-6.0 KHz. The temporal resolution of PW-DTS was 
4±3 ms. A sample volume of 4 mm3 was used. The continuous measurement of 
velocity of the myocardium close to the mitral annulus was sampled in apical 
views [posterior septum, anterior sephull, lateral, inferior, anterior, and posterior 
wall] during a minimum of 5 consecutive beats in order to minimise the 
variability induced by respiration. The depth of the sample volume of evelY wall 
was kept constant during DSE to make sure that LV myocardium was sampled 
close to the mitral annulus. 
The Doppler velocity profiles, electrocardiogram and phonocardiogram tracings 
were simultaneously stored on videotape. All the measurements were perfOlmed 
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off-line using a computer assisted drawing system. The velocity values [cm/s] 
were obtained on calibrated still frames by manually measuring the distance 
between the zero baselines and the peak Dopplcr profile of ejection phase [EJ], 
early [E] and late diastole [A] in reference to both electrocardiogram and 
phonocardiogram. The E/ A ratio was also calculated. Cardiac cycles with 
extrasystolic, post-extrasystolic beats or any rhythm disturbance were excluded. 
Recordings and measurements were made at baseline, low dose [10 fIg/kg/min] 
and peak dobutamine infusion rate. 
Dabl/tamine stress echocardiagraphy: Beta-blockers were not interrupted before 
testing. After baseline echocardiography, dobutamine was infused at a starting 
dose of 5 fIg/kg/min for 5 min, followed by 10 fIg/kg/min for 5 min [low-dose 
stage]. Dobutamine was then increased by 10 fig/kg/min evelY 3 minutes up to a 
maximum dose of 40 fIg/kg/min. Atropine [1-2 mg] was added at the end of the 
last stage if the target heart rate [85% of the maxinlal predicted heart rate] had 
not been achieved. ~mages were acquired continuously and recorded on tape at 
the end of evelY dose-step. In addition the baseline, low-dose, peak stress, and 
recovelY images [standard apical and short-axis views] were displayed in a 
cine loop fon11at. End points for intel111ption of the test were: I) achievement of 
target heart rate; 2) maximal dose of both dobutamine and atropine; 3) extensive 
new wall motion abnonnalities; 4) horizontal or downsloping ST-segment 
depression [0.2 mV 80 ms after the J-point compared with the baseline]; 5) 
severe angina; 6) symptomatic reduction in systolic blood pressure> 40 nun Hg 
from baseline; 7) hypeltension [blood pressure >2401120 mm Hg]; 8) significant 
arrhythmia's or 9) any serious side effect regarded as being due to dobutamine 
infusion. 
Echocal'diagraphic analysis: The LV was divided into six segments, [posterior 
sephnn, anterior septum, lateral, inferior, anterior, and posterior]. Each segment 
was divided into 3 sub-segments and visually scored by 2 experienced reviewers 
[R.R and D.P., blinded to the FDG-SPECT data] for both systolic wall 
thickening and inward wall motion. Wall motion was scored by the pattern 
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displayed by 2/3 of the sub-segments. A 5-point scoring system [I ~ 
normokinesis; 2 ~ mild hypokinesis; 3 ~ severe hypokinesis; 4 ~ akinesis and 5 
~ dyskinesis] was used. Segmeuts with normal wall motion or mild hypokinesia 
were considered normal and viability was assessed only in the severely 
dysfunctional segments [severe hypokinesia, a- or dyskinesia]; four types of wall 
motion responses were observed during the infusion of dobutamine: I) biphasic 
pattern: improvement of wall motion during low-dose with worsening at high-
dose; 2) worsening: deterioration of wall motion without initial improvement; 3) 
sustained improvement: improvement of wall motion at low- or high-dose 
dobutamine; 4) no change: unchanged wall motion. Severely dysfunctional 
segments exhibiting a biphasic response, worsening or sustained improvement 
wcre considered viable, whereas the severely dysfunctional segments with 
unchanged wall motion were considered scar tissue. The inter- and intra-
observer concordance of resting wall motion score wcre respectively 94% and 
97%, whereas the inter- and intra-observer concordance for the response of wall 
motion during dobutamine infusion were 92% and 94% respectively. 
FDG-SPEer imaging: Patients received an intravenous dose of 600 MBq 
99"'teclmetium-tetrofosmin to evaluate resting regional perfusion. To enhance 
cardiac FDG uptake, the patients received 500 mg Acipimox [Byk, The 
Netherlands] orally, followed by a carbohydrate-enriched meal. Acipimox is a 
potent nicotinic acid derivative that reduces plasma levels of free fatty acids, 
thereby stimulating cardiac glucose [and FDG] uptake. This meal stimulated 
endogenous insulin release, thereby further promoting cardiac glucose [and 
FDG] uptake. Several shldies have shown that this approach yields an excellent 
image quality, comparable to that obtained with hyperinsulinemic glucose 
clamping [10, 11]. FDG [185 MBq] was injected 60 min after the meal. A 45-
min period after FDG injection was allowed for myocardial FDG uptake, 
followed by the dual-isotope simultaneous acquisition SPECT. Cardiac 
medication was not discontinued for the SPECT study. 
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Data acquisition was performed with a triple-head gamma camera system 
[Picker Prism 3000 XP, Cleveland, OH, USA] equipped with 511 keY 
collimators. The energies were centred on the 140 ke V photon peak of 
99mteclmetium-tetrofosmin with a 15% window and on the 511 ke V photon peak 
of FOG with a 15% window. Imaging was performed over 3600 [120 sectors of 
3°] with a total imaging time of 32 min. Data were stored in a 64x64, 16-bit 
matrix. The raw scintigraphic data were reconstructed by filtered back projection 
using a Butterworth filter [cut-off frequency at 0.17 cycle/pixel, of order 3.5]. 
No attenuation correction was employed. Fmther reconst1'llction yielded standard 
long- and shott-axis projections perpendicular to the heart-axis. Reconst1'llcted 
slices were 8 n1111 in all projections. The perfusion and FDG short -axis slices 
were adjusted to peak myocardial activity [100%]. The myocardium was divided 
into six segments [matching the echocardiographic segments, including anterior, 
lateral, posterior, infetior, posterior septum and anterior septum]. Segments were 
divided into four categories [assessed visual with the assistance of nonllalised 
tracer activity], showing normal tracer uptake [>75% activity], mildly reduced 
tracer uptake [50-75% activity], severely reduced tracer uptake [<50% activity] 
or absent tracer uptake. 
The dysfimctional segments [identified by resting echocardiography] were 
divided into viable and nonviable segments. Segments with normal perfusion, 
mildly reduced perfusion and FDG uptake, or severely reduced/absent perfilsion 
with increased FDG uptake [mismatch] were classified viable, while segments 
demonstrating severely/absent perfusion with concordantly reduced FDG uptake 
were classified nonviable. 
Statistical analysis. Unless specified, data were expressed as mean values ± SD. 
Comparison of continuous variables was performed with the Student's t-test. 
Comparison of proportions was performed with the chi-square test and the 
Fisher's exact tests. Sensitivity and specificity were presented with their 
corresponding 95% confidence intelval [CI]. Kappa value was also calculated. 
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To assess the optimal cut-off point ofPW-DTS assessed EJ velocity at low dose 
and at peak dose dobutamine for the detection of myocardial viability, we used 
receiver operator's characteristics [ROC] curve. In theses curves, the sensitivity 
vs. specificity of a test was plotted, in which the sensitivity is a fraction of 
positive classification for all patients who satisfY the viability criteria of FDG-
SPECT and specificity is the fraction of all negative classifications for all 
patients who satisfY the non-viability criteria of FDG-SPECT. A p-value< 0.05 
was considered significantly. 
RESULTS 
Baseline characteristics. Visual assessment by resting echo was feasible in 230 
out of 240 segments [96%). One hundred seventy seven [77%) segments showed 
severe dyssynergy at rest; severe hypokinesia in 115 [65%); akinesis in 61 
[34%); and dyskenesis in I [0.6%). Per patient the mean number of 
dysfunctional segments was 4.4±2.5. During dobutamine infusion PW-TDS 
could be assessed in 227 / 240 [95%) segments and wall motion patte111s could 
be scored in 230 / 240 [96%). The analysis of FDG-SPECT was feasible in all 
240 segments. 
FDG-SPECT: In 177 severely dyssynergic segments viability was present in 95 
[54%); nonnal perfusion in 57 [32%); mildly reduction in perfbsion and FDG 
uptake in 20 [I 1%); mismatch in 18 [10%). Non-viability was present in 82 
segments [46%) [Figure I). 
P/Y-DTS. The feasibility of the anterior wall, anterior septum, posterior, inferior, 
lateral, posterior septum was 85%, 90%, 93%, 100%, 100%, and 100% 
respectively. The analysis of PW-DTS velocity profile showed significant 
morphological variations for each wall and each dobutamine step. Velocity 
patte111s assessed at rest, low dose and at peak dobutamine are presented in Table 
II. 
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Table II. Pulsed Doppler mean ejection phase velocities (cm/sec ± Standard 
Deviation) and E/A ratio's of each left ventricular wall during dobutamine stress 
echocardiography. (1) Viable myocardium, as assessed by FDG-SPECT, reveals 
bigher ejection phase velocities than (2) nonviable myocardium both at low dose 
and peak dobutamine. No significant differences are shown by rest ejection 
phase velocities and by E/ A ratio 
EJ rest (1) EJId (1) EJ peak (1) EJ rest (2) EJ Id (2) EJ peak 
(2) 
PS 5.8 ± 1.7 7.8 ±2.6 9.8 ± 3.2* 5.4 ± 2.2 7.0 ± 3.3 7.4 ± 3.0 
L 6.0 ± 1.6 8.6 ± 2.4* 9.6 ± 3.2* 4.1 ± 1.5 4.5 ± 1.8 4.6 ± 1.7 
I 6.8 ± 1.6 8.3 ± 2.0* 9.1±3.0* 4.9 ± 2.1 6.2 ± 3.2 7.1 ± 3.2 
A 6.2 ± 1.8 8.3 ± 2.8* 9.1 ± 2.8* 4.8 ± 1.7 6.5 ± 2.4 5.5 ± 3.3 
AS 6.3 ± 1.6 8.2 ± 2.4* 9.4 ± 2.9* 4.8 ± 2.3 6.2 ± 2.8 6.2 ± 3.0 
P 6.4 ± 1.9 8.6 ± 2.9* 9.3±3.1* 4.5 ± 1.5 6.0 ± 1.8 6.2 ± 2.1 
Total 6.4 ± 1.9 8.6 ± 2.9* 9.3±3.1* 4.5 ± 1.5 6.0 ± 1.8 6.2 ± 2.1 
E/A rest (I) E/A Id (I) E/A peak E/A rest (2) E/A Id (2) E/A peak 
(1) (2) 
PS 0.6 ± 0.2 0.6 ± 0.2 0.4 ± 0.2 0.9 ± 0.2 0.7 ± 0.3 0.6 ± 0.3 
L 0.5 ± 0.2 0.4 ± 0.2 0.4 ± 0.4 0.6±0.2 0.6 ± 0.3 0.4 ± 0.3 
I 0.6 ± 0.2 0.4 ± 0.3 0.3 ± 0.2 0.8 ± 0.3 0.7 ± 0.4 0.3 ± 0.2 
A 0.7 ± 0.2 0.7 ± 0.2 0.4 ± 0.3 0.8±0.2 0.5 ±0.3 0.4 ± 0.3 
AS 0.9 ± 0.2 0.7 ± 0.2 0.3 ± 0.4 0.7±0.2 0.7 ± 0.2 0.3 ± 0.2 
P 0.8 ± 0.2 0.7 ± 0.3 0.4 ± 0.2 0.8 ± 0.3 0.8 ± 0.4 0.3 ± 0.4 
Total 0.5 ± 0.2 0.5 ± 0.2 0.4 ± 0.4 0.8 ± 0.3 0.8 ± 0.3 0.6 ± 0.3 
A - anterior wall, A - late diastole, AS - anterior septum, E - early diastole, EJ - ejection 
phase, I = inferior wall, L = lateral wall, Id = low dose, P = posterior wall, PS = posterior 
septum, (l) viable segments, (2) non-viable segments, * p < 0.05. 
For each segment PW -DTS recognised 4 patterns of contraction [Figure 2). E/ A 
ratio was not feasible in 15 patients [38%) at peak stress, because of 
superinlPosition between A and E waves, thus limiting the feasibility of PW-
DTS diastolic evaluation at peak stress to 62%. 
DSE. The 177 severely dyssynergic segments exhibited four different patterns of 
wall thickening. [Figure 3). Ninety-seven segments [55%) were considered 
nonviable. 
PW-DTS "S. FDG-SPECT. Improvement of ejection phase velocities at low dose 
and peak stress dobutamine for viability assessment were classified in two 
patterns with the highest sensitivity and specificity based on ROC curves using 
FDG-SPECT as a reference. Viability by PW -TDS at low-dose corresponded 
124 
82 
18 
m normal 0 mildly reduced 0 mismatch ~ nOll viability 
Figure 1. Pie-chart showing FOG-SPECT patterns of 177 severely dyssynergic 
segments for viability: normal perfusion and FOG uptake n = 57 (32%), mildly 
reduced perfhsion and FOG uptake n = 20 (II %), mismatch n = 18 (I 0%); and 
for nonviability: n = 82 (46%). 
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rnJ sustained 0 biphasic 0 late worsening mJ sea .. 
Figure 2. Pie-chart showing PW-TOS patterns of 177 severely dyssynergic 
segments: sustained improvement n = 102 (58%), biphasie n = 20 (II %), late 
worsening n = 7 (4%), no change n = 48 (27%). 
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Figure 3. Pie-chart showing DSE patterns of 177 severely dyssynergic 
segments: sustained improvement n ~ 48 (27%), biphasic n ~ 20 (11 %), late 
worsening n = 12 (7%), no change n = 97 (55%). 
with an improvement of velocity of 1±0.5 em/sec [n ~ 129) [73%). Non-viability 
corresponded with no improvement [O±0.5 cm/sec) [n = 48) [27%). PW-TDS 
had a sensitivity of 87% [82-92), specificity of 52% [44-59) for the prediction of 
viable myocardium. 
Viability by PW-TDS at peak-dose corresponded with an improvement of 
velocity of 0±0.5 cm/sec with a sensitivity of 64% [58-71), a specificity of 62% 
[56-69). However, these data added no diagnostic value to PW PW-DTS for the 
assessment of myocardial viability [p=NS). 
Agreemellt betweell PW-DTS alld DSE vs. FDG-SPECT. Mean EJ velocity 
values increased at low dose dobutamine more in viable than non-viable walls 
[Table III). This increase, 1±0.5 cm/see, compared to 0±0.5 cm/sec, exhibited an 
incremental value to DSE for the diagnosis of myocardial viability. The 
sensitivity of DSE respectively PW-DTS was 75/87% [p <0.05), specificity was 
51152% [p ~ NS) [Table III). 
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Table III. Diagnostic accuracy for detection of myocardial viability in severely 
dyssynergic segments: (I) DSE versus FDG-SPECT, (2) PW-TDS versus FDG-
SPECT. PW-TDS shows an increased sensitivity (p <0.05) to DSE to detect 
myocardial viability. Data are presented as percentages with 95% confidence 
intervals. 
Sensitivity Specificity PPY NPY Accuracy 
(1) DSE versus FDG-SPECT 
75 (67-81) 51 (45-59) 72 (65-79) I 54 (47-60) 66 (58-73) 
2) PW-TDS versus FDG-SPECT 
87 (82-92)' 52 (44-59) 76 (62-82) 69 (62-75) 74 (67-80) 
NPY = negative predictive value, PPY = positive predictive value, * p < 0.05. 
E/ A ratio showed a regional variation. However, E/ A ratio changes from rest to 
low dose failed to predict myocardial viability. 
DISCUSSION 
In patients with ischemic LV dysfunction and myocardial contractile reserve, 
coronaty revascularization improves both functional capacity and prognosis of 
survival [I]. The most cost-effective imaging teclmiques to detect reversible 
contractile function currently are stress echo cardiography and nuclear 
perfusion/metabolism imaging. Echoeardiography has the advantage of 
widespread availability but subjective evaluation remains a limitation [3]. 
Doppler tissue imaging provides quantitative data and therefore merits clinical 
evaluation for testing patients for viability. The PW-TDS allows sampling of 
selected segments and we used this for measuring the velocities of six 
myocardial segments. We conelated subjective wall motion scores during DSE 
and quantitative data of PW-DTS with FDG-SPECT. This method has 
comparable accuracy for viability detection to positron emission tomography 
and was used as a reference [8]. 
The main finding of the present study is a higher sensitivity of PW-DTS than 
DSE for myocardial viabi lity detection when FDG-SPECT is used as a 
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reference. This finding is explained by the amplification effect of basal 
assessment by PW-DTS, able to detect even small amounts of viable 
myocardium disseminated between base and apex. However, PW -DTS may 
overestimate the presencc of myocardial viability. In segments with scar tissue 
increased contraction velocity during low-dose dobutamine may occur due to a 
tethering effect of adjacent viable segments. Most of these observations are 
made in akinetic segments in the intravcntricular septum. A possible way to 
avoid this would be a multi-sampling approach, in additional areas between the 
base and the apex or by using parasternal views [the latter allows assessing a 
limited number of segments]. On the opposite, an underestimation may be 
related to a lack of contractile function in severely dyssynergic areas, with 
preserved epicardial metabolic activity. These findings arc consistent with 
higher myocardial integrity required for an inotropic response than for a 
metabolic uptake. This was also shown by PET imaging werc areas with a 
mismatch patte1'll of flow/metabolism by PET failed to improve after 
revascularization [1]. 
Potential advantages of /Ising the long axis. Cumulative velocities obtained in 
apical views by PW -DTS, in contrast to the equatorial velocities, represent the 
vectorial sUtn of contraction velocities of myocardial fibres between the base and 
apex. The importance of the longihtdinal contraction for the evaluation of the 
LV function was emphasised by Gibson et al. [12] using M-mode at the level of 
the mitral amlUlus in apical views. It was shown that longihtdinal contraction 
contributes to half of the LV ejection fraction and adds prognostic infol1nation 
for late cardiac event [7]. Also diastolic PW-DTS parameters are better 
investigated by the longihtdinal approach [13,14]. Finally the use of apical views 
excludes virtually any global cardiac displacement, as the apex acts as a fixed 
reference point and the displacement of the cardiac base toward the apex as the 
result of only myocardial fibres contraction [15]. 
RespiratolJ' effect on LV jimction. Respiration affects more right than left 
ventricular dynamics. Garcia et al. [13] showed by averaging a sequencc of 5 
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beats, usually encompassing a nOimal respiratOlY cycle, a minima1 effect on LV 
dynamics. In our study we also used the average of 5 consecutive beats. 
Dohutamine infusion protocol. We used a low-dose dobutamine [5 and 10 
~Ig/kglmin, 5-min step] infusion protocol. As shown in a previous study, in the 
"classic" low-dose stepwise protocol starting with I O-~Ig/kglmin for 3-min, 
sufficient dobutamine plasma concentrations might not be achieved to evaluate 
improved wall thickening in all patients [16]. In all patients a sufficient plasma 
dobutmnine concentration to evaluate improved wall thickening [80-90 nglml] 
was achieved after a 6-min. infusion period. We therefore assessed improved 
wall thickening after IO-min. dobutamine infusion. 
Comparison with previous Doppler tissue studies. So far, few repOits indicate 
the potential of Doppler tissue imaging [DTI] and more particularly PW -TDS, to 
detect myocardial viability [6]. Gorcsan et al. [17] sampled velocity profile by 
colour M-mode during dobutamine in apical 4-chamber view close to the mitral 
annulus. They demonstrated an increased sensitive for myocardial viability, 
compared to the same approach in parasternal view. Moreover, even other 
traditional viability parameters were less sensitive than the basal longitudinal 
approach. Recently, the longitudinal approach using PW-DTS was also used to 
detect myocardial ischemia in the animal model [18]. After induction of 
ischemia in pigs it was shown that myocardial contraction velocity was reduced 
using a single sample ofPW-DTS in apical views. 
In our study peak EJ velocity of nonviable myocardium reproduced velocity 
values ofabnOimal myocardium found by Katz et al [l9] and Yamada et al [20]. 
Most of our EJ velocity values remained below the cut-off of 12 cm/sec as 
reported by Yamada et al [20] as typical of normal contracting myocardium. 
The severity of resting myocardial dyssnergyy in our study may explain the low 
magnitude of velocity increase under dobutamine, wIllIe in normal myocardium 
a higher and earlier increase of EJ velocity was reported by Gorcsan et al [17]. 
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Study limitations. Due to time limitations of the standard DSE protocol, 
especially at peak stress, we rejected a 16-segment approach. We were also not· 
able to measure the equatorial contraction, due the Doppler angular dependence. 
Recent advances, e.g. anatomical M-mode, show potential for overcoming tlus 
latter limitation [2l]. 
In conelusion: In patients with severe LV dysfunction, longitudinal PW-DTS 
provides quantitative information and was complementaty to DSE for the 
assessment of myocardial viability. 
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ABSTRACT 
Background: Viable myocardium in patients with severe left 
ventricular (LV) dysfunction predicts improved outcome and survival after 
revascularization. 
Aim: To compare two different techniques: dobutamine-atropine stress 
echo cardiography (DSE) and dual-isotope simultaneous acquisition (99mTc_ 
tetrofosminlfluorinc 18-fluorodeoxyglucose (FOG» single photon emission 
computed tomography (DISA-SPECT) for assessment of viable myocardium. 
Methods: One hundred ten patients (mean age 55±9 years) with LV 
dysfunction (mean LV-ejection fraction 27±13%) underwent both DISA-SPECT 
and DSE. A 16-segment scoring model was adopted for both techniques. Four 
types of wall motion during DSE were assessed: I) biphasic: improvement at 
low dose (10 flg/kg/min) with worsening at high dose; 2) worsening: 
deterioration without initial improvement; 3) sustained: persisted or late 
improvement and 4) no change. Viability criteria were biphasic, worsening and 
sustained improvement by DSE. Viability criteria by DISA-SPECT were normal 
perfusion and metabolism (normal) or concordantly mildly reduced perfusion 
and metabolism (subendocardial scar) or severely reduced perfusion and 
increased metabolism (mismatch). Myocardium was considered non-viable by 
DSE in case of unchanged wall motion, or moderate reduction or absence of 
both 99"'Tc-tetrofosmin perfusion and FOG uptake by DISA-SPECT. 
Results: Of 1756/1760 analyzable left ventricular segments, 1373 (78%) 
had severe wall motion abnonllalities at baseline (severe hypokinesia, akinesia, 
or dyskinesia). Out of these abnormal segments, 282 (21 %) wcre considered 
viable dUling DSE: 63 (5%) with biphasic response, 47 (3%) with ischemia and 
172 (13%) with sustained improvement, while 1091 (79%) were considered 
nonviable. By DISA-SPECT, 396 (29%) segments were considered viable: 312 
(23%) with matched perfusion/metabolism and 84 (6%) with mismatch, wIllIe 
977 segments (71 %) were considered nonviable. Both techniques showed 
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agreement for viability in 20 I segments and 896 were concordantly classified as 
non-viable. Disagreement was present in 276 segments of which 195 (71%) 
were non-viable by DSE and viable by DISA-SPECT. The overall agreement 
between the two techniques was 81 %, kappa 0.46, in a subgroup of patients with 
an ejection fraction <25% 78%, kappa 0.39. 
Conclusions: DSE and D1SA-SPECT showed a good agreement for the 
assessment of viable myocardium not influenced by resting ejection fraction. 
However, DSE underestimated the amount of viable tissue as compared to 
D1SA-SPECT. 
INTRODUCTION 
Non-invasive assessment of viable myocardium helps to determine the 
optimal treatment in patients with chronic ischemic left ventricular dysfunction: 
medical therapy, coronary revascularization or heart transplantation. In the 
presence of viable myocardium, revascularization may improve LV function and 
prognosis (l,2). Both nuclear imaging and dobutamine-atropine stress 
echocardiography (DSE) are available to assess myocardial viability (3-5). 
DSE is a relatively new developed technique to assess viability (3,4). The 
halhnark for viability is the improvement of systolic wall thickening and motion 
of a dysfunctional segment during low-dose dobutamine infusion. Many studies 
have determined the value of low-dose dobutamine echocardiography for the 
prediction of functional recovelY after revascularization (6). More recently, a 
combination of low- and high-dose dobutamine echocardiography appeared 
more accurate to assess myocardial viability (7). This was related to the 
induction of ischemia during high-dose dobutamine infhsion. 
Currently, nuclear imaging with F-18 f1uorodeoxyglucose (FDG) and positron 
emission tomography (PET) remains the reference method to detect viable 
myocardium(8). In the PET studies,regional FOGuptakc iscQmpared with 
regional perfusion. It appeared that dysfunctional segments with either normal 
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perfusion and FDG uptake or decreased perfusion with (relatively) increased 
FDG uptake (perfusion-FDG mismatch) have a high likelihood of functional 
recovelY after revascularization. In contrast, dysfunctional segments with 
concordantly reduced perfusion and FDG uptake (perfusion-FDG match) do not 
improve in function after revascularization (9). However, PET imaging is 
currently not able to mcet the increasing demand for viability studies, due to its 
limited availability (10). Therefore, various centres have recently explored the 
use of single photon emission computed tomography (SPECT) to evaluate 
cardiac FDG uptake (11-14). Besides the widespread availability, SPECT 
imaging allows simultaneous acquisition of perfusion and cardiac FDG uptake. 
The dual-isotope simultaneous acquisition protocol shortens imaging time and 
enhances patient throughput. 
While combined perfusion-FDG imaging with either PET or SPECT provides 
information on viability (or resting ischemia), DSE provides information on both 
viability and stress-induced ischemia. It is unknown how these two approaches 
comparc. Accordingly, we have performed a head-to-head comparison between 
FDG SPECT and DSE in patients with chronic ischemic left ventricular 
dysfunction. 
METHODS 
Patient selection: We prospectively enrolled 110 patients (mean age: 
55± 9 years, 79 men). Inclusion criteria were: I) stable coron3lY altery disease, 
(i.e. no recent myocardial infarction, unstable angina or ovelt heart failure), 2) a 
resting left ventricular ejection fraction 530% assessed by radionuclide 
ventriculography, 3) presence of 2 or more adjacent severely dysfunctional 
segments on resting echo cardiography, 4) no primary cardiomyopathy. The local 
medical ethics committee approved the study protocol. 
DSE: All 'echocardiograms were performed with an ATL HDI 3000 
imaging system equipped with a 1.8 MHz transducer using second harmonic 
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lI11agmg to optimize endocardial border detection. Beta blockers were not 
interl1lpted before testing. After baseline echocardiography, dobutamine was 
infused at a statiing dose of 5 J.lg/kg/min for 5 min, followed by 10 rlg/kg/min 
for 5 min (low-dose stage). Dobutamine was then increased by 10 J.lg/kg/min 
evelY 3 minutes up to a maximum dose of 40 J.lg/kg/min. Atropine (1-2 mg) was 
added at the end of the last stage if the target heart rate had not been achieved. 
Images were acquired continuously and recorded on tape at the end of every 
dose-step. In addition the baseline, low-dose, peak stress, and recovelY images 
(standard apical and shOli-axis views) were displayed in a cineloop format. End-
points for intel111ption of the test were: I) achievement oftat'get heart rate (85% 
of the maximal predicted heart rate); 2) maximal dose of both dobutamine and 
atropine; 3) extensive new wall motion abnol1nalities; 4) horizontal or 
downsloping ST-segment depression ~0.2 mV 80 ms after the J-point compared 
with the baseline; 5) severe angina; 6) symptomatic reduction in systolic blood 
pressure> 40 nun Hg from baseline; 7) hypeliension (blood pressure >240/120 
nun Hg); 8) significant arrhytlullia' s or 9) any serious side effect regarded as 
being due to dobutamine infusion. 
Echocardiographic analysis: The left ventrie1e was divided into 16 
segmcnts (according to the American Society of Echocardiography, (15) and 
visually scored by 2 experienced reviewers (D.P., R.R., blinded to the SPECT 
data) for both systolic wall thickening and inward wall motion. AS-point 
scoring system (I ~ nortllokinesis; 2 ~ mild hypokinesis; 3 ~ scvere hypokinesis; 
4 ~ akinesis and 5 ~ dyskinesis) was used. Segments with normal wall motion or 
mild hypokinesia wcre considered normal and viability was assessed only in the 
severely dysfunctional segments (severe hypokinesia, a- or dyskinesia). Four 
types of wall motion responses were observed during the infusion of 
dobutamine: I) biphasic pattem: improvement of wall motion during low-dose 
with worsening at high-dose; 2) worsening: deterioration of wall motion without 
initial improvement; 3) sustaincdimprovcment: improvement of wall motion at 
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low- or high-dose dobutaminc; 4) no change: unchangcd wall motion. Severely 
dysfunctional segments exhibiting a biphasic response, worsening or sustained 
improvement were considered viable, whereas the severely dysfunctional 
segments with unchanged wall motion were considered scar tissuc. Segments 
with akinesia at rest, which bccame dyskinetic during stress were not considered 
ischemic. Tllis is considered to be a mechmlical phenomenon (16) The inter- and 
intra-observer concordance of resting wall motion score were respectively 94% 
and 97%, whereas the inter- and intra-observer concordance for thc response of 
wall motion during dobutamine infusion were 92% and 94% respectively. 
Dual-isotope simultaneous acquisition SPECT: Following an 
overnight fast, the patients received an intravenous dose of 600 Mbq technetium-
99m tetrofosmin to evaluate resting regional perfusion. To enhance cardiac FDG 
uptake, the patients received 500 mg Acipimox (Byk, the Netherlands) orally, 
followed by a carbohydrate- and protein-enriched meal (providing 70 g 
carbohydrate, 41 g protein and 21 g fat for a total of 639 calories). Acipimox is 
nieothlic acid derivative that reduces plasma levels of free fatty acids, thereby 
stimulating cardiac glucose (and FDG) uptake. This small meal sthnulated 
endogenous hlSUlhl release, thereby further promothlg cardiac glucose (and 
FDG) uptake. Several studies have shown that tllis approach yields an excellent 
image quality, comparable to that obtained with hyperinsulinemic glucose 
clamphlg (17). FDG (185 Mbq) was injected 60 min after the meal. A 45 min 
period after FDG injection was allowed for myocardial FDG uptake, followed 
by the dual-isotope simultaneous acquisition SPECT. Cardiac mcdication was 
continued during the SPECT study. 
Data acquisition was performed with a triple-head gamma camera systcm 
(Picker Prism 3000 XP, Cleveland, OF!, USA) equipped with 511 keY 
collhnators. Thc energies were ccntcrcd on the 140 ke V photon peak of 
teclmetium-99m tctrofosmin with a 15% window and on the 511 keY photon 
peak of FDG with .. a 15% .. window . .Imaging was perfonnedover360°(l20 
sectors of 3°) with a total imaging time of 32 min. Data were stored in a 64x64, 
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16-bit matrix. From the raw scintigraphic data 6-n1ln thick (I pixel) transaxial 
slices were reconstructed by filtered back projection using a Butterworth filter 
(cut-off frequency at 0.17 cycle/pixel, of order 3.5). Slices were not corrected for 
attenuation. Further reconstruction yielded long- and short-axis projections 
perpendicular to the heart-axis. 
SPECT analysis: For the interpretation of the SPECT llnages, the 
technetium-99m tetrofosmin and the FDG short- and long-axis slices were 
displayed side-by-side. The left ventricle was divided into 16 segments (6 basal 
(anterior, anterolateral, inferolateral, inferior, inferoseptal, anteroseptal), 6 distal 
and 4 apical segments, conesponding to the echocardiographic segments (see 
above). The segmental tetrofosmin and FDG uptake was scored by consensus of 
2 experienced observers (blinded to the echo data) using a four-point grading 
system (0 = nonnal, I = mildly-moderately reduced, 2 = severely reduced and 4 
= absent). According to this scoring model, criteria of viability were: I )normal 
perfusion and FDG uptake, 2)concordantly mildly-moderately reduced perfusion 
and FDG uptake, or 3)reduced pcrfhsion with preserved or increased FDG 
uptake (mismatch). Segments with severely reduced or absent perfusion and 
concordantly reduced (or absent) FDG uptake was considered scar tissue. 
Radionuclide ventriculography: Radionuclide ventriculography was 
perfonncd at rest with the patient in SUPllIC position after administration of 740 
Mbq of technetium-99m. Images were acquired with a small filed of view 
gamma camera (Orbiter, Siemens Corp.) oriented in the 45° left anterior oblique 
position with a 5° to 10° caudal tilt. The left ventricular ejection fraction was 
calculated by an automated tecimique. 
Statistical analysis: Unless specified, data were expressed as mean 
value ± standard deviation or percentage ± confidence interval (CI). Comparison 
of dichotomous variables was performcd by contingency tables, from which 
correlation and kappa-values with standard enors were calculated. A p-value of 
<0.05 was considered significant. 
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RESULTS 
Mean LV ejection fraction assessed by radionuclide ventriculography 
was 27±13%. Patient characteristics are presented in Table I. 
Table I Characteristics of 110 patients , 
Number of patients (%) 
LV ejection fraction 25-30% 78 (71) 
L V ~ectioll fraction <25% 32 (29) 
Angina pectOlis 93 (86) 
Class 1 1 (1) 
Class II 20 (19) 
Class III 71 (66) 
Class IV 1 (1) 
Diabetes mellitus 14 (13) 
Medication 
ACE-inhibitors 80 (73) 
Beta blockel's 58 (54) 
Calcium antagonists 46 (43) 
Nitrates 48 (44) 
Diuretics 56 (52) 
COl'onal'Y angiogl'aphy 
t -vessel disease 33 (30) 
2-vessel disease 37 (34) 
3-vessel disease 40 (36) 
. . .. ACE-mlubltors- angtotensill COllvertmg enzyme mlubltOlS. 
DSE. During DSE heart rate increased from 66±9 to 129± 14 beats/min 
(p <0.01). Blood pressure increased from 113±19/66±18 to 130±25171±14 
mmHg (p <0.01). Test end-point was target heart rate in 105 (95%) patients. The 
test was intel111pted in five patients at peak stress because of side effects. Three 
patients experienced severe and symptomatic hypotension (decrease systolic 
blood pressure >40 nlluHg) and two patients developed sustained ventricular 
tachycardia (> 10 complexes). There were no fatal complications or myocardial 
infarctions. Adequate echographic visualization was achieved in 1756/1760 
(99%) LV segments. Of 1756 ventricular segments, 1373 (78%) had severe 
abnormal wall motion at baseline (including 823 severely hypokinetic segments, 
517 akinetic and 33 dyskinetic segments). Wall motion assessed during DSE 
yielded 4 different patterns: 63 (5%) biphasic, 47 (3%) worsening, 172 (13%) 
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sustained improvement and 1091 (79%) no change (table II). The prevalence of 
viable myocardial segments, according to DSE, was 282/1373 (21%), while 
1091 (79%) were considered nonviable. 
Table II. Agreement for each pattern of wall motion during DSE for assessment 
of viability 
Echo pattel11 N Scan viable (%) Scan nonviable (%) 
Biphasic 63 53 (86) 10 (14) 
Sustained In 145 (84) 27(16) 
Ischemic 47 32 (68) 15 (32) 
Scar 1091 195 (18) 896 (82) 
99mTc-tetl'ofosminIFDG SPECT. Feasibility of 99ll'Tc-tetrofosmin/FDG 
SPECT was 100%. Of the 1373 severely dysfunctional segments 396/1373 
(29%) were classified viable according to the scan findings: 190 (14%) exhibited 
normal FDG uptake and 99n'Tc-tetrofosmin perfusion in, 122 (9%) had a mild-
moderate reduction in both perfusion and metabolism and 84 (6%) had a 
mismatch pattem. Conversely, 977 (71 %) segments exIlibited no viability, as 
defined by concordantly severely reduced or absent perfusion and metabolism. 
Comparison of the two techniques: The wall motion responses during 
DSE and the c011'esponding DlSA-SPECT pattcms are presented in figure I. 
While segments with a biphasic response showed the highest incidence of 
viability assessed by scan (53/63, 84%), the segments with no change during 
DSE revealed the highest incidence of nonviability by scan (925/l091, 85%). 
The segments with sustained improvement and worsening on DSE had an 
intermediate incidence of viability by scan of 84 and 68% respectively. Hence, 
the agreement between the two techniques was 80%, with a kappa value of 
0.46±O.03 (table II). This concordance was not significantly different for 
segments with severe hypokinesia at rest vs segments with a or dyskinesia at 
rest. 
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Fig. 1: Correlation between DSE patterns of \vall motion and simultaneous myocardial 
flow/metabolism assessed by DISA-SPECT. DSE wall motion patterns were described 
as: biphasic: improvement of wall motion during "low-dose" dobutamine with 
worsening" at peak. Ischemic: deterioration of wall motion without initial improvement. 
Sustained: improvement of wall motion at low or high dose dobutumine. Scar: no 
change. Scan patterns were described as: Nannal: normal perfusion and metabolism. 
Mild match: concordantly mildly reduced perfusion and metabolism (subendocardial 
scar). Mismatch: severely reduced perfusion and increased metabolism. Scar: moderately 
reduced to absent perfusion and FDG uptake. 
Agreement of a subgroup 32 patients with a L YEF <25% was slightly 
lower 78%, kappa 0.39±0.04 than those with a higher L YEF (Table III). 
Disagrcement was present in 276 segments of which 195 (71 %) were non-viable 
by DSE and viable by DISA-SPECT. 
Table m. Agreement by DSE and scan for assessment of viability in relation to 
. . . fi' I b d' I'd . I I rest111g ejectIon mctIon assessee yra [onuc [ e vcntncu ograp [y. 
N Agreement (%) Kappa± SEM 
All patients 110 80 0.46±0.03 
Ejection fraction >25% 78 81 0.46±0.03 
Ejection fraction <25% 32 78 0.39±O.04 
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The relation between rest myocardial perfusion, assessed by 99mTc-tetrofosmin, 
and wall motion pattern during DSE is presented in Table IV. There was a 
significant reduced perfusion at rest in segments with a scar pattel11. Segments 
with a sustained improvement and an ischemic response showed a normal or 
mildly reduced perfusion in respectively 78 and 70%. 
Table IV. Relation between myocardial perfusion, assessed by 99mTc-tetrofos-
min and wall motion pattem during DSE 
DSE No. Nonnal perfusion (%) Mildly reduced Severe reduced 
pattem peribsion (%) perfusion (%) 
Biphasic 63 56 19 25 
Ischemic 47 54 16 30 
Sustained 172 62 16 22 
Scar 1091 19 12 69 
DISCUSSION 
The present Shldy addresses a head-to-head comparison in patients with 
severe LV dysfunction between patterns of wall motion during DSE and 
simultaneous resting myocardial flow/metabolism assessed by DISA-SPECT for 
the detection of viable myocardium. There is a good con'elation of the two 
imaging teclmiques for detection of myocardial viability on segmental basis, 
uninfluenced by resting ejection fraction. These data are in agreement with 
previous reports correlating low dose DSE with thallium-201('oITI)IFDG 
SPECT (6). 
Nuclear imaging techniques. The reference method to detect viable 
myocardium remains FDG PET (8,9). FDG uptake within hypoperfused 
segments predicted fimctional improvement after revascularization with the 
highest accuracy (8,9). To overcome limitations to FDG PET routine clinical 
use, due to restricted availability, high costs and complex teclmology, an 
alternative technique has been recently developed, able to image both FDG 
uptake and myocardial perfusion by SPECT (11-13). FDG uptake may be 
studied by special gamma cameras equipped with special511keV collimators, 
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obtaining cither planar imaging or SPECT imaging (13). This approach has been 
validated for prediction of functional recovelY aftcr revascularization in patients 
with LV dysfunction. The sensitivity and specificity of this method for 
prediction of recovery of function was respectively 85% and 86%, comparable 
to FDG PET (6). Howcver, so far, myocardial perfusion and metabolic uptake by 
SPECT required separate acquisitions, rcsulting in a misaligmnent between flow 
and metabolic imaging. This was overcome by the use of 99"'Tc_MIBI or 99mTc_ 
tetrofosmin, both 99mTc-agents, allowing dual-isotope simultaneous acquisition 
(13). The simultaneous acquisition of both perfusion and metabolism, as in the 
present study, may improve accuracy for detection of viable myocardium. The 
diagnostic accuracy may be further increased by the use of a nicotinic acid 
derivative (acipimox) (17). By the reduction of circulating free fatty acid levels 
and the stimulation of glycogcn synthetase activity the glucose and subsequently 
the FDG uptake of the hemt is increased. This simple orally taking drug offers a 
practical advantage over the previous hyperinsulinemic glucose clamping 
method (18). 
DSE patterns. DSE has become a promising imaging modality to assess 
viable myocardium (3,4). A complete test, compared to only low dose, is more 
accurate to predict left ventricular functional recovelY after revascularization. 
This was ascribed to the ability of full dose dobutamine to recognize more 
accurately the 'biphasic and ischemic response, which have thc best prognosis for 
recovelY of function after revascularization (7). These ischemic responses may 
be missed if only a low dose dobutamine protocol was performed. 
Correlation DSE patte1'lls and scan, what do they mean? The 
pathological substrate of each pattem is a subject of discussion. A biphasic 
responsc is considered the best marker of myocardial viability (3,4). After an 
improvement of wall motion at low dose, a decrease at peak dobutamine 
indicates a limited coronalY flow reserve. In this study this response had the 
highest perceutage of viable tissue .assessed bytetrofosnunlFDG SPECT, 86%. 
This is in agreement with the study of Afridi et al (7). In a group of 34 patients, 
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12 showed predominantly a biphasic response during OSE. In this group wall 
motion score improved after revascularization significantly at rest, low and 
peak-dose dobutamine. Tlus improvement of contractile response after 
revascularization during OSE may also have additional prognostic value. Further 
studies are needed to clarify this issue. 
In the ischemic segments, only worsening during stress, there was a 
moderate correlation between the resting myocardial flow and metabolism, 68% 
of these segments showed viability hy tetrofosmin/FOG SPECT. Coronary flow 
reserve and collateral flow is probably so limited that initial improvement of 
wall thickening in these segments is impossible. This can occur irrespective of 
resting myocardial flow and metabolism as shown in our study. 
Sustained improvement is a pattern with a good agreement for nuclear 
assessed viability. This pattern should indicate viable epicardial myocardium, 
able to compensate the subendocardial scar, with preserved coronalY flow 
reserve. Unlike the biphasic pattern, after a hypercontractile response at low 
dose, at peak stress there is no worsening. However, if we describe 1ubemating 
myocardium as a reduction of coronary flow reserve in dyssynergic segments, it 
is difficult to include this pattern in lubemation, as the coronmy flow reserve is 
able to meet the increased metabolic requirement at peak stress. This probably 
explains to low prognostic value for improvement of function of segments with a 
sustained improvement during DSE after revascularization as shown by the 
studies of Afridi et al (3,7). 
The last pattern of no wall motion change represents a transmural scar 
and we observed a significant reduction of both myocardial flow and FOG 
uptake in 82% of these segments. However, 18% segments with tlus pattern 
exhibited FOG uptake. These data comply with previous studies demonstrating 
that segments, akinetic at DSE, can be viable at FDG-PET, and exhibit 
improvement of contractile function after revascularization (17). 
Coronaty flow assessed by tetrofosmin perfusion at rest is not 
discriminative for a DSE pattern, with the exception of a scar. A scar pattern 
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during DSE exhibited a nOl1nal or mildly reduced perfusion at rest in only 31 %. 
In segments with a biphasic, ischemic and sustained improvement a n01111al or 
mildly reduced perfusion was present in 75, 70, and 78% respectively. However, 
this resting flow pattern is not related with coronary flow reserve which is the 
limiting factor in both ischemic and biphasic pattems. 
Major flndings. We found a high conelation between DISA-SPECT 
and DSE, irrespective of resting ejection fraction and wall motion pattern by 
echo, even if the two teclmiques assess different aspects of myocardial function. 
Another ftnding of our study is that DISA-SPECT, compared to previous results 
by using thallium-imaging (6), has a better discrimination for nonviable 
segments. Tllis superiority of DISA-SPECT may be explained by the fact that 
FDG uptake is based on membrane metabolic function. Tllis pelformance 
renders DISA-SPECT quite similar to FDG-PET in detecting viable 
myocardium. 
Disagreement between the two techniques. We found a higher 
prevalence of viability by nuclear imaging, compared to DSE. This may be 
related to the degree of myocyte damage, in wllich the functional integrity 
required for contractile response is lost, wllile the metabolic activity for 
membrane function is preserved. The agreement between DSE and DISA-
SPECT of about 80% probably results from the fact that these two teclnliques 
assess different myocardial functions. This may suggest a complementary use of 
both. 
Study limitations. There were two major linlitations. Firstly, DSE 
interpretation was, subjective. Although there was a high inter and intraobserver 
agreement tllis potential disadvantage may reduced by the introduction of 
quantitative techniques like Doppler tissue imaging (19). A second linlitation of 
the present protocol of DISA-SPECT was the performance under resting 
conditions. For a complete reconstruction of the viability proftle of each 
myocardial segment a s.tress teclnlique may be required, thus allowing 
assessment of flow/metabolic ischemia, to match with the dobutamine ischemia. 
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Unfortunately, we did not have the opportunity to compare our results with the 
improvement of left ventricular function after revascularization; however, tlus 
was not goal of the present study. 
CONCLUSIONS 
There is a good correlation between myocardial flow/metabolism assessed by 
DISA-SPECT and myocardial viability assessed by DSE irrespective of resting 
ejection fraction. Tlus suggests that these two tec1nuques share a potential for an 
accurate prediction of functional improvement after revaseularization. 
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ABSTRACT 
Objective: To assess the feasibility, safety and side effects of atropine 
addition to dobutamine stress echocardiography (DASE) for the detection of 
viable myocardium in patients with left ventricular (LV) dysfunction [ejection 
fraction (EF) $35%] prior to coronaty revascularization. 
Background: The assessment of viable and/or ischemic myocardium has 
high prognostic value for improvement of function and survival after coronaty 
revascularization. The addition of atropine to dobutamine during 
echocardiographic testing for the presencc of viable myocardium is not common 
practice. Consequently, no data exist on safety and additional diagnostic value of 
this practice. 
Methods: Two hundred patients with LVEF $35% were studied. 
Results: Test end-point were: target heatt rate in 164 (82%), severe 
angina in 18 (9%), maximum dobutamine-atropine dose in 6 (3%), severe ST-
segment changes in 5 (2%), cardiac arrhythmias in4 (2%), and hypotension in 3 
(I %) of the patients. Viability could be assessed echocardiographically in 
105/200 (53%) by a bi-phasic response (improvement of wall motion at low 
dose dobutamine and worsening at high dose) or ischemia in 93 and sustained or 
late improvement in 12 patients. In 36/105 (34%) patients ischemic myocardium 
could only be assessed after the addition of atropine. Cardiac arrhythmias 
occurred in 111200 (6%) and hypotension (decrease of systolic blood pressure 
>30 mmHg) in 211200 (II %). Neither the use of atropine nor the induction of 
ischemia were associated with an increased incidence of cardiac al1'hythmias or 
hypotension. 
Conclusions: In a large group of patients with severe LV dysfunction 
DASE is feasible in 186/200 (94%), safe and atropine addition was necessaty in 
34% to assess myocardial viability. Hypotension and cardiac arrhythmias were 
the most frequent occurring side effects, but were not related to the induction of 
ischemia and addition of atropine. 
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INTRODUCTION 
Dobutamine-atropine stress echocardiography (DASE) is commonly 
employed to assess the location, extent and severity of coronmy mtelY disease 
(I). DASE is particularly useful in patients who Call1lOt exercise because of non-
cardiac disease, and when ECG abnormalities preclude the diagnosis of 
ischemia. Dobutamine is a relatively selective p I-adrenoceptor agonist with 
weak a and p2-adrenoceptor stimulating propelties. At infusion rates of 5-10 
pg/kg/minute, dobutamine elicits primarily a positive inotropic response, while 
significant positive chronotropic effects are apparent when more than 20 
~lg/kg/minute is infused (2). During DASE, atropine is mostly used to increasc 
heart rate when the c1n·onotropic response to dobutamine is inadequate to induce 
ischemia (3-5). 
The safety of DASE for ischemia detection has been extensively 
evaluated. The most frequent side effects are hypotension and an-hythmia's (3-
10). Hypotension occurs more often in the absence of chronic beta-adrenoceptor 
therapy (2). Cardiac an-hythmias occur in about 3% of patients and are related to 
the presence of extensive resting wall motion abnormalities and a histOlY of 
atrial or ventricular an-hytlunia's (8). 
Recently, DASE has been used to evaluate the extent of viable 
myocardium in patients with severe left ventricular dysfunction (11,12). When 
stUlllled, hibernating, or ischemic myocardium is demonstrated, aggressive anti-
ischemic therapy, and/or coronary revascularization may improve cardiac 
function and survival, providing an alternative to heart transplantation (13). Two 
characteristic echocardiographic patterns have a high diagnostic value for viable 
myocardium: I) a bi-phasic response to dobutamine infusion, with initial 
improvement in wall motion at low doses, followed by worsening at higher 
infusion rates and 2) an ischemic response (14). In order to make a correct 
decision for revascularization in these high risk patients both factors are 
important. We believe that a complete DASE testing. may provide additional 
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information, especially regarding worsening of wall motion at peak stress with 
or without initial improvement at low-dose dobutamine. However, recently 
Rahimtoola (15) and Nagueh (16), expressed their concern that DASE may 
induce cardiac anhythmias or myocardial infarction in patients with extensive 
rest wall motion abnormalities. The principal purpose of this study was I) assess 
the utility of addition of atropine to high dose dobutamine for the detection of 
myocardial viability and 2) to evaluate the feasibility and safety of DASE in 
patients with a reduced left ventricular function, prior to coronary 
revascularization. 
We hypothesized that use of atropine is feasible, safe and has 
incremental diagnostic value in severe ischemic cardiomyopathy. 
METHODS 
DASE was attempted in 201 qualifying patients during the period 1995-
1997. All patients had undergone coronaty angiography within the preceding six 
weeks, and were selected to undergo coronary revascularization. All were 
studied for detection of jeopardized myocardium and had a resting L VEF of 
~35% as assessed by radionuclide ventriculography or cineventticulography. 
Adequate echo cardiographic unages could not be obtained in one (0.5%) patient. 
Data from the remaining 200 patients are reported here. 
DASE: Beta-blocker medication was not discontumed for the study. A 
resting two-dimensional transthoracic echocardiographic examination, including 
standard apical and parasternal views of the left ventricle was performed and 
recorded on quad screen format (n~80) or as consecutive standard views 
(n~120) on video tape. A restulg 12-lead ECG was obtained. Dobutamine was 
administered intravenously by infusion pump at 5 flglkg/minute and increased to 
10 fIg/kg/minute after 5 minutes (low dose stage). The uuusion rate was then 
ulcreased by 10 J.lg/kg/millute evelY 3 minutes to a maximum of 40 
J.lg/kg/minute .. (high .dose stage), and continued for 6 minutes. If signs and 
symptoms of ischemia were absent during the high dose stage, and a target heatt 
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rate [(220-age) X 0.85 in men, and (200-age) X 0.85 in women] was not 
achieved, atropine was administered iv in 0.25 mg increments, to a maximum of 
2 mg, while the dobutamine infusion was continued. During the test, the 12-lead 
EeG was monitored continuously and recorded each minute. Blood pressure was 
measured non-invasively at rest and at each stage of the protocol. The two-
dimensional echocardiogram was monitored continuously and recorded during 
the last minute of each stage and during recovery. The recovery phase was 
considered complete, when heart rate had returned to within 10 bpm of baseline. 
The criteria for stopping the test were: a symptomatic decline in systolic 
blood pressure of more than 30 mmHg from the resting value or a systolic blood 
pressure of less than 90 mmHg; significant cardiac anhythmias; severe anginal 
chest pain; horizontal or downsloping electrocardiographic ST depression of 
20.2 mV measured 80 ms after the J point; ST-segment elevation of20.2mV in 
the absence of Q waves; and severe new echo cardiographic wall motion 
abnormalities in multiple locations. 
Off-line assessment of echocardiographic images was performed by two 
independent investigators. The intra and inter-observer agreement of the 
interpretation of the echocardiographic images was respectively 92 and 90%. 
The left ventricular wall was divided into 16 segments (17) and wall motion 
subjectively scored on a five-point scale: I = normal; 2 = mildly hypokinetic; 3 
= severely hypokinetic; 4 = akinetic, and 5 = dyskinetic. Viable myocardium 
was considered to be present in segments exhibiting severe dysfunction at rest 
(severe hypokinesia, akinesia, or dyskinesia) plus either of the following: I) 
improvement at low dose and worsening at high dose (bi-phasic response); 2) 
continuous or late improvement; 3) worsening of movement without initial 
improvement, with the exception of akinesia becoming dyskinesia whieh was 
considered to be a mechanical phenomena. Severely dyssynergic segments 
without change of wall motion during DASE were considered as non-viable or 
scar. For each patient, a wall motion score index (total score divided by the 
number of assessable segments) was calculated at rest, at the end of the 10 
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fIg/kg/minute stage, and during peak strcss based on the standard 16 segment 
modcl. 
Statistical analysis: The study population (with LVEF S35%) was 
divided in two sub-groups according to their ejection fraction. Chi-square 
analysis was performed to evaluate differences in the use of atropine, the 
occurrence of angina, ST -segment changes, NWMA, hypotension and cardiac 
all'hytlunias during DASE bctween patients with LVEF S25% and those with 
LVEF >25%. Reportcd are odds ratio's (OR) with corresponding 95% 
confidence intervals (Cl). 
Haemodynamic variables (heart rate, systolic and diastolic blood 
pressure) are described as mean ± standard deviation (SD). Differences in 
hacmodynamic measurements at rest, low-dose (l0 J.lg/kg/min) and peak-dose 
dobutamine infusion between patients with and without viable myocardium were 
evaluated by Student's t-tests. Differences were considered significant at the 
0.017 probability level (thus applying Bonferroni's correction for 3 repeated 
comparisons). 
RESULTS 
Demographics. The study group had the following characteristics: male, 
188 (94%); mcan age 63 years, range 34 to 78; previous myocardial infarction, 
188 (94%); typical angina pectoris, 134 (67%); diabetes mellitus rcquiring drug 
therapy, 16 (8%). Eighty patients (40%) were being treated with angiotensin 
converting enzyme inhibitors, and 22 (11%) were taking ~-adrenoceptor 
blocking agents. LVEF was S25% in 96 patients (48%), and between 26 and 
35% in 104 (52%). All patients had angiographically significant coronary artery 
stenosis (>50% narrowing of the luminal diameter). Single vessel coronmy 
artelY disease was present in 24 patients (12%); two-vessel disease in 64 patients 
(32%), and three-vessel disease in 112 paticnts (56%). 
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Feasibility af DASE. In 13 patients the test was non-diagnostic either 
becausc it was stopped prematurely because of side effects (sustained ventricular 
tachycardia (dO complexes) [n~31, atrial fibrillation [n~ll, severe, symptomatic 
hypotension [n~3]), or because the target heatt rate was not achieved despite 
maximal dobutamine and atropine doses [n~61. The overall feasibility of the test 
was 187/201 (93)%. The number of patients at dobutaminc stages during stress 
test is presented in table I. 
Table 1: Hemodynamic characteristics of 200 patients during dobutamine-
ttl d' I D t t d ± SD a ropme s ress ec lOCal' IOgrapny. a a prcsen c aSlnean 
Dobutamine rest 5 10 20 30 40 40+ 
I ~Iglkg/min atropine 
N 200 200 200 182 124 III 64 
Heart rate (bpm) 76±13 76±13 89±17 101±18 113±19 125±26 135±16 
SBP (mmHg) 124±22 125±22 125±23 I 26±24 I 24±24 I 24±25 121±22 
DBP (nllnHg) 74±14 67±14 67±14 65±14 65±13 66±13 67±13 
n.- number of pattents stttdted; bpm- beats per mmute; SBP- systolIc blood 
pressure; and DBP~ diastolic blood pressure. 
In the remaining 187 patients the test endpoint was: the target hcart rate (n~164, 
82%); angina pectoris (n~18, 9%); electrocardiographic evidence of severe 
ischemia (n~5, 2.5%). Stress induced ischemia developed in lOS patients (52%), 
manifest as bi-phasic response or new or worsening wall motion abnormalities in 
93 patients (46%), and ST segment changes in 81 patients (40%). The mean wall 
motion score at rest was 2.24, range \.60-3.5. Stress induced ischemia was more 
frequent in patients with L YEF <;25%. In 3611 05 patients ischemia could only be 
assessed during the addition of atropine on top of dobutamine. During the 
recovelY phase no persistent new wall motion abnormalities were detected. 
Echocardiographically detected viable myocardium was present in 105 patients 
(52%); sustained or late improvement in 12 and bi-phasic response or ischemia 
in 93 patients. 
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Hypotension. Hypotension occurred in 31 % of patients during DASE. In 
40 patients (20%) the decrease of systolic blood pressure was 10-30 mmHg and 
in 21 patients (11%) >30 mmHg. The test had was stopped in only 3 patients 
(1.5%) because of severe dizziness, in all other patients the decrease of 
bloodpressure occurred at the end of the test. The occunence of hypotension was 
not correlated with stress induced ischemia (OR 0.9, 95% CI 0.5 to 1.9), diabetes 
mellitus (OR 2.1, 95% CI 0.7 to 6.0), absence ofbeta blockers (OR 1.3, 95%CI 
0.3 to 4.8) or L VEF :0:25% ( OR 1.8, 95% CI l.l to 9.5). 
Cardiac arrhythmias. Cardiac arrhythmias occurred in II patients (5%); 
supraventricular tachycardia in 2 (1%); nonsustained ventricular tachycardia « 
I 0 complexes) in 5 (2.5%); sustained ventricular tachycardia (2 10 complexes) 
in 3 (1.5%); and atrial fibrillation in I (0.5%). Anhythmia's were not more 
frequent in patients with LVEF :0:25% (OR 0.9, 95% CI 0.8 to 2.8) or when 
myocardial ischemia was induced by DASE (OR 0.9, 95% CI 0.3 to 3.4) 
Atropine. Atropine was added in 64 patients (32%) of which 36 showed 
myocardial ischemia and was administered more frequently to patients with 
L VEF :0:25% (OR 2.3, 95% CI 1.3 to 4.3) (Table 2). 
Table 2: Clinical and dobutamine-atropine stress test characteristics of patients 
. I 1ft· I d ft (EF <25'X) Wit I severe e ventncu ar ::tys lllction o . 
O.R 95% CI 
Atropine 2.3 1.3-4.3 
ST segment l' J, 1.9 1.1-3.4 
NWMA 1.8 1.0-3.2 
Hypotension 1.8 0.7-4.6 
Anhythmia's 0.9 0.8-2.8 
Diabetes mellitus 0.9 0.4-1.9 
Beta blockers 0.8 0.3-1.9 
.. Atropme - atropllle addItIOn on top of maxnllum dose dobutanllne, up to 2.0 mg 
i.v.; NWMA ~ echocardiographic detected new wall motion abnol111alities; 
Hypotension ~ decrease of systolic blood pressure> 30 mmHg compared to rest. 
Patients on beta blocker therapy did not require atropine more frequently (OR 
0.8, 95% CI 0.3 .to 1.9). There .was no association between atropine 
administration and the induction of cardiac arrhytlnllias (OR 0.7,95% CI 0.2 to 
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2.9) or the occurrence of hypotension (decrease bloodpressure >30 mmHG) (OR 
1.8, 95% 0.94-3.4) (Figure I), although the latter relationship approached 
statistical significance. 
Figure 1: The percentage of patients with hypotension with or without additional 
atropine administration. lvlild hypotension~ decrease of systolic blood pressure of 10-30 
mmHg and severe hypotension= decrease of systolic blood pressure >30 mmHg during 
DASE. There was no significant increase of mild or severe hypotension after atropine 
addition. 
Blood pressure response /0 low-dose dobu/amine. Haemodynamic 
changes during DASE are presented in Table I. In patients with viable 
myocardium both systolic and diastolic blood pressure were significantly higher 
during low dose dobutamine infusion, than in patients without myocardium at 
risk (1'< 0.05) (Table 3). Tills difference was no longer apparent at peak 
c10butamine infusion rates and may reflect improved myocardial function at low 
dobutamine infusion rates in patients with viable myocardium. 
Recove!)'. No persistent wall motion abnormalities were detected at thc 
end of the recovery phase. There were no deaths or myocardial infarctions. 
Table 3: Hemodynamic changes during DASE in patients with and without echocardio-
I' I d bl d' grap llcally detecte via e myocar Itun. 
Dobulamille rest rest p LO\v low Ip ! peak peak Ip 
Viable no I yes No yes no yes 
n 98 102 98 102 28 36 
Heart rate 76±13 76±I3 0.8 91±18 87±17 0.3 138±I3 I3I±19 0.06 
(bpm) 
SBP(mmHg) 126±22 121±22 0.08 122±22 132±24 0.03 120±20 118±23 0.8 
DBP(mmHg) 73±14 75±I3 0.3 65±14 71±14 0.01 65±II 68±14 0.4 
n~ number of patIents studied; bpm- beats per lllmute; SBP= systolIc blood pressure; 
D8P~ diastolic blood pressure; viable~ echocardiographically detected improved wall 
motion with or without worsening at peak stress or new wall motion abnonnalities; p = 
difference between viable a'nd 110il viable gi"oilp; lo\v= 'low"'" dose d6hiltail11ile 
(lOflg/kglmin); peak~ 40flg/kglmin with addition of atropine; and ns ~ not significant. 
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DISCUSSION 
Our results show that the addition of atropine was nccessary III 36 
patients to peak dobutamine infusion for the assessment of myocardial ischemia 
in 200 patients with severe LV dysfunction during stress echocardiography. So 
atropine addition inlproves the accuracy of stress echocardiography for ischemia 
assessment in 34%. DASE can be safely used to detect the presence of viable 
myocardium in patients with coronaty mtely disease and severe LV dysfunction. 
The presence of viable myocardium was infen'ed if wall motion improved with 
low dose dobutamine infusion, or if new wall motion abnormalities developed at 
any point during DASE. 
It was necessmy to administer atropine to 41 % of the entire study group 
in order to reach the target heart rate. Atropine was requircd more frequently in 
the patients with more severe LV dysfunction (EF <;25%), although beta 
blockers were not used more frequently in this subgroup. Thc addition of 
atropinc did not induce cardiac arrhythmias, although there was a tendency for 
hypotcnsion (a decrease of systolic blood pressure of >30 ml11Hg compared to 
the resting valuc) to occur morc frequently after atropinc administration (OR 1.8, 
95% CI 0.94 to 3.3). 
Comparison with previous sludies. DASE is conmlOnly used for the 
detection and evaluation of coronary artelY diseasc (14,18). In patients with 
severe LV dysfunction it can detect the prcsence of viable myocardium 
(improvement of wall motion at low dose followed by worsening at high dose, 
ischemia, 01' late or sustained improvement) which influences prognosis and 
therapy (12,14,19). The recent study of Williams et al (19) evaluating the 
prognostic value of viable andlor ischemic myocardium by DASE in patients 
with severe LV dysfunction, showed a high cardiac event rate during 16±8 
months of follow-up of 43 vs 8% in patients with viability andlor ischemia. The 
cardiac event rate was not diffcrent in patients with viable or ischemic 
myocardium. Especially for the ischemic response high dose of dobutamine 
often in combination with atropine is frequently neccssaly. Safety ofDASE with 
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regard to cardiac arrhythmias was however not asscssed. There is the concern 
that serious cardiac arrhythmias or infarction might be more frequent in patients 
with a history of severe left ventricular dysfunction (8). In our study, side effects 
caused the test to be stopped prematurely in only 6% of patients. These results 
compare favorably with pooled data from the literature evaluating patients with 
proven or suspected coronary artelY disease (Table 4), where a failure rate of 
16% was repOited. 
Table 4: Overview of dobutamine-atropine stress cchocardiography data for analysis of 
proven or suspecte d d' coronatyartclY lsease. 
Author year n Atro- Feasibility arrhythmia's Hypo· mml-lg 
pine tension 
~lcrtes 1993 illS no 73711118 86 AF/shVf 36 16·84 
1'larwick 1993 217 no 152/217 6 shVT/SVT 36 >20 
Poldennans 1994 650 yes 633/650 24 AF/shVTI 34 >20 
susVTIVF 
Picano 1994 2949 yes 2608/2949 178 Ventricular 62 >30 
tachyarrhy/SVT 
Pingitore 1996 360 yes 323/360 23 Ventricular 3 >30 
tachYan-h'IAF 
Ling* 1996 1171 yes 240 SVT/AF/shVT 
Anthopouios 1996 120 no 1081120 2 AI' 8 >20 
Totul 6595 4562(84%) 559(8%) 179(3%) 
n= total number of patients; ""= the study of Lmg et al was only evaluated for the 
presence of cardiac arrhythmias; atropinc= addition of atropine in sub-maximal cases; 
AF~ atrial fibrillation or atrial flutter; shVT~ shott ventricular tachycardia (3-10 
complexes); susVT= sustained ventricular tachycardia (> I 0 complexes); 
velltrtachyarrhy= complex ventricular tachyarrhythmias; and hypotension= fall of 
systolic blood pressure compared to rest value (mmHg) 
Our comparative success may reflect increasing experience with DASE. For 
example, one of the earliest shldies, by Mertes et al (6), reported a feasibility of 
only 66%, whereas more recent publications report success rates of 85-90% 
(2,9). 
Atropine lise ill patients lVith severe LV dysjilllctimi. Atropine was 
needed more frequently in patients with L VEF $25%. One explanation for the 
increased usc of atropine in patients with severe LV dysfunction is decreased 
beta-adrenergic responsiveness and/or reduced baroreflex sensitivity in patients 
with stress induced ischemia (2). In a previous study of 360 patients who were 
not taking beta blockers, we observed a decreased chronotropic response to 
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dobutamine in patients with acutely induced myocardial ischemia. In the present 
study, patients with more advanced LV dysfunction (EF S25%) developed stress 
induced ischemia significantly more frequently. This reduced responsiveness to 
beta-adrenergic stimulation can be overcome by thc addition of atropine, which 
potentiates the effect of ~-adrenergic stimulation by blockade of vagal efferents 
to the hemt. 
Side effects. Hypotension, occurring in 11% of patients, was the most 
frequently observed side effect. However, it was ustJally asymptomatic, 
occurring at the end of the tcst and necessitated interruption of the test in only 3 
cases (1.5%). The supine testing position may explain why hypotension was 
gcnerally wcll toleratcd. In our experience, stopping the dobutamine infusion 
and elevating the legs is a simple and effective trcatment for hypotension once 
the test is complete. The occurrence of hypotension was unrelated to the 
presence or extent of stress induced ischemia, and beta blocker medication was 
not protective. Hypotcnsion was not more frequcnt in patients with an EF of 
S25%, compared to those with a EF of 26 to 35% (OR 1.8, 95%CI 0.7 to 4.6). 
However, comparcd to poolcd data from the literature, hypotension has occurred 
much more frequently in our patients with LV dysfunction (11% vs 3%). 
Impaired cardiac function probably explains the high incidcnce of hypotension 
in our study (Table 4). Presumably, in patients with significant LV dysfunction 
dobutamine causes a decrease in systemic vascular resistance that is 110t matched 
by a corresponding increase in cardiac output. Stress-induced ischemia does not 
explain the inadequate cardiac response, because we noted no association 
between hypotension and echocardiographic or electrocardiographic evidence of 
ischemia. 
Cardiac an'hythmias were the second most frequent side effect observed 
during DASE. In contrast to hypotension, whcn cardiac arrhythmias occur thc 
test is often stopped. In our patients with severe LV dysfunction cardiac 
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arrhythmias occurred at a similar Jiequency as in pooled data from the literature. 
Conversely, we consider multi focal ventricular ectopic beats to be more benign. 
In contrast to our previous study (8) we found no correlation between 
the extent of resting wall motion abnormalities and cardiac arrhythmias. This 
may simply reflect the relative inhomogeneity of the population of patients with 
significant LV dysfunction. This confirms the findings of Come I et al (l3), who 
evaluated a smaller group of patients with less severe ventricular dysfunction. 
The most widely used antidote for stress induced side effects IS 
intravenous administration of a beta blocker. However, if coronmy-spasm is 
suspected, one should restrain from beta blocker administration, as an 
unopposed a-adrenergic vasoconstriction may aggravate coronary spasm. In 
these cases and in patients with severe asthma intravenous nitroglycerine or 
ShOll acting calcium antagonists should be used first. 
Blood pressure response to loll' dose dobutamine. Besides improved 
wall motion, patients with viable myocardium had higher systolic and diastolic 
blood pressure at low dobutamine infusion rates, compared to patients without 
this contractile reserve. Presumably the systolic improvement represents 
transiently improved function of stunned or hibernating myocardium in response 
to low doses of dobutamine. This initial difference was not apparent at high 
doses of dobutamine, perhaps indicating inadequate oxygen delivery (i.e. a bi-
phasic response). 
Safety. During the recovery phase no persistent new wall motion 
abnonnalities were obselved, indicating that neither prolonged ischemia andlor 
infarction resulted from DASE. However, special care should be taken in 
performing a DASE in patients with advanced LV dysfunction as the appearance 
of new wall motion abnonnalities andlor ECG abnormalities, which are a test 
end-point may be difficult to assess due to pre-existing abnormalities. 
Study limitations. In the population studied, consisting of a selected 
group of two hundred patients all awaiting elective coronary revascularization 
and high male propOllion (94%), angina pectoris occurred frequently as all 
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patients were scheduled for elective coronary revascularization. The presence of 
viable myocardium was infelTed from echocardiographic analysis of wall motion 
patterns only. The ultimate proof is improved function after revascularization, 
both echocardiographically and clinically. Such follow-up was not performed in 
this study. 
In conclusion, in patients with more advanced LV dysfunction atropine 
addition improved diagnostic accuracy of OASE for viability with 34%. The 
addition of atropine is safe and does not increase the incidence of cardiac 
arrhythmias or hypotension. 
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ABSTRACT 
Quantification of dysfunctional, but viable myocardium has high prognostic 
value for improvement of left ventricle (LV) function after coronary attery 
bypass surgelY (CABG). Dobutamine stress echocardiography (DSE) can assess 
viable myocardium by segmental wall motion changes during stress. However, 
analysis of wall motion is subjective with only moderate interinstitutional 
agreement (70%) and frequently overestimates functional improvement after 
CABG. Analysis of ejection fraction (EF) responses during DSE is more 
objective and allows a more precise quantification of global contractile reserve. 
The aim of the study was to compare the prognostic value of EF responses and 
segmental wall motion changes, during DSE for the prediction of improvement 
of LV function after CABG. Forty patients underwent a DSE prior to CABG. EF 
responses were assessed at rest, low dose dobutamine and at peak stress using 
the bi-plane discs method. Wall motion was scored using a 16-segment 5-point 
model. Resting radionuclide ventriculography (RNV-LVEF), performed before 
and 8±2 months after CABG was used as an independent reference. Five patients 
were excluded because of perioperative infarction or poor echo images. In 11/35 
patients RNV-LVEF improved >5%. Improvement of EF during dobutamine 
predicted RNV-LVEF recovelY after CABG significantly better than segmental 
wall motion changes, 72% vs. 53%, p~0.03. A biphasic-EF response (i.e. 
improvement of 210% at low dose and subsequent worsening at peak stress) had 
the highest predictive value (80%) for late functional recovelY. In conclusion, 
EF response to dobutamine was superior to segmental wall motion changes in 
the prediction ofRNV-LVEF improvement after CABG. 
INTRODUCTION 
In patients with severe left ventricular (LV) dysfunction the presence of 
myocardial viability has impOltant therapeutic and prognostic implications. It 
predicts functional improvement and long-term outcome after coronaty 
revascularization (CABG).'-3 Dobutamine stress echocardiography (DSE) is 
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frequently used to assess the presence of myocardial viability. An improved 
contraction and or ischemic change during dobutmnine of dysfimctional 
segments characterizes viability. The test is highly feasible and safe, even in 
patients with poor LV function.4 However, segmental wall motion assessment 
during DSE is subjective with moderate interinstitutional agreement (70%) and 
frequently overestimates the recovery of LV fimction after CABG.'·5.6 In 
contrast, analysis of ejection fraction (EF) response to dobutamine infusion is 
less subjective and allows a more precise quantification of global contractile 
reserve. 
The aim of the study was to compare the prognostic value of EF 
responses and segmental wall motion changes, during dobutamine infilsion, in 
predicting recovelY of LV function after CABG using resting radionuclide 
ventriculography (RNV) as an independent reference. 
METHODS 
Patients: Patients with a resting EF <40% scheduled for coronary artery bypass 
grafting (CAB G) were enrolled in the study. Diabetes mellitus requiring 
treatment was present in six patients and twenty-eight used angiotensin 
conveliing enzyme inhibitors. Exclusion criteria were unstable angina, recent 
myocardial infarction ( <6 months), and valvular disease including significant 
mitral valve regurgitation. 
Study protocol: Each patient underwent a DSE and a resting RNV one to two 
weeks before CABG. A second resting RNV was performed after CABG. LV 
function recovery was defined as RNV -L VEF improvement of ~5% after 
CABG. Patients were divided in two groups on the basis of LV fimction change 
after CABG. 
Dobutamine stress echo cardiography: Beta-blocker medication was not 
discontinued for the study. Dobutamine was administered intravenously by 
infusion pump at 5 Ilgikg/min and increased to 10 Ilg/kg/min after 5 min (low 
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dose stage). The infusion rate was then increased by 10 flglkg/min evelY 3-min 
to a maximum of 40 fig/kg/min (high dose stage), and continued for 6 min. If 
signs and symptoms of ischemia were absent during the high dose stage, and a 
target heart rate [(220-age) x 0.85 in men, and (200-age) xO.85 in women)] was 
not achieved, atropine was administrated intravenously in 0.25 mg increments 
per minute, to a maximum of 2 mg, while the dobutamine infusion was 
continued. The ECG was continuously monitored. Blood pressure was measured 
at end of each stage. The two-dimensional echocardiogram was continuously 
monitored and recorded during the last minute of each stage and during 
recovelY· 
Wall motion analysis: LV wall motion was recorded in 3 planes and divided 
into 16 segments as recOlllinended by the American Society of 
Echocardiography.7 Two experienced investigators (G.R., D.P.) performed 
subjective off-line assessment of wall-motion using a five-point scale: I 
indicated normal; 2, mildly hypokinetic; 3, severely hypokinetic; 4, akinetic, and 
5, dyskinetic. For each patient a wall motion score index (WMSI) (total score 
divided by the number of analyzable segments) was calculated at rest, low dose 
(10 fig/kg/min), and at peak stress. Wall motion patterns are presented in Table 
L 
TABLE I. Description of segmental wall motion patterns and ejection fraction 
patterns during low-high-dose dobutamine stress echocardiography 
Responses Viable 
Biphasic Improvement at low-dose and worsening at peak stress Yes 
Sustained Continuous improvement during stress Yes 
Ischemic Only worsening during stress Yes 
Scar No change during stress. For wall motion analysis including No 
akinesia becoming dyskinesia, which is considered to be a 
mechanical phenomenon. 
EF analysis: End-diastolic and end-systolic volumes and EF were assessed off-
line by two-dimensional biplane discs method at rest, low dose and peak stress. 
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The biplane discs method measures LV volume using a modification of 
Simpson's mle described by Schiller et alY Two-chamber and four-chamber 
apical views were recorded. The endocardial borders of these views were 
digitally traced at end-diastole and end-systole and volumes and ejection fraction 
were calculated. EF was assessed during five consecutive heatibeats and the 
average value was calculated. Investigators were blinded to the results obtained 
by RNV-LVEF. Both wall motion changes and EF changes during dobutamine 
infusion were classified into four different pattems of contractile response 
(Table I). 
Variability analysis: Intra- and interobserver variability of the echo data was 
assessed in a sub-group of 15 patients. Variability of EF calculation was 
expressed as 2 standard deviations of the difference of the two readings. EF was 
obtained at rest, low dose and peak dobutamine stress in two different blind 
evaluations 30 days apati for intraobserver variability and by two different 
observers (G.R., R.R) for interobserver variability. Intraobserver variability of 
EF calculation was 3.3% (mean difference 0.2±1.7%) and intcrobserver 
variability was 5.3% (mean difference 0.4±2.6%). The inter- and intra-observer 
agreement for wall motion intelpretation during low-high DSE was respectively 
92% and 88%. 
Resting radionuclide ventriculography: LVEF was assessed by radionuclide 
ventriculography (RNV) before and 8±2 months after CABG and used as an 
independent reference. RNV-LVEF was perfonned at rest with the patient in the 
supine position after intravenous administration of 740 MBq of 99mTeclll1etium. 
Images were acquired in a small field of view gamma camera (Orbiter, Siemens 
Corp., Erlangen, Germany), oriented in the 45° left anterior oblique view by an 
automated technique. RecovelY of resting RNV-LVEF was considered as the 
"gold standard" for the assessment of myocardial viability and was defined as an 
improvement of resting RNV-LVEF >5% after CABG. This criterion has been 
applied in many other viability studies because it is higher than inter-observer 
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and intra-observer variability of the technique in patients with left ventricular 
dysfunction.9 
Statistical analysis: EF responses and wall motion score changes were 
calculated at rest, low-dose and peak dose dobutamine. Data are presented by 
mean value ± SD. Patients were divided into two groups based on presence or 
absence of an improvement of resting RLW-LVEF of>5% after CABO. Data of 
the two groups were compared and differences were evaluated by paired Student 
I-tests, and by two-way analyses of variance (ANOVA) with repeated measures 
for the dobutamine dose-steps. A p-value <0.05 was considered significant. 
RESULTS 
Study popUlation: FOIty patients were enrolled 111 the study. All patients 
presented with heart failure symptoms with mean NYHA class of3.1±0.5. Eight 
patients presented also with angina pectoris. All patients were studied more than 
six months after myocardial infarction and were stable during the entire study 
period. Five patients were excluded: three of them because of inadequate two-
dimensional images to perform measurements by biplane discs method, and two 
because of a non-fatal myocardial infarction during CABO. The remaining 35 
patients (29 males, mean age 59±11 years) represented the study population. 
Coronaty angiography was perfonned in all patients; the mean number of 
affected vessels was 2.9±0.2. The resting RNV -LVEF and echo-EF were 
respectively 33.7±9.7% (range 38-15%) and 33.6±12.3% (range 39-14%) 
(p=0.97). Resting RNV-LVEF was repeated 8±2 moths after CABO. Patients 
were divided in two groups on the basis of the response of LV function after 
CABO. RNV-L VEF improved >5% in 11 patients (group A) whereas in 24 
patients EF remained unchanged or worsened (group B). Baseline characteristics 
of the two groups were similar (table II). 
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TABLE II. Baseline characteristics of patients according to left ventricular 
function improvement after CABO 
Improvement No improvement p value 
(n~ II )(group A) (n~24 ) (group B) 
Age (years) 58.8±12.0 58.8±10.3 1.00 
Female gender 18% (2/11) 17% (4/24) 0.73 
Previous anterior MT 46% (5/11) 46% (11/24) 1.0 
Previous inferior MI 27% (3/11) 29% (7124) 0.78 
Both anterior and inferior MI 27% (3/11) 25% (6/24) 0.77 
Diabetes mellitus 18% (2/11) 17% (4/24) 0.73 
Beta-blocker therapy 18% (2/11) 17% (4/24) 0.73 
NYHA class 3.1±0.4 3.0±0.5 0.56 
Angina Pectoris 18% (2/11) 25% (6/24) 0.98 
Number affected vessels 3.0±0 2.96±0.2 0.51 
End-diastolic volume by echo 173.9±61.8 ml 187.6±60.8 0.54 
(ml) 
Rest pre CABG EF by RNV 33.5±13.2% 33.8±8.1% 0.93 
Rest pre CABG EF by echo 33.4±11.7% 33.8±12.7% 0.92 
Rest pre CABG \vMSI 2.31+0.77 2.31+0.67 1.00 
CABO - coronary artClY bypass grafting; Ml - myocardial infarction; EF - ejection 
fraction; RNV = radionuclide ventriculography; \VMSI = walJ motion score index. 
During DSE, EF improvement from rest to low dose was statistically higher in-
group A than in-group B (p~O.OI), whereas WMSI improvement was higher in 
group A but not significantly different from group B UFO.06)(table III). 
TABLE III. Comparison of different variables according to left ventricular 
function improvement after CABG 
Improvement No improvement p value 
(n~ll) (IF24) 
(group A) (group B) 
EF improvement at low dose +12.2±5.3 +5.6±7.6 0.01 
dobutamine 
Number of improving segments 6.8±3.1 4.7±2.8 0.06 
at low dose dobutamine. 
WMSI improvement at low dose 
-0.42±0.18 -0.29±0.19 0.06 
dobutamine 
EF worsening at peak stress 
-4.2±7.3 -0.11±8.3 0.17 
(ischemia) 
Number of worsening segments 3.3±3.3 2.3±2.4 0.30 
at peak stress 
CABG ~ coronary atielY bypass grafling; EF ~ ejection fraction; WMSI ~ wall 
motion score index. 
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At peak stress group A showed higher reduction of EF (ischemia), but the 
difference was not statistically significant (p=0.17) (table III) (figure I). 
LVEF (%) 
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o Improvers vs. non-improvers 
rest low dose peak stress 
Fig 1. Scatter plots showing the individual EF responses from rest to low-dose 
dobutamine and from low-dose dobutamillc to peak stress. The solid rounds represent 
group A (improvement of RNV -EF after revascularization) and open rounds represent 
group B (non-improvement). 
Analysis of EF changes showed that the positive predictive value for LV 
function recovclY after CABO was proportional to the degree of EF 
improvement at low dose DSE, whereas negative predictive value was inversely 
related. Analysis of the four different patterns of contractile response showed 
that biphasic response (viability plus ischemia) had the best positive predictive 
value for LV function improvement after revascularization. A decrease of EF of 
25% from low dose to peak stress increased the positive predictive value for 
resting RNV -L YEF improvement after CABO for evelY degree of EF 
improvement at low dose dobutamine. Moreover, resting RNV -L VEF recovelY 
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after revascularization was significantly higher in patients with a biphasic 
response when compared to patients with the three other predefined patterns of 
response (respectively +8.5±1O.2% vs. -0.96±5.7%; p~0.002). 
Mean predictive value for resting RNV-L VEF improvement after CABG was 
significantly higher when viability and ischemia were assessed by EF changes 
than by segmental wall motion changes (72% vs. 53%; p~0.03). EF 
improvement at low dose of 210% and worsening at peak stress of 25% 
(biphasic response) had the best predictive value (80%) for LV function 
improvement after CABG (table IV). 
TABLE IV. Predictive value of ejection fraction response and segmental wall Illotion 
response to dobutamillc infusion for left ventricular function recovery after CABG 
Improvement Worsening Positive PV Negative PV Overall PV Mean overall PV 
At low dose at peak 
EFz5% no 40%(10/25) 90% (9/10) 54% (19/35) 
EFz5% EFz5% 58% (7/12) 87% (20/23) 77% (27/35) 
EFzlO% no 60% (9/15) 85% (17/20) 74% (26/35) 72% 
(25.2/35) 
EF~10% EF~5% 70% (7/10) 84% (21125) 80% (28/35) • 
EF2IO% EFzlO% 75% (3/4) 74% (23/31) 74% (26/35) 
P~O.O 
22 segments no 31% (9/29) 66% (4/6) 37% (13/35) 
22 segments 22 segments 35% (6/17) 61% (I 1/18) 48% (17/35) 
24 segments no 32% (7/22) 69% (9/13) 46% (16/35) 53% 
(18.8/3) 
24 segments ~ segments 43% (6/14) 76% (16/21) 63% (22/35) 
~4 segments 24 segments 56% (5/9) 81% (21126) 74% (26135)' 
* Best predictive value among EF response and segmental wall motion response to 
dobutamine (both in patients with a biphasic response). CABO ~ coronary artelY 
bypass grafting; PV ~ predictive value. 
DISCUSSION 
Dysfunctional, but viable myocardiulll is a clinical situation in which impaired 
LV function at rest is reversible after revascularization. Before reconunending 
revascularization an estimate of the extent of lllyocardial viability is important to 
detennine the expected improvement of LV recovelY and patient long-term 
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outcome, sll1ce the risk of perioperative complications and mortality is 
considerable.3•IO•1I The most commonly used tests for diagnosing myocardial 
viability are DSE, thallium or sestamibi single-photon emission computed 
tomography (SPECT) and positron emission tomography (PET)." Using DSE, 
the common criteria to identifY viability are improved wall thickening in at least 
two adjacent abnol1nal segments of LV at low dose dobutamine infusion. 13 
However, the improvement of LV fill1ction after CABO is frequently less than 
expected. I,14 Therefore, we evaluated whether EF changes during DSE could 
provide a better marker of myocardial viability. 
Ejection fraction improvement at low dose. Late functional improvement of 
LV function after CABO was related to the degree of EF improvement at low 
dose dobutamine (p=O.OI), An EF improvement 210% was predictive for 
postoperative functional recovelY 1I1 60% of patients, whereas an EF 
improvement <5% was predictive for absence of postoperative functional 
recovelY in 90% of patients. These data suggest that the degree of EF 
improvement at low dose DSE reflect the extent of hibernating myocardium. 
Biphasic response. Recent studies demonstrated that a biphasic response during 
DSE is the best predictive echocardiographic pattern for recovery of fimction 
after revascularization. 14,15 Sustained improvement, although a marker of 
residual viability, is a poor predictor. This may be related to the absence of 
ischemia at peak stress, indicating the absence of a critical stenosis. We analyzed 
different pattems of response to DSE using EF change~ as a test result rather 
than segmental wall motion changes. The presence of a biphasic response (EF 
increasing at low dose 210% and EF decreasing at peak 25%) had the highest 
predictive value (80%) for post-operative LV function recovelY (table 4). 
Moreover, resting L VEF recovery after revascularization was significantly 
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higher in patients with a biphasic response when compared to patients that 
presented one ofthe other tln'ee predefined patterns (p~O.002). 
Ejection fraction compared to wall motion. Mean predictive value for 
functional recovelY after CABG was significantly higher when viability was 
assessed by EF responses than by segmental wall motion changes during 
dobutamine infusion (72% vs. 53%; p~O.03) (table 4). In the patients with post-
CABG improvement of RNV-L YEF 'VMSI improvement at low dose 
dobutamine was higher but not significantly different liCln group B (p~O.06). 
This was probably because of the small sample size, whereas EF improvement at 
low dose dobutamine was higher in group A and significantly different from 
gro1lP B (p~O.OI) (table 3). 
Rationale for use of ejection fraction changes. EF changes during DSE allow 
a global quantitative assessment of viability less subjective than segmental wall 
motion score. EF calculation does not nceds dedicated echo readers and is an 
easy method common to cardiological community at large. On the other side EF, 
as an index of global function, does not provide information on the segmental 
nature of the myocardial dysfunction and is influenced by heart rate, preload and 
afterload. Being a ratio, it offers no information on absolute LV volumes. 
However, patients evaluated for viability have diffuse coronmy disease and 
global LV dysfunction: 97% (36/37) of our patients had extensive coronary 
disease ("three vessel disease") and almost all the segments were hypo-akinetic 
(mean rest WMSI~2.31±O. 71). For this reason LV -function recovelY results 
from global function improvemcnt rather than wall motion improvement of few 
segments. 
Quantification of the extent of viable myocardium: A strong correlation 
between the number of dysfunctional segments with contractile reserve during 
DSE and the improvement of L YEF after revascularization has been found 
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recently.l6·17 The extension of dysfimctional but viable myocardium predicts a 
better prognosis and allows risk stratification of patients with LV dysfunction 
referred for bypass surgely. 
Wall motion score provides the number of improving segments but roughly and 
subjectively quantifY the amount of improvement of each segment. In most of 
segments the improvement is of one grade only (100% of our patients) even 
using a five-point scale. Moreover most of the centers base the classification of 
DSE on change in wall motion (improvement or not) rather than absolute wall 
motion score. 10. This method has a lower variability but does not take into 
account the degree of wall motion improvement of each segment. Probably, EF 
responses can better quantifY the amount of global improvement of LV function 
at low dose dobutamine. This can explain the higher predictive value of EF 
changes for LV fimction recovery after CABO. 
Study limitations. The number of patients in our study was relatively small and 
follow-up coronaty angiography was not performed. However, all infarct zones 
underwent adequate revascularization as shown by surgical repOits (39/40 
patients received at least 3 grafts), and two patients that presented perioperative 
infarction were excluded from the analysis. Therefore, we can assume that the 
revascularization was complete in all patients. 
During DSE we used a two-dimensional acquisition method to calculate L VEF 
that is known to have high inter-observer and intra-observer variability. 
However the results of the study suggest to use EF responses during a single 
DSE and not to use EF absolute values for prediction of LV function recovery. 
Therefore we were interested only in intraobserver variability that is known to 
be lower than interobserver variability.18 A previous study showed that 
intraobserver variability for 2-D Simpson's method in our laboratOlY was 
3.5%.18 In tlus study intraobserver variability, expressed as 2 standard deviation 
of the two different readings,. was 3.3%. This value was more than twice lower 
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of the main EF change cut-off value suggested by the results of the study 
(improvement of 21 0% at low dose DSE). 
Conclusions and clinical implications. In patients with LV dysfunction, EF 
response to dobutamine infusion has an high prognostic value in predicting LV 
function recovelY after CABG, superior to traditional wall motion score 
evaluation. The degree of EF improvement at low dose dobutamine reflects the 
extent of hibernating myocardium. EF worsening at peak stress is a marker of 
ischemia. EF improvement of 210% at low dose together with EF worsening of 
25% at peak stress (biphasic response) identifies 80% of patients who will 
benefit from revascularization. 
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ABSTRACT 
Background. Patients with symptomatic myocardial ischemia due to a cln'onic 
totally occluded coronaty (TOC) attety are usually referred for coronaty attelY 
bypass surgety. As in recent years guidewirc technology has improved 
considerably, percutaneous coronaty angioplasty became a useful technique in 
opening chronic TOC atteries. We evaluated the early functional results of 
successful percutaneous recanalization by performing dobutamine stress 
echo cardiography (DSE). 
Methods. Fifteen patients with a chronic TOe artety who underwent a 
successful recanalization were prospectively studied. Each patient had a DSE 
within 24 h before and 48 h after the procedure. Wall motion was scored 
according to a 16 segmentsf5 points model. A clinical and angiographic follow-
up of 6 months was obtained. 
Results. The wall motion score index at rest improved from 1.26 ± 0.23 pre- to 
1.22 ± 0.21 post-procedure (p <0.05). Of those 10 segments that improved at 
rest, 7 were collateral-recipients and 3 were collateral-donors. The number of 
ischemic segments decreased from 46 pre- to 4 post-procedure (p <0.0001). Wall 
motion score index at peak stress improved from 1.34 ± 0.20 pre- to 1.15 ± 0.12 
post-procedure (p <0.05). DSE was positive for ischemia in 15 patients pre- and 
2 patients post-procedure (p <0.0001). Angina was present in 12 patients pre-
and in 2 patients after recanalization (p <0.0001). Two patients (13%) had 
angiographic reocclusion and 5 (33%) restenosis after 6 months offollow-up. 
Conclusions. Successful percutaneous recanalization of chronic TOe artery 
results in an early improvement of both clinical status and resting or stress-
induced wall motion abnol1nalities, as detected by DSE. 
INTRODUCTION 
Angina pectoris is usually related to a significant stenosis of one or more 
coronary atteries (I). Progression of a stenosis .may lead to dn'onie total 
occlusion of the vessel, also in the absence of myocardial infarction (2). Patients 
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with a chronic totally occluded coronmy (TOC) attery may experience 
exeltional angina, possibly due to an invelted shunt of coronalY flow fi'om the 
occluded segment(s) through collaterals to the non-occluded segments in times 
of increased blood flow requirements (3). Therapeutic options are limited, as 
medical treatment is not always sufficient and corollalY angioplasty is associated 
with both a high failure rate (4) and a high restenosis or reocclusion rate. 
Therefore, patients with significant symptoms are routinely referred for coronaty 
bypass surgelY (5). However, various recent improvements in guidewire 
technology have considerably increased the success rates of percutaneous 
attempts at recanalization (6-8). The efficacy of successful recanalization has 
been proven in the late follow-up by exercise test (9) and early after the 
procedure by cardiac pacing (l0,11). Dobutamine stress echocardiography 
(DSE), an established technique for the detection of myocardial ischemia (12), 
has not been used to test the effects of recanalization ofTOC artelY early after a 
successful procedure. Therefore, we perfonned DSE to investigate whether a 
successful procedure results in an early reduction of myocardial ischemia in 
patients who underwent guidewire percutaneous recanalization of a chronic TOC 
artery. 
METHODS 
Patient population: Patients were prospectively included according to 
presence of angina pectoris and/or objective signs of ischemia in relation to a 
chronic TOC artelY. An attempt was made to recanalize the target occlusion, for 
which various guidewire technologies were used. This included the use of the 
excimer laser guide wire (Spectranetics Corp., Colorado Springs, CO) in case of 
a failed attempt by using conventional guide wires. An informed consent was 
obtained from all patients, according to the guidelines of the Medical Ethics 
Committee of the University Hospital Rotterdam. 
Angiographic data.: AlOC mtery was considered chronic if more than 
4 weeks of angiographically proven duration (4) elapsed between the diagnostic 
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coronary angiography and the date of the attempt at recanalization. For each 
patient the echocardiographic 16 segments model (13) was assigned to each 
coronalY field and when collaterals were found, the corresponding 
echo cardiographic segments were divided in either collateral-donors or 
collateral-recipients. 
Dobutamille stress cchocardiography: Dobutamine was administered: 
10 llg/kg/min for 3 minutes, increasing by 10 flg/kg/min evelY 3 minutes to a 
maximum of 40 flg/kg/min. In submaximal non-diagnostic DSE, atropine was 
added: 0.25 mg repeated to a maximum of 1.0 mg in 4 minutes. Criteria for a 
positive DSE were stress-induced new or worsened wall motion abnormalities. 
Additional criteria were: ST-segment elevation ~ 0.1 mV after the J point in 
patients without prior myocardial infarction and horizontal or downsloping ST-
segment depression ~ O.lmV 80 ms after the J point and angina. Pre-test criteria 
for intermption of DSE were: achieved 85 % of the maximal for sex and age 
predicted target hemt rate, achieved maximal dose of both dobutamine and 
atropine, new significant wall motion abnormalities, horizontal or downsloping 
ST-segment depression >0.2 mV 80 ms after the J point compared with the 
baseline, ST-segment elevation >0.1 mV 80 ms after the J point in patients 
without prior myocardial infarction, severe angina, symptomatic reduction in 
systolic blood pressure >40 nun I-Ig from baseline, hypertension (blood pressure 
>2401120 nUI1 I-Ig), significant cardiac tachyarrhythmias and any serious side 
effect attributed to dobutamine infusion, such as e.g. headachc, dizziness or a 
symptomatic vagal activation (12). 
Echocardiographic imaging: The left ventricle was divided in 16 
segments (13) and visually assessed for both systolic wall thickening and inward 
wall motion. Each segment was graded on a 5-point scoring system (I ~ normo-
or hyperkinesis; 2 ~ mild hypokinesis; 3 ~ severe hypokinesis; 4 ~ akinesis and 
5 ~ dyskinesis ) by an experienced observer blinded to both prc- and post-
procedural data. The scoring was repeated by the same,observer and in case of 
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intra-observer disagreement the judgment of a second observer was obtained. 
Ischemia was defined as a deterioration in score at any stage of the test in one or 
more segments, unless an akinetic segment at rest and low dose dobutamine 
became dyskinetic at peak stress (14). Wall motion score index was defined as 
the sum of the scores of the individual segments divided by the total number of 
segments. The medication used during the two DSE was not significantly 
different. The beta-blocking agents were withdrawn 3 days before the fll'St DSE 
and not reintroduced before the second DSE. 
The angioplasty procedure: The attempt at recanalization was 
perfollned typically using either the Choice PT wire (Scimed, Minueapolis, 
MN), Terumo Crosswire (Terumo, Japan) or the Prima laser wire (Spectranetics 
Corp., CO). The technique of the laser wire procedure has been extensively 
described elsewhere (6,7,15). After successful crossing of the occlusion by the 
guidewire, angioplasty was performed either by balloon angioplasty, or a 
combination of excimer laser coronaty angioplasty (ELCA) using the 
Spectranetics 1.4 mm or 1.7 mm Vitesse-C rapid exchange coronary catheters 
with adjunctive balloon angioplasty. Routinely, one or more intracoronaty stents 
were implanted to obtain an optimal procedural result. Following a successfhl 
angioplasty, patients were kept on a heparin infusion for 24 hours, maintaining 
the activated prothrombin time (APTT) between 60 and 90 seconds. 
Follow-up study: All patients underwent a 6 months clinical and 
angiographic follow-up. Functional classification was performed according to 
the Canadian Cardiovascular Society. Restenosis was defined as >50% diameter 
stenosis at the treated coronary site, relative to the baseline value before the 
procedure, as detennined by on-line quantitative angiographic analysis. 
Statistical analysis: Unless specified, values were expressed as mean ± 
SD. Comparison of variables was perfOlmed with two-tailed Student's t test for 
continuous variables and chi-square test for discrete variables. Differences of p 
<0.05 were considered. significant. 
183 
RESULTS 
Protocol compliance: Of 34 consecutive patients with a chronic TOC 
altelY and a DSE before the procedure, 22 (65%) patients were successfully 
recanalized. Of these, 2 patients were excluded due to poor echocardiographic 
image quality and 5 for no adherence to the protocol. Therefore, 15 patients 
fulfilled the study protocol, by undergoing two DSE: before «24h) and after 
«48h) successful recanalization. The pre-test baseline characteristics are given 
in Table I and COnflllll that the patient population is representative of current 
clinical practice with coronaty angioplasty. 
TABLE I. Pre-test baseline chamctcristics of the patient ponulation. 
Subject Ago Sex AP(CCS) PriorMI Hypertension Smoke Diabetes Hyperchole- FamHx 
sterolemia 
1 48 F 3 0 + 0 + 0 0 
2 71 F 3 + + 0 0 0 0 
3 39 
" 
2 + 0 + 0 + + 
4 57 
" 
3 + 0 + 0 0 + 
5 69 M 3 0 + 0 0 0 0 
6 62 M 3 0 0 0 0 0 + 
7 36 
" 
2 0 0 + 0 + 0 
8 67 M J + 0 0 0 + 0 
9 54 M 3 0 0 + 0 + 0 
10 67 F J + 0 0 0 0 0 
" 
67 F 3 + + 0 0 + 0 
12 62 M 3 + + + 0 0 0 
13 45 M 2 + 0 0 0 + + 
14 58 
" 
2 0 + 0 0 0 0 
15 50 M 4 + 0 + 0 0 0 
Mean+SD 56 + II 2.8 
Total 11M 91\11 6 6 I 6 4 
AP angina pectoris; ecs Canadian Classification; F - female; FamHx family history, M mare; MI 
mvocardial infarct. 
Angiographic data: The angiographic data are given in Table II. The 
TOC mtelY was right coronary artelY (RCA) in 7 patients (47%), left anterior 
descending coronmy artery (LAD) in 7 (47%) and left circumflex coronary 
mtclY (LCX) in one patient (6%). 
Dobutamine stress echocardiogl'aphy: The hemodynamic data of DSE 
pre- and post-procedure arc given in Table III. As shown, there 
was no significant difference between the pre- and post-procedural data. 
Wall motion score index (Table IV) at rest improved from 1.26 ± 0.23 pre- to 
1.22 ± 0.21 
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TABLE II. Angiographic and pre- and post-procedure clinical data. 
Angina ST-T 
Subject Occluded vessel Collateral-donor vessel (s) Pre Post Pre Post 
I RCA LAD + 0 0 + 
2 RCA LAD + + 0 0 
3 RCA LAD, LCX 0 0 0 0 
4 RCA LAD 0 0 0 0 
5 RCA LAD,RCA + 0 + 0 
6 RCA LAD,LCX + 0 0 0 
7 RCA LAD + 0 0 0 
8 LAD RCA + 0 0 0 
9 LAD RCA + 0 0 0 
10 LAD LCX,RCA + 0 0 + 
II LAD LCX, RCA + 0 + + 
12 LAD LCX,RCA 0 0 + 0 
13 LAD RCA + + + + 
14 LAD RCA + 0 + 0 
15 LCX LAD + 0 0 + 
Total 48 12 2' 5 5 
LAD left anterior descending coronary artery; LCX circumflex coronary artery; Post post-proccdure; 
Pre = ore-procedure; RCA = right coronary artery, * = p < 0.0001 )re- vs post-procedure. 
TABLE IV. Wall motion analysis pre- and post-procedure. 
WMA resting segments Ischemic Resting \vMSI Stress \VMSI 
segments 
Subject Pre Post Pre Post Pre Post Pre Post 
I 0 0 I 0 1.00 1.00 1.13 1.00 
2 3 J 3 I 1.19 1.06 1.19 1.06 
3 5 5 I a 1.31 1.31 1.25 1.19 
4 3 3 2 0 1.31 1.31 1.19 1.13 
5 2 0 2 0 1.13 1.00 1.13 1.00 
6 3 3 6 0 1.31 1.31 1.50 1.25 
7 0 0 5 0 1.00 1.00 1.38 1.00 
8 8 7 I 0 1.75 1.69 1.81 1.25 
9 7 7 5 0 1.50 1.50 1.38 1.31 
10 0 0 I 0 1.00 1.00 1.06 1.00 
II 4 4 7 0 1.25 1.25 1.56 1.25 
12 4 3 4 0 1.25 1.19 1.50 1.13 
13 4 4 5 3 1.25 1.25 1.31 1.25 
14 0 0 2 0 1.00 1.00 1.31 1.19 
15 6 2 1 0 1.63 1.38 1.38 1.31 
Sum and 49 39 46 4' 1.26± 1.22 ± 1.34 ± 0.20 1.15 ± 
means (+SD) 0.23 0.21* 0.12* 
Post = post-pr'ocedure; Pre = pre-procedure; WMA = wall motion abnormalities, W[vISI - wall motion score 
index; * = p < 0.05 pre- vs post-procedure. 
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TABLE III. Hemodynamic data at rcst and leak dobutamine pre- (1) and )ost- (2) procedure. 
(I) Pre-procedure 
Subiect HR rest HR peak SBP rest SBr peak DP rest Dr leak 
1 64 116 140 125 8,960 14,500 
2 80 133 92 86 7,360 11,438 
3 75 135 147 163 II ,025 22,005 
4 90 143 153 153 13,770 21,879 
5 61 105 142 124 8,662 13,020 
6 71 120 110 115 7,810 13,800 
7 74 117 145 180 10730 21,060 
8 70 130 163 144 11,410 18,nO 
9 70 138 112 107 7,840 14,766 
10 60 115 130 130 7,800 14,950 
11 74 142 137 103 10,138 14,626 
12 70 132 98 100 6,860 13,200 
13 60 132 135 135 8,100 17,820 
14 59 91 145 151 8,555 13,741 
15 50 126 110 125 5,500 15,750 
tvfean ± SD: 68± 10 125 ± 14 130±21 129 ± 25 8,968±2100 16,085 ± 3,392 
DP = double (heart rate. systolic blood pressure) product in beats.mm Hglmin; fiR = heart 
rate in beats/min; SBP = systolic blood pressure in mill Hg. 
(2) Post-procedure 
HR rest IlRpcak SBP rest SBP peak DP rest DP peak 
80 127 90 66 7,200 8,382 
90 130 86 80 7,740 10,400 
85 130 110 100 9,350 13,100 
80 137 132 162 10,560 22,194 
62 121 141 107 8,742 12,947 
70 120 120 120 8,400 14,400 
80 133 125 150 10,000 19,950 
76 131 126 109 9,576 14,279 
74 144 137 131 10,138 18,864 
n 113 111 86 7,992 9,718 
88 115 115 95 10,120 10,925 
77 158 112 129 8,624 20,382 
84 142 120 120 10,080 17,040 
70 118 126 110 8.820 12.980 
50 117 108 125 5,400 14,625 
76±1O 130± 13 117±15 113 ± 26 S,849± 1,380 14,679±4,IS5 
after the procedure (p <0.05). Of 10 segments (in 5 patients) that improved at 
rest, 7 were collateral-recipients and 3 were collateral-donors. DSE was positive 
for ischemia in 15 patients pre- and in 2 patients post-procedure (p <0.0001). 
The number of ischemic segments decreased from 46 pre- to 4 post-procedure (p 
<0.000 I). Wall motion score index at peak stress improved from 1.34 ± 0.20 
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pre- to 1.15 ± 0.12 post-procedure (p <0.05). Angina was experienced during 
DSE by 12 patients pre- and 2 paticnts post-procedure (p <0.0001) (Table II). 
Follow-up data: A 6 months clinical and angiographic follow-up was 
available for all patients. No major cardiac events such as death, myocardial 
infarction, coronalY bypass surgery, repeated PTCA or hospital admission for 
unstable angina occurred in this paticnt group. At six month follow-up four 
patients (27%) were in stable angina, while angiographycally two patients had a 
reocclusion (13%) and five (33%) had restenosis. 
DISCUSSION 
Shortly after the introduction of coronary angioplasty by Andreas 
Gruentzig in 1977, this technique was attempted in patients with chronic TOC 
arteries. Successive investigators reported on the relatively low procedural 
succcss rates and high restenosis rates following successful percutaneous 
recanalization (16-18). However, the long-term clinical improvement (19,20), 
the increased resting left vcntricular function and the reduction of exercisc-
induced ischemic symptoms in the late follow-up of paticnts after successful 
recanalization (7), supportcd the continuing effOlt in developing more effective 
technologies for percutaneous treatment of cln'onic TOC arteries. Typical 
examples of improved technology are the introduction of hydrophilic coated 
guide wires and the excimer laser guide wire. 
Thus far, no study documented the early functional impact of a successful 
percutaneous recanalization of a chronic TOC artCly, in tenns of resting regional 
left ventricular function and stress-induced myocardial ischemia. Obviously, a 
successful revascularization procedure should result in a reduction of myocardial 
ischemia. We used DSE, an established teclmique for the detection of 
myocardial ischemia, 24 h before and within 48 h after a successful 
revascularization to evaluate the immediate functional outcome of the procedure. 
As a main result of our study, we found a significant improvcment of stress-
induced wall motion abnormalities. Therefore, DSE is helpful to document 
187 
objectively the early functional outcome of a successful procedure. Besides, we 
also detected a significant improvement of resting wall motion abnormalities, 
involving 7 segments of the collateral-recipient coronmy mtelY and 3 segments 
of the collateral-donor. These result suggests the presence of dysfunctional but 
viable myocardium, which improves early after revascularization, consistently 
with previous studies documenting an immediate functional recovelY after 
revascularization (21). Viable myocardium is also present in some collateral-
donor segments (although supplied by a non-diseased coronmy artery) possibly 
through a stealing effect resulting in repetitive stunning. The immediate increase 
of both coronalY flow and flow reserve after revascularization, involving both 
collateral-recipient and collateral-donor segmcnts, parallel with the angiographic 
disappearance of collaterals, may be the vascular substrate of the early 
functional recovelY detected in our patients (22). 
Although not aim of the prcsent study, a reocclusion rate of 13% and a restenosis 
rate of 33% at six-month follow-up angiography appear significantly better than 
previously reported rates of the literature. The consequent use of intracoronary 
stents to stabilize the angioplasty results could be responsible for this favorablc 
outcome. 
STUDY LIMITATIONS 
A possible limitation of the present study is the inclusion of patients 
after a successful revascularization only. However, the focus of this study was 
not the evaluation of the success rate of percutaneous revascularization in 
chronic TOe arteries, but the effectiveness of DSE to document the early 
functional and clinical impact of a successfulrevascularization. We feel that the 
demonstration of improvement of myocardial function early after a 
revascularization of chronic TOe artelY is important, and may support further 
efforts to improve non-surgical techniques for revascularization of Toe arteries. 
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CONCLUSIONS 
In patients with symptoms andlor signs of myocardial ischemia 
dependent from a chronic TOC artety, DSE performed before and within 48 
hours after a successful percutaneous recanalization documents a significant 
improvement of both clinical status and resting or stress-induced wall motion 
abnormalities. 
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ABSTRACT 
Cardiac evaluation using dobutamine-atropine stress echo cardiography 
m hypotension-prone [HP) and hypotension-resistant [HR) hemodialysis 
patients. 
Background: Hypotension during hemodialysis occurs frequently but the 
precise mechanism remains unclear. In this sllldy the presence of myocardial 
ischemia and myocardial contractile reserve during infusions of the beta-
adrenergic receptor agonist dobutamine were assessed by means of stress 
echocardiography [DSE) in hypotension-prone [HP) and hypotension-resistant 
[HR) hemodialysis patients. 
Methods: Eighteen lIP patients [age 53±6 years) were compared with 18 
HR patients [age 53±3 years), matched with respect to duration of hemodialysis, 
and cardiovascular histOlY. New wall abnonnalities during dobutamine stress 
reflect the presence of myocardial ischemia, whereas the increase in stroke index 
and cardiac index reflects myocardial contractile reserve. 
Results: Wall motion score at rest [1.42±0.53 versus 1.44±0.57) and 
dobutamine-induced new wall motion abnormalities [4 versus 3 patients) 
between lIP and HR patients were similar, but responses of cardiac index, stroke 
index and systolic blood pressure to dobutamine between the two groups were 
different. Notwithstanding a similar cardiac index at rest [2.4±1.l Llmin/m' in 
HP and 2.8±1.2 Llmin/m' in HR patients), were dobutamine-induced increments 
in cardiac index considerably smaller in the former [0.8±1.3 Vminlm') than in 
the latter patients [2.3±1.6 Vmin/m', p=0.002), predominantly because of a 
progressive decrease in stroke index in the lIP patients. 
Conclusion: Impaired myocardial contractile reserve rather than 
ischemia is predominant in HP patients. This impaired myocardial contractile 
reserve may play a role in the development of hemodialysis-induced 
hypotension. 
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INTRODUCTION 
Hypotension during hemodialysis occurs in approximately 30% of patients [I). 
The pathophysiology of hemodialysis-induced hypotension is multifactorial, 
ranging from primarily patient related factors such as underlying coronalY artelY 
disease, diastolic and systolic dysfunction [2), to more hemodialysis related 
factors such as speed and amount ofuItrafiItration and used dialysate (3). 
Atherosclerosis occurs frequently in patients with renal insufficiency. 
Cardiovascular disease is repOlted to cause about 50% of deaths among patients 
with end-stage renal failure [2). Factors causally related to tlus high frequency of 
coronmy mtelY disease are hypertension, hypertriglyceridenria, and 
hypercholesterolemia [4). More recently, hyperhomocysteinemia, endothelial 
dysfunction and increased oxidant stress have been identified as additional 
cardiovascular risk factors [5). 
Assessment of left ventricular function and presence of coronmy artery disease 
can be performed by dobutamine-atropine stress echocardiography [DSE]. At 
low infusion rates [10 J.lg/kglmin 1 dobutamine predominantly exelts an inotropic 
effect, whereas at higher infusion rates the chronotropic effect prevails. Hence 
with the lower infusion rates of dobutamine information about myocardial 
contractile reserve, whereas with higher infusion rates infOlmation about the 
presence of ischemia is obtainable. Ischemia is detected by DSE as new wall 
motion abnOlmalities. The accuracy of DSE for diagnosing coronary mtely 
disease has been confirmed in a large number of patients, including patients with 
end stage renal disease with significant coronary altelY disease as diagnosed by 
coronmy angiography [6.8). 
The ainl of the present study was to investigate whether HP and HR 
hemodialysis patients differ with respect to the presence of coronmy artelY 
disease and myocardial contractile reserve as assessed by DSE. 
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METHODS 
Patients: 
Eighteen HP dialysis patients were studied. Hypotension prone was defined as: I) 
symptoms of hypotension [dizziness and syncope 1 during hemodialysis during at 
least one third of dialysis sessions for more than one year in combination with a 
reduction in systolic blood pressure by at least 25% and/or a systolic blood pressure 
below 100 nunHg; 2) requirement of intravenous inotropic pressor agents and/or 
fluid infusion to avoid hypotension. 
Relevant clinical characteristics of the patients are given in Table 1. Eighteen HR 
dialysis patients served as a control group. These patients were matched with the 
HP group with respect to age, gender, cardiovascular history and symptoms, 
presence of diabetes mellitus, and duration of hemodialysis [Table 1]. 
Table 1: Clinical characteristics ofHR and HP hemodialysis patients. 
HR HP p-value 
Number 18 18 n.s. 
Age [mean] 53±6 53±3 n.S. 
Sex [M IF] 15/3 10/8 n.s. 
BSA [m'] 1.73 1.76 n,s. 
Duration of hemodialysis [yrs] 3.1±2.1 3.5±1.9 n,s. 
Hematocrit [LIL] 0.31±0.06 0.32±0.05 n,s, 
HistDlY of myocardial infarction 14 8 n,s. 
Angina pectoris [n] 8 10 n.s. 
Diabetes mellitus [n] 2 I n.s 
ACE-inhibitors [n] 9 5 n.s. 
Norepinephrine [pg/ml] 429±209 381±174 n.s. 
Atrial natriuretic peptide [pg/ml] 817±491 809±429 n.s. 
Beta blocker treatment [n] 12 6 0.04 
Rest wall motion score 1.42±0.56 1.40±0.52 Ns 
BSA~ body surface area. n.s.: not significant. 
Beta-blockers were more frequently used by the HR than by the HP patients. All 
subjects were dialyzed tlu'ee times weekly using a bicarbonate containing dialysate 
and attificial kidneys with biocompatible membranes [Gambrane, Hemophane or 
Polysulphone]. All patients were infonned about the aim and procedures of the 
study. If they consented verbally to participate, an appointment to perfOlm a DSE 
was made. hl each patient the DSE was pelfonlled one day before a hemodialysis 
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session. If patients were using beta-blockers or other antihypettensive medications 
this treatment was discontinued on the day DSE was performed. The local Ethics 
Committee approved the study protocol. 
Centra! venous pressure measurement {CVPj: 
This was petfonned in 9 of the HP and in 8 of the HR patients. For this pm}lose a 
small catheter with a length of 12 and a diameter of 0.6 trun was inserted in the 
internal jugular vein using the Seldinger technique. CVP was measured just prior 
the DSE for a period of 5 minutes and values were averaged. Via the same catheter 
a blood sample was taken for measurement of the concentrations of attial 
nattiuretic peptide [ANP] and norepinepluine [NOR] in plasma. 
Dobutamine-atropine stress echocardiography: 
DSE was perfonned as previously described [9J. In shott, after a two-dimensional 
resting echocardiographic examination, dobutamine was infiJsed intravenously. 
Dobutamine infusion was statted at 5pg/kg/min for 5 minutes followed by 
IOpg/kg/min for 5 minutes. After this "low dose" stage, the dobutamine infusion 
was increased evety 3 minutes by 10 flg/kg/min to a maximum of 40 flg/kg/min 
unless a test end-point was reached. Test end-points were achievement of a target 
heatt rate [maximum heart rate adjusted for age and gender], signs of myocardial 
ischemia and side effects. If one of the test end-points was not achieved, despite the 
maximal dobutamine infusion rate, atropine was added to a maximum of 2 mg 
intravenously. Blood pressure and heatt rate were measured at baseline and at the 
end of evety dose step by a semi-automatic oscillomett'ic blood pressure monitor 
[AccutotT 2, Datascope, Datascope Cot}l. CA, USA]. Echocardiographic images 
were recorded from standard parasternal long and shott-axis and apical two- and 
four-chamber views. Images were monitored continuously and recorded at the end 
of each dose step. The echocardiographic unages were analyzed off-line, for the 
presence of wall motion abnormalities and to obtaut values of stroke volume. Two 
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experienced investigators [DP, RR] perfOimed analyses, unaware of the clinical 
condition of the patients. 
Wall motion analysis: The left ventricular wall was divided into 16-segments, and 
wall motion was scored by using a five-point scale with values indicating: I, 
normal; 2, mild hypokinetic; 3, severe hypokinetic; 4, akinetic, and 5, dyskinetic. 
For each patient a wall motion score index [total score divided by the number of 
segments] was calculated at rest, at low dose dobutamine infusion, and at peak dose 
dobutamine infusion. Reduction of wall thickening and new wall motion 
abnormalities [NWMA's], with exception of the transition of akinesia to 
dyskinesia, during the stress test is considered to be halhnark of ischemia. TI,e 
transition of akinesia to dyskinesia does not reflect ischemia, but is a mechanically 
induced phenomenon [10] 
Stroke volume: Stroke volume was measured at rest, at low dose, and at peak 
dose dobutamine by means of the bi-plane discs method. The volume of the left 
ventricle was calculated from the apical two- and four-chamber views using a 
modification of Sinlpson's I'Ule [Ill. The principle of Simpson's rule is to divide 
the left ventricle into slices of known thickness. The volume of the ventricle is 
then equal to the sum of the volume of the slices. Two-chamber and four-
chamber apical views were recorded and stored. The endocardial borders of 
these views were digitally traced at end-diastole and end-systole. Each 
projection was divided in 20 sections along the long axis. Then the volumes 
were computed. Stroke volume was calculated as the difference between end-
diastolic and end-systolic volume. The stroke volume as detennined by the two 
investigators was averaged. Cardiac output was calculated as stroke volume 
times heart rate. 
Pulse-wave Doppler. Pulse-wave Doppler studies were recorded from the apical 
four-chamber view, with the Doppler sampler positioned just within the inflow 
portion of the left ventricle, midway between the almular margins of the mitral 
valve. Mitral velocity profiles were digitized from the modal velocity of the 
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Doppler tracings. The peak E [early rapid ventricular filling] and peak A [atrial 
assisted filling] wave velocities were computed to calculate the E/A velocity 
ratio. Pulse-wave Doppler signals were only measured at rest. 
Analytical methods: Blood samples for determination of ANP was collected in 
chilled tubes containing EDT A and aprotinin. Samples for measurement of 
catecholamines were collected in chilled heparinized tnbes containing 
gluthatione. All samples were in1l11ediately centrifuged at 40,and plasma was 
stored at -SO°e, ANP was measured by a radioimmunoassay using a 
commercially available kit [Nichols Instihlte, Wijchen, The Netherlands]. 
Plasma NOR was measured with fluorometric detection after HPLC separation. 
Statistical analysis: 
Hemodynamic variables are expressed as mean ± SD. Cardiac output and stroke 
volume are expressed per body surface area. Total peripheral vascular resistance 
was calculated as mean atterial pressure divided by cardiac index. Differences in 
discrete variables between HR and HP groups were analyzed by chi-square tests. 
Fmthelmore, a 2-way analysis of variance was applied to evaluated changes in 
hemodynamic variables with increasing dobutamine dose (repeated measures) as 
well as differences in response between HR and HP groups. For all tests a p-
value < 0.05 was considered to be statistically significant. 
RESULTS 
The relevant clinical characteristics of the two groups of patients are given in 
Table I. The two groups did not differ with respect to age, gender, duration of 
hemodialysis, cardiovascular history or cardiovascular disease, presence of 
diabetes mellitus, and rest wall motion score [Table 1]. Adequate 2-D unage 
recordings at rest and during stress were obtauled in all patients. Wall motion 
abnonnalities at rest were present in 11 of the patients of the HP and II of the 
patients of the HR group. 
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In both groups thc target heatt rate was reached in 89% of patients. The 
frequency of the occurrence ofNWMA's between the two groups did not differ 
[Table 2). 
Table 2: Results of dobutaminc stress echocardiography in HP and HR hemodialysis 
patients. 
HR HP p-value 
Patients with rest wall motion abnonnalities [n] 11 11 n.s. 
E/A velocity ratio 0.81±0.31 0.79±0.20 0.86 
Test ellfl-poil1ts 
Target hemi rate 16 16 0.3 
Severe angina I I 0.7 
Side effects I I 0.7 
Atropine addition 9 5 0.2 
NWMA's 4 3 1.0 
Hypotension during DSE 2 4 0.4 
Angina during DSE 4 3 0.7 
ST changes during DSE 7 6 1.0 
NWt\1A's: New wall motion abnonnalities; DSE: dobutamine stress echocardiography; 
Hypotension during DSE: reduction of systolic blood pressure> 40 mmHg during test. 
In 9 HP and 8 HR patients, CVP, plasma ANP and NOR and EtA ratio's were 
measured as well. CVP values were not low in any of the patients and values 
betwecn the two groups did not differ. Due to chronic renal failure plasma ANP 
values were increased, but values between the HP and HR groups were not 
different. Values of plasma NOR were normal and did not differ between the 
two groups [Table 1). 
EtA ratios were only measured at rest. The ratio was below 1.0 in 7 of the 9 HP 
patients and in 5 of the 8 HR patients [p = 0.06). 
The resting values of blood pressure, heart rate, stroke index, cardiac index and 
total peripheral vascular resistance for the two groups arc given in Table 3. Most 
likely related to the use of beta-blockers, heart rate was lower and stroke volume 
was higher in the HR group, but resting cardiac output between the two groups 
did not differ. The responses of these hemodynamic variables to doblltamine for 
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the two groups are summarized in Table 3, whereas the hemodynamic responses 
of individual patients are depicted in Fig. I A-D. 
Table 3: hemodynamic characteristics ofHP and HR patients during dobutamine stress 
echocardiography 
RcslHP Rest HR LowilP LowHR Peak flP Peak HR P, P, 
Heart rate 76±13 69±12 92±22 81±18 126±17 130±19 <0.0001 0.021 
[bpm] 
SBP 135±28 147±22 137±34 150±31 127±39 1 53±37 0.627 0.152 
fnilllH£] 
MAP i~ill'Hgl 94±J5 106±16 97±20 WHI9 89±25 108±26 0.761 0.089 
DBP 73±13 85±14 76±18 8!±!4 71±20 85±23 0.820 0.103 
[mmllg] 
TPRI(u) 2.28±0.05 2.26±O.O5 2.24±0.01 1.9I±{).06 1.75±O.O6 1.36±O.O5 <0.0001 0.124 
81 mlfm 59±19 71±16 54±18 75±21 46±21 68±23 <0.0001 0.081 
CI 2.4±1.I 2.8±1.2 2.8±1.7 3.4±\.8 3.2±2.6 5.1±3.3 <0.0001 0.001 
[l/min/m2] 
P1= difference dUrIng dobutanllne mfuslOtl (rest-low-peak); P2: difference III response 
betwecn HP and HR patients during respectively low and peak dobutamine stress. 
In response to dobutamine, stroke index decreased in the HP group, whereas it 
did not change in the HR group. Due to these different responses in stroke index, 
the increase in cardiac index was considerably lower [p<O.OOOIJ in the HP 
group. Systolic blood pressure tended to increase in the HR and to decrease in 
the HP group, but there was no significant difference between the two groups 
[p=O.627J. 
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Fig. lA-D: Hemodynamic responses of individual patients during dobutamine stress 
echocardiography. The dotted lines represent patients with beta blocker therapy. 
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DISCUSSION 
In tIllS study DSE was applied to evaluate cardiac contractile reserve and the 
presence of myocardial ischemia in HP and HR hemodialysis patients. Due to 
high incidence of previous myocardial infarction, wall motion abnormalities at 
rest were present in a large propOltion of both HP and HR patients. Dobutamine-
induced ischemia, as defined by new wall motion abnOlmalities, was observed in 
only 3 of the HR and 4 of the HP patients, but compared to the HR patients, 
myocardial contractile reserve [increase in stroke index in response to 
dobutamine 1 was impaired in a considerable larger propOltion of the HP than HR 
patients. As a consequence of this reduced myocardial contractile reserve the 
dobutamine-induced maximal increase in cardiac index was much lower in the 
HP patients. 
Volume status is among olle of the most impOltant determinants for allowing 
stroke index and cardiac index to increase in response to increasing doses of 
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dobutamine. To ascel1ain that patients were studied in a volume'repleted state, 
DSE was always performed one day before the next hemodialysis session. 
Central venous pressure just prior to the DSE was measured in about 50% of the 
patients. In these patients central venous pressure was relatively high, further 
confirming that the patients were indeed not volume-depleted. 
Left ventricular hypertrophy and uremic myocardial fibrosis are commonly 
present in hemodialysis patients [2,4.12.131. These abnol1nalities impair ventricular 
relaxation and hence diastolic filling, resulting in a decrease in cardiac ontput. 
At this time we can not rule out that these abnormalities were more advanced in 
the HP patients. A greater EI A velocity ratio in HP than in HR patients, as a 
reflection of diastolic dysfunction, has been reported previously [141. In the 
present study no difference in the EI A velocity ratio, although abnormal in 
almost all patients, between the two groups could be detected. 
Dysfunction of cardiac beta-adrenergic receptors could also explain the 
diminished myocardial responsiveness to dobutamine in the HP patients. High 
circulating levels of norepinephrine and epinephrine have been reported in 
patients susceptible to development of hypotension during hemodialysis[15,161. 
This high sympatho-adrenergic state was associated with a down-regulation of 
platelet alpha 2- and lymphocyte beta 2 -adrenoceptors, as well as a decreased 
intracellular cAMP generation after isoproterenol stimulation[171. In the present 
study no difference in plasma concentrations of norepinephrine between HP and 
HR patients was present. Is should be stressed that the concentrations of 
norepinephrine were not measured during the hemodialysis sessions but only 
under baseline conditions. 
Since antihypertensive therapy may adversely affect the development and course 
of hemodialysis-induced hypotension we were not surprised to see that blood 
pressure lowering agents were more frequently used by the HR than by the HP 
patients. Especially the difference in the use of beta-blockers between the two 
groups was notable. Because of the possibility of the occurrence of beta-blocker 
withdrawal phenomena these agents were only discontinued on the day the DSE 
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was performed. When considering the individual responses of stroke index and 
cardiac index to dobutamine it seems unlikely that the unequal use of beta-
blockers provides an explanation for the difference in hemodynamic responses 
between the two groups. 
When translating the results of DSE to the clinical sihmtion, we want to suggest 
that the inability of cardiac index to increase in response to sympathetic stress 
can playa key role in the pathogenesis of hemodialysis-induced hypotension. If 
the hemodialysis-induced activation of the sympathetic nervous system does not 
lead to an appropriate rise in cardiac output to maintain blood pressure, fillther 
sympathetic discharge is likely to occur. Evenhmlly, due to exhaustion, the 
autonomic nervous system is no longer capable to maintain this high level of 
sympathetic tone and blood pressure will fall. The cause of hemodialysis-
induced hypotension in this situation is not primarily a consequence of failure of 
the autonomic nervous system, but the consequence of diminished myocardial 
responsiveness or myocardial contractile reserve (Fig. 2). TIllS hypothesis fits 
well with the observations of Zocalli et a1. showing that tachycardia and not 
bradycardia is the predominant hemodynamic response to hypotension during 
hemodialyis[l8). 
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Hypovolemia , 
Fall in cardiac filling pressure , 
Decrease In cardiac output , 
Aclivalion of sympathetic nervous system 
Adequate increase In cardiac oulput , No adequate Increase In cardiac output , 
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sympathetic nervous system 
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ten~ioJII. 
Fig 2. Scheme of proposed pathophysiological mechanism of hemodialysis-induced 
hypotension 
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SUMMARY AND CONCLUSIONS 
Summary. 
The main fmding of the present thesis is that a quantitative approach of 
echocardiography is feasible and highly accurate to detect left and right 
ventricular dysfunction. Moreover, we demonstrated that this approach might be 
applied to the technically demanding setting of dobutamine stress 
echocardiography. We found evidence that the traditional qualitative evaluation 
of stress echocardiography may be improved. 
The following list offmdings summarizes the major results of the present thesis. 
Chapter 1: We found that both a reasonable echocardiographic image quality 
and severe wall motion abnormalities appeared the strongest predictors of 
echocardiographic assessement reproducibility and that new standardized 
guidelines should emphasize this finding. 
Chapters 2 and 3: The evaluation of stress tests results, even by optimizing the 
echocardiographic recording and scoring, remains subjective. This is the major 
limitation of the test. To overcome this limitation we started the quantitative 
evaluation of ventricular function by using Doppler tissue imaging, and 
patticularly its color-independent application: pulsed wave Doppler tissue 
sampling. We showed that pulsed wave Doppler tissue sampling is able to 
quantitate left and right ventricular function. 
Chapter 4: Pulsed wave Doppler tissue sampling systolic velocities exhibited 
by the right ventricle during dobutamine stress echocardiography showed a 
depressed pattem in the case of right ventricular dysfunction, con'elated to either 
a prior posterior myocardial infarction or right coronary artelY stenosis. We 
considered this pattern expression of a resting dysfunctional myocardium with 
jeopardized viable component that improved wall motion at low-dose 
dobutamine wIllIe worsening at peak-dose, possibly expressing right ventricular 
ischemia. This pattern resembles the biphasic pattern of myocardial viability 
reported in the literature. 
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Chapter 5-6: We demonstrated that during dobutamine infusion, an increase of 
myocardial systolic velocities by pulsed wave Doppler tissue sampling from rest 
to low-dose predicts myocardial viability more accurately than stress echo. 
Absolute systolic velocities at peak-dose test were similarly higher in viable than 
nonviable segments. We used as a reference standard for myocardial viability 
either traditional wall motion scoring by dobutamine stress echocardiography or 
99"'Technetium-tetrofosm in-1sF -fluorodeoxyglucose-single photon emission 
computed tomography (FOG-SPECT). 
Chapter 7: We were able to correlate successfully dobutamine stress 
echocardiography to FOG-SPECT to detect myocardial viability, thanks to an 
analogous scoring model for myocardial contraction, perfusion and membrane 
uptake. 
Chapter 8: We proved that a full dobutamine-atropine dose is safe, feasible and 
accurate for myocardial viability detection in patients with severe left ventricular 
dysfunction. 
Chapter 9: We found that ejection fraction increase at low-dose stress testing, 
with subsequent worsening at peak, quantitatively predicts functional recovelY, 
defined as functional recovery after coronary revascularization. Also in this case 
a biphasic pattern appears the best predictor of myocardial viability. Left 
ventricle functional improvement after revascularization is proportional to the 
degree of ejection fraction improvement at low-dose dobutamine and it is 
linearly related to the number of viable segments. 
Chapter 10: We succeeded in detecting a functional improvement of either left 
ventricular resting performance or stress-induced myocardial ischemia by 
performing dobutamine stress echocardiography immediately after percutaneous 
transluminal coronary angioplasty in cln'onic totally occluded coronmy arteries. 
Chapter 11: The absence of contractile reserve during low-dose dobutamine 
performed in end-stage renal failure patients before hemodialysis was able to 
predict hypotension occurring during hemodialysis. Therefore, the absence of 
left ventricular functional reserve, as induced by dobutamine, may playa critical 
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role in the phatophysiology of patients with end-stage renal failure and possibly 
stratifies a higher risk group. 
Future perspectives of quantitative assessment of ventricular function. 
At the present cardiac imaging is one of the fastest growing areas of cardiology 
and there is justification of the many efforts that are converging to develop new 
techniques for quantification of echocardiography. It is difficult at the present to 
predict which technological trend will ultimately prevail. Apart pulsed wave 
Doppler tissue sampling, many other noninvasive approaches are hying to 
extract quantitative functional informations from the myocardium, for example: 
acoustic quantification/color kinesis, anatomical M-mode, strain imaging, grey-
scale videodensitomelly, tracking of the specklc pattern, contrast 
echo cardiography, computerized tomography, positron emission tomography, 
magnetic resonance imaging, etc. It is out of thc goal of the present thesis to 
discuss each one of these new techniques. 
Conclusions. 
The present thesis is a demonstration that the old dream of quantifying 
ventricular function is feasiblc and probably close to be achieved in a near 
future. At least one (or more) of the many techniques presently under 
investigation will ultimately reach tltis goal. Among many new methods, we 
focused on pulsed wave Doppler tissue sampling as applied to dobutamine stress 
echocardiography, technique that is both relatively cheap and largely available. 
We considered also some new aspects of nuclear imaging, technique, which is 
sharing with echocardiography relatively large availability. We demonstrated 
that both echocardiography and nuclear imaging can be optilltized to study 
ventricular function by improving both the scoring model and by adding 
quantitative data. We selected pulsed wave Doppler tissue sampling because it is 
a velY simple technique, not sofware demanding, neither requiring complex 
modifications of the echocardiographic system. However, the application of 
color Doppler tissue imaging demands fulther sofware developments to be 
introduced in the clirtical arena and its clinical value must be validated versus 
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other quantitative approaches. If in the future an other quantitative technique 
will be available, we will recognize to Doppler tissue imaging the merit of 
having greatly contributed to the understanding of the pathophysiolgy of 
ventricular function in many different clinical settings. 
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SAMENVATTING EN CONCLUSIES 
De belangrijkste eonclusie van dit proefsehrift is dat een kwantitatieve 
eehoeardiografische analyse praktiseh uitvoerbaar is. Deze kwantitatieve analyse 
is beter dan de tot nu toe gebruikte subjeetieve analyse voor het opsporen van 
afwijkingen aan zowel de linker als reehter ventrikel. Dit onderzoek kan 
gebeuren zowel in rust als tijdens dobutamine belasting. 
De belangrijkste gegevens van het pl'Oefsc1n'ift worden in de volgende 
hoofdstukken bespl'Oken. 
Hoofdstuk 1: De variatie 111 interpretatie tussen beoordelaars van 
eehocardiografiseh onderzoek, door subjectieve interpretatie, kan worden 
verminderd Walmeer gebruik wordt gemaakt van kwalitatief goede eehobeelden 
en gestandaardiseerde richtlijnen voor het beoordelen van wandbewegingen. 
Hoofdstllkken 2 en 3: De variatie in interpretatie van cehocardiografisch 
onderzoek kan verder worden venninderd door gebruik te maken van een 
kwantitatieve meting. Hierbij wordt de snelheid van eontractie van de hartkamer 
gemetellll met behulp van de pulsed wave Doppler techniek en als een absoluut 
getal weergegeven. Deze snelheid wordt bepaald door haltspiervezels die zowel 
in de longihmale en cquitoriale vlak verlopen. Door de snelheid van eontractie in 
een bepaald gebied van de hart te bepalen tijdens verschillende stadia van 
"dobutamine stress echografie", kan de functie als een absolute waarde worden 
weergegeven. 
Hoofdstuk 4: Afwijkingen van contractie van de rechterkamer kUl1l1en met de 
zogenaamde pulsed wave Doppler sampling methode worden opgespoord. Een 
verminderde contractie snelheid is aanwezig bij patienten met een infarct van de 
reehterkamer. Ook kan ischemie van de rechterkamer worden vastgesteld met 
deze methode. Tijdens dobutamine stress echografie treedt tijdens een lage dosis 
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dobutallline cen snell ere contractie op van de ventrikelwand, in de aanwezigheid 
van corornair afwijkingell treedt tijdens hogere doseringen dobutamine zuurstof 
tekort op, zich uitend in een verlllinderde contractie snelheid. De aanvankelijke 
verbeterde contractie gevolgd door een verslechtering bij hogere belasting lijkt 
sterk op het bifasische wandbewegingspatroon wat gecorreleerd is aan 
myocardvitaliteit. 
Hoofdstukken 5 en 6: Dysfunctioneel maar vitaal myocard weefsel kan met 
behulp van eell dobutamine stress echografie test worden opgespoord. 
Segmenten vertonen een verbeterde contractie tijdens lage dosis dobutamine 
eventuweel gevolgd door eell verminderde contractie tijdens piek stress. De 
gevoeligheid voor het opsporen van vitaal hartspierweefsel is minder dan een 
nucleaire test. Wa1llleer cchter tijdens dobutamine stress echografie de contractie 
van wandbeweging in het basale gedcclte van het hart wordt gemeten mct de 
pulsed wave Doppler sampling methode verbeteti de gevoeligheid watllleer de 
nucleaire methode als "goudcn standaard" wordt beschouwd. 
Hoofdstuk 7: Vitaalmyocardspierweefsel kan worden aangetoond met nucleaire 
technieken, waarbij pcrfusie en metabolisme worden bepaald van de 
hartspiercel. Recent is aangetoond dat dobutamine stress echografie evencens 
vitaalmyocardspierweefsel kan aantonen. In een vergelijkend onderzoek waarbij 
beide testen werden uitgevoerd werd een hoge mate van overeenkomst tussen 
beide mcthoden gevonden niet belnvloed door de uitgang ejcctie fractie van de 
patient. 
Hoofdstuk 8: Dobutamine stress echocardiografie heeft verschillende 
bijwerkingen zoals hypotensie en ritme stoornissen. In een grote groep van 
patienten met een venuinderde linker ventrikel functie werd aangetoond dat ten 
opzichte van patienten met een "norlllale" ejectie fractie hypotensie significant 
vaker optreedt tijdens dobutamine stress echocardiografie. De bijwerking 
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herstelt snel na het stoppen van het onderzoek. Hartritmestoornissen treden in 
gelijke mate op ten opzichte van de "nol111ale" populatie. 
Hoofdstllk 9: De aanwezigheid van vitaal myocardspierweefsel kan worden 
aangetoond door een verbeterde contractie van dysfunctionele segmenten tijdcns 
lage dosis dobutamine. De ejectie fractie vertoond ook cen verbetering in de 
aanwezigheid van vitaal myocardspierweefsel. Wanneer patienten voor een 
coronair revascularizatie werden geevallleerd met behulp van linker ventrikel 
ejectie f1'actie dan bleek de toename van ejectie f1'actie tijdens lage dosis 
dobutamine en de verdere verslechtering tijdens piek stress de beste voorspelling 
te geven voor herstel van functie na revascularizatie. 
Hoofdstuk 10: Dobutal11ine stress echocardiografie kan worden gebruikt voor 
zowel het herstel van dysfunctionele segmenten als de aanwezigheid van 
ischemie tijdens dobutamine stress na een revascularizatie methode. Bij 
patienten behandeld door laeser therapie kan het herstcl van coronair 
doorgankelijkhcid worden geobjectiveerd. 
Hoofdstuk 11: Hypotensie treedt frequent op bij patienten met nierinsufficientie 
die behandeld worden door middel van hemodialyse. De oorzaak hiervoor is 
onbekend. In een studie werden patienten met en zonder dialyse gelnduceerde 
hypotensie vergeleken door l11iddel van dobutamine stress echocardiografie. 
Patienten met dialyse gelnduceerde hypotensie had den een venllinderde 
contractiele reserve tijdens lage dosis dobutamine. Deze contractiele reserve 
werd gemeten als een toename van het slagvolul11e. Tevells werd gevonden dat 
stress gelndllceerde ischemie evellveel voorkwam in beide groepen. 
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Toekomst yel'wachtingel1 yan kwantitatieye bepalil1gen yan yentrikel 
functic: 
In de huidige cardiologische praktijk neemt beeldYorming door echografie een 
steeds belangrijker plaats in. Verschillende technieken worden toegepast am de 
uitslag van het echo onderzoek te kwantificeren. Welke teclmiek uiteindelijk de 
beste zal zijn is moeilijk te yoorspellen. Naast pulsed wave Doppler sampling 
wordt gebruik gemaakt van acoustic quantification/colour kinesis, anatomic M-
mode, strain imaging, gray-scale videodensiometrie, tracking of the speckle 
pattem, contrast echocardiografie, computer tomografie, positron emissie 
tomografie, magnetische resonantie afbeelding, enz. Het valt buiten het kader 
van dit proefschrift om al deze yerschillende teclmieken te bespreken. 
Conclusies: Dit proefschrift toont aan dat het (bijna) mogelijk is de ventrikel 
functie kwantitatief te beoordelen. Dit proefschrift heeft zich yooral 
geconcentreerd op pulsed wave Doppler sampling tijdens dobutamine stress 
echocardiografie, een methode die wijdverspreid aanwezig is en niet duur. 
Teyens werden nieuwe ontwikkelingen van nucleaire geneeskunde besproken, 
die eYeneens op veel plaatsen aanwezig is. Beide methoden kunnen door een 
kwantitatieve beoordeling de ventriculaire functie nog beter beoordelen. De in 
dit proefscln'ift bescreven pulsed wave Doppler sampling methode is relatief 
simpel en maakt uitgebreide aanpassingen aan het echoapperaat niet no dig. De 
introductie yan colour Doppler weefsel afbeelding daarentegen zal eerst nog 
yerdere teclmische ontwikkelingen vergen en gevalideerd moeten worden in de 
praktijk. Indien pulsed wave Doppler sampling in de toekomst niet de methode 
van keus wordt heeft het weI bijgedragen aan de ontwikkeling en begrip over 
toepassingen en ontwikkelingen betreffende kwantificatie van ventrikel functie, 
dat voorheenniet mogelijk was. 
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